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Abstract 
 Vibrio cholerae, the causative agent of cholera, regulates expression of virulence factors 
such as the cholera toxin and the Toxin Co-regulated Pilus through the master virulence regulator 
ToxT. Transcriptional activation of toxT is in turn co-activated by the transmembrane winged 
helix-turn-helix (w-HTH) transcription factors ToxR and TcpP. ToxR is a fully functional 
transcriptional activator and is able to directly activate transcription of the outer membrane porin 
encoded by ompU. However, ToxR does not activate transcription of toxT directly, but instead 
assists TcpP-mediated activation of the toxT promoter. We have found, through mutational 
studies that ToxR binds the toxT promoter 3-helical turns upstream of the promoter proximal 
TcpP binding site. This is in contrast to the ToxR binding site on the ompU promoter, which is 
just upstream of the -35 element and in the opposite orientation. Additionally, different faces of 
the ToxR protein are preferentially required for co-activation of toxT as compared to direct 
activation of ompU. This highlights the different functions of ToxR as a co-activator and a direct 
activator. Although, w-HTH proteins often interact through the wing, the wing of ToxR is not 
required for ToxR interaction with TcpP. However, the wing of ToxR is required for binding to, 
and transcriptional activation of, both toxT and ompU promoters. Finally, we investigated the 
regulation of TcpP stability in transcriptional activation of toxT. Controlled proteolytic 
degradation of TcpP has been previously shown to downregulate activation of toxT under non-
inducing conditions. We have found that the periplasmic cysteines in TcpP form an 
intramolecular disulfide bond, and that this bond protects TcpP from proteolytic degradation, 
allowing TcpP to activate transcription of toxT. Similar periplasmic cysteine bonds are present in 
! $"""!
ToxR, however they are not critical for stability or transcriptional activation.  ToxR may co-
activate the toxT promoter by binding to, and altering the structure of, the toxT promoter thereby 
enhancing TcpP binding. Additionally, ToxR-TcpP interactions may help recruit TcpP to the 
promoter. Co-activation of toxT by ToxR and TcpP allows for integration of many environmental 







 The disease cholera is characterized by profuse watery diarrhea, which is often described 
as rice water diarrhea due to its appearance. The fluid loss due to cholera is so dramatic that it 
can result in severe dehydration and even death within 48 hours of onset of symptoms. Cholera is 
caused by ingestion of the gram-negative bacterium Vibrio cholerae, and subsequent 
colonization of the small intestine. The profuse watery diarrhea caused by V. cholerae is a result 
of secretion of the cholera toxin (CT), which induces elevated levels of cAMP resulting in rapid 
ion secretion into the lumen of the intestine, followed by water to balance osmolarity. The other 
major virulence factor is the toxin co-regulated pilus (TCP), which allows for microcolony 
formation and colonization of the intestine (2). Transcription of both of these virulence factors is 
controlled by the master virulence regulator ToxT (5). toxT expression, in turn, is co-regulated 
by the membrane-localized transcription factors ToxR and TcpP (6-8).  
 
Cholera as a driving force for microbiology, a historical perspective 
Cholera has been reported for centuries, with descriptions appearing in ancient Greek, 
Arabic, and Sanskrit writings dating back to 500 BC (10, 11). During this time period cholera 
was primarily a seasonal endemic disease, although this would change as global travel and trade 
routes expanded (11, 12). Beginning in the early 19th century, pandemics of cholera spread 
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throughout the world, decimating populations, inducing fear, and motivating microbiological and 
epidemiological research. From 1817-1823 the first cholera pandemic swept out of India along 
the trade routes. The second pandemic, from 1829-1851, spread even further decimating Russia, 
reaching the Americas by 1832, and leaving no continent, except Antarctica, untouched (11, 14).  
The first hint of a treatment for cholera was found during the 2nd pandemic when 
Scottish physician Latta had the idea of using intravenous (IV) fluids to restore the specific 
gravity of the blood. Due to problems with IV fluid administration and composition only 5 of the 
15 patients survived, and IV therapies wouldn’t be used again to treat cholera until the 1890s 
(11). Although Latta’s technique failed, his concept was sound, as today the amount of fluid 
administered is determined by the volume of fluid lost through diarrhea, thereby restoring the 
specific gravity of the blood. Although most cases of cholera are currently treated by oral 
rehydration therapy, in severe cases this may be insufficient and IV fluids are administered.  
In 1849, during the 2nd pandemic John Snow presented the idea that cholera could be 
transmitted through fecal contamination of the water supply, using one of the first applications of 
epidemiology to map out cases. Snow went so far as to remove the pump handle of a 
contaminated well in London, in order to prevent the spread of the disease. Although many 
people dismissed Snow’s hypothesis at the time, it proved true as improvements in sanitation of 
drinking water during the 5th and 6th pandemic helped to protect Europe and the United States 
from cholera. By 1926, improvements in sanitation worldwide led many to hope that there would 
be no subsequent cholera pandemics.  
It was during the 3rd pandemic from 1852-1859 that the bacterium was first observed and 
described by Filippo Pacini in Italy while examining the luminal contents of patients, although 
his findings were lost (11). During the 5th pandemic Koch re-discovered the bacterium V. 
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cholerae, and proved that it causes the disease cholera. Koch called for better understanding of 
the disease and the biology of the organism as a way to control outbreaks. Koch’s observations 
lead him to propose that the interaction of V. cholerae with the environment may be critical to 
understanding spread of the disease, a theory that still drives much of the research on cholera 
today.  
Despite improvements in sanitation and identification of V. cholerae and its major 
virulence factors, today we are in the midst of the 7th and 8th pandemics, resulting in endemic 
cholera in Asia, Africa, and parts of South America. The endemic cholera in these regions 
primarily affects children (<5 years) since infection does result in some protection from 
subsequent infections (17). Additionally, there are sporadic outbreaks among all age groups due 
to breakdowns in sanitation and/or introduction of the bacterium into non-endemic environments. 
A dramatic demonstration of this was the outbreak in Haiti following an earthquake in 2010 
which affected over 500,000 people and resulted in over 7,000 deaths (18). The 7th pandemic is 
caused by the El Tor strain, whereas the 5th and 6th pandemics, and likely previous pandemics, 
were caused by the classical strain (10, 11). Both the El Tor strain and the classical strain are 
serotype 01, which is the only serotype, aside from 0139, that has been shown to cause cholera 
epidemics despite approximately 200 serotypes present in the environment. Serotype 0139 is 
responsible for the 8th pandemic, likely as a genetic crossover event from an El Tor strain (10).  
 
Transition of V. cholerae from aquatic organism to pathogen 
 V. cholerae cycles between aquatic and host environments. Both V. cholerae pandemic 
strains as well as non-pandemic, non-toxigenic strains are found naturally in estuaries and other 
aquatic environments. V. cholerae survival is optimal in warm, slightly salty water, where it can 
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remain viable for at least 50 days (10). In freshwater, the lack of salt can be compensated for by 
increased organic nutrients and/or divalent cations. In non-optimal aquatic environments, V. 
cholerae enters a viable but non-culturable stage that maintains virulence if ingested (10). In 
aquatic environments, V. cholerae is primarily found on biofilms associated with chitinous 
organisms such as plankton and copepods (19). Copepods can be colonized by up to 104 V. 
cholerae cells, enough for an infectious dose (10). Since most V. cholerae are present in biofilms 
on these marine organisms, simply filtering them out with folded cloth can greatly reduce 
endemic cholera (20).  
Upon ingestion of the V. cholerae the bacterium travels to the small intestine where it 
colonizes. A relatively high infectious dose (104-1011 bacterium depending on the study) is 
required likely due to acid sensitivity during passage through the stomach (10, 19). Upon 
ingestion, TCP is expressed, allowing V. cholerae microcolonies to form and colonization to 
occur (2). Symptoms of cholera appear 12 to 27 hours after ingestion, although some people can 
be asymptomatic temporary carriers (17). During the height of infection, up to 1 L/hour of fluid 
can be lost, resulting in severe dehydration and even death if not treated (17). This rapid 
dehydration is due to production of CT, an AB toxin which binds to the GM1 ganglioside of 
intestinal epithelial cells. Upon entry into the intestinal epithelial cell, CT is activated inducing 
increased levels of cAMP. This results in increased secretion of sodium chloride and 
bicarbonate, which, due to osmotic pressure, results in secretion of water. Along with water and 
electrolytes, 1010-1012 V. cholerae per liter are shed in the characteristic rice water stool secreted 
during the height of infection, and bacteria can be shed for 1-2 weeks (17). In late stages of 
infection, changes in transcription, including down regulation of the ToxR regulon, and 
induction of flagella, Fur and c-di-GMP occur, preparing the bacterium to exit the host and 
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survive the environment (17, 21). The resulting V. cholerae released in the stool is hyper-
infectious, reducing the number of V. cholerae cells required for infection over 100-fold. This 
hyper-infectivity is due in part to a decrease in chemotaxis and increase in motility (22). Hyper-
infectivity lasts at least 5 hours in aquatic environments likely accelerating outbreaks in crowded 
regions with poor sanitation (22).  
There are few differences between the environmental strains of V. cholerae, which do not 
cause cholera, and the epidemic strains that do (23). Of the 200 serotypes only two, 01 and 0139 
have been shown to cause cholera, and in order to do so they must first acquire pathogenicity 
factors by phage and/or horizontal gene transfer. Toxigenic V. cholerae has a pathogenicity 
island (VPI-1), which is not prevalent in non-toxigenic non-O1/non-O139 strains (24). This 
pathogenicity island encodes toxT, the master virulence regulator. It also encodes genes required 
for TCP, which is required for microcolony formation and intestinal colonization (25). The TCP 
also acts as a CT phage (CTX!) receptor, allowing these bacteria to acquire the CT locus (26, 
27). One of the transcription factors required for toxT activation, TcpPH, is encoded on VPI-1, 
while the other, ToxRS, is not (24). ToxR is found in pandemic V. cholerae strains, as well as 
non-toxigenic strains, and other Vibrio species. In addition to co-activation of toxT, ToxR has the 
additional role of regulating expression of two outer membrane porins: ompU and ompT (28, 29).  
 
Environmental signaling and induction of the virulence cascade:  
Transition from the aquatic environment to the intestine is accompanied by dramatic 
shifts in salinity, temperature, nutrient availability, and other factors. These environmental 
stimuli feed into multiple steps in the activation cascade, resulting in ToxR and TcpP activation. 
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Fig 1.1 Virulence gene activation in V. cholerae. Environmental stimuli feed into the 
transcriptional activation cascade by activating transcription of tcpP, activating transcription of 
toxT, and regulating ToxT activity. Proteins in the activation cascade are designated by circles, 
and genes by rectangles. Direct activation of the virulence cascade is indicated by arrows, 
posited and unconfirmed activation pathways are designated with dashed arrows. Repression is 
designated by lines without arrowheads.  
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ToxR and TcpP, then activate toxT expression, which if the environmental conditions are correct, 
results in expression of TCP and CT (Fig 1-1). The ToxR regulon is often used to describe the 
transcriptional activation and repression cascades that occur as a result of activation of ToxR and 
TcpP. 
Virulence gene expression is tied closely to several endogenous systems in V. cholerae 
through quorum sensing. Cell density of V. cholerae and other gram-negative bacteria is 
monitored by two autoinducers, AI-1 and AI-2, which feed into the LuxO system (30). Quorum 
sensing induces expression of LuxO, which represses HapR (30)(Fig. 1-1). HapR is a repressor 
of AphA, the master quorum-sensing regulator at low cell density (30, 31). Additionally, cyclic 
di-GMP the secondary messenger that regulates biofilm production, links into the quorum 
sensing machinery in V. cholerae (Fig. 1-1). The exact role of cyclic di-GMP is unclear because 
it both increases expression of AphA and represses virulence gene expression (32, 33). However, 
most studies agree that cyclic di-GMP likely ties into the quorum sensing machinery through 
repression of HapR (32). In the absence of HapR, due to low cell density and high di-cyclic-
GMP levels, AphA is activated (33). AphA is a winged-helix transcription factor, which 
enhances activation of TcpPH expression by the LasR-type transcription factor AphB (34-
37)(Fig. 1-1). AphB is most active at low pH (34), and low oxygen levels (38, 39). Additionally, 
transcription of tcpP is induced by decreased temperature in vitro (37). In addition to AphA and 
AphB binding sites on the tcpP promoter, there is an overlapping catabolite repression protein 
(CRP) binding site, indicating that cAMP and CRP may down-regulate tcpP expression (40, 
41)(Fig 1-1). PhoBR is also able to bind to the tcpP promoter, thereby increasing expression in 
response to low phosphate levels (42). Although ToxRS has generally been believed to be 
constitutively expressed (43), expression of ToxR may also be activated by AphB (44). ToxR 
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and TcpP are co-transcribed with periplasmic co-activators designated ToxS and TcpH, 
respectively (6, 45-47). 
The activities of ToxR and TcpP are also regulated by environmental stimuli. ToxR 
transcriptional activation activity, and possibly toxR transcription, is induced in media that 
contains the amino acids asparagine, arginine, glutamic acid, and serine (NRES) (48, 49). It is 
also likely that central metabolism is linked into regulation of virulence gene activation through 
acetyl CoA and ToxR, however the mechanism behind this remains elusive (50). ToxR activity is 
often investigated by monitoring expression of ompU and ompT since ToxR directly regulates 
these promoters, while it is a co-activator of toxT. ToxR induces expression of ompU through 
direct activation of this locus (28). ToxR also represses expression of ompT, which is induced by 
iron utilizing the Fur system (29, 51). Bile can increase activity of ToxR as can be seen by an 
increase in ompU expression and a decrease in ompT expression (52). Because OmpT increases 
V. cholerae bile sensitivity, the presence of bile results in increased bile resistance by increasing 
ompU expression and ompT repression (53). TolC, an outer membrane protein, is required for 
repression of either TcpP or ToxR activity under non-inducing laboratory conditions such as 
minimal media lacking NRES or LB with additional salts (54). Additionally, FadD, a long-chain 
fatty acyl coenzyme A ligase, is required for proper localization of TcpP to the membrane, and 
therefore toxT activation (55). ToxS and TcpH are co-transcribed with ToxR and TcpP, 
respectively, and can influence the ability of ToxR and TcpP to activate transcription by 
promoting dimerization and enhancing stability (45, 47). 
Upon induction of TcpPH and ToxRS, these transcription factors bind to the toxT 
promoter, relieving repression by the histone-like nucleoid structuring protein H-NS, and 
activating toxT transcription (56). ToxT is bound to the lipid cis-palmitoleic acid when inactive, 
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indicating a critical role for bile in down regulating activity of this protein (57). Additionally, in 
classical strains, ToxT activity is higher at 30oC than 37oC indicating that activity of this protein 
is influenced by temperature (58). In both El Tor and classical strains the activity of ToxT is up-
regulated in the presence of sodium bicarbonate (59). Expression of toxT is further activated by 
induction of an autoactivation loop in which read-through transcription from ToxT activation of 
the TCP locus results in increased activation of toxT (60, 61). The genes for accessory 
colonization factors (acfA-D), which are required for colonization in the infant mouse model, are 
downstream of toxT and part of the ToxR regulon (61, 62). ToxT is generally referred to as the 
master virulence regulator because, once active, it is able to directly activate expression of the 
genes required for CT, TCP, and other virulence factors (5). CT production is repressed by H-NS 
binding overlapping the ToxT-binding site, and must be relieved in order for transcription of 
ctxAB (63, 64). Although ToxT is accepted as the primary transcriptional activator of ctxAB, 
ToxR is also able to activate this locus under certain conditions (8, 65, 66). 
One of the major environmental factors that V. cholerae encounters when it enters the 
small intestines is bile. Several studies have found that bile activates the virulence gene cascade, 
while others find bile has an inhibitory effect. Part of the reason for this may be due to the 
complex chemistry of bile. Bile contains conjugated acids, unconjugated acids, pigments, 
inorganic salts, cholesterol, and phospholipids (67). In classical strains grown under inducing 
conditions, addition of 0.2-0.4% bile reduced transcription of ctxAB resulting in a 97% decrease 
in CT secretion (68). A decrease in both CT and TCP expression in a strain containing plasmid-
expressed toxT was also observed indicating that ToxT activity is reduced in the presence of bile 
(58). Fractions of bile containing unsaturated fatty acids including arachindonic, linoleic, and 
oleic acids were also found to decrease CT expression (67). However, bile acids can up-regulate 
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ToxR activity, thereby possibly increasing expression of toxT (52, 69). Bile can also increase 
dimerization and therefore transcription activation activity of TcpP (70). It is likely that bile may 
increase or decrease virulence factor expression in V. cholerae depending on composition and 
concentration, allowing for differential expression of virulence gene depending on the location of 
the bacterium in the intestine. 
 In the laboratory, virulence gene expression in classical strains is induced by decreasing 
the temperature to 30oC and the pH of the media to 6.5. Although the laboratory conditions differ 
from the inducing conditions found in the intestines, it is understandable why they work. 
Decreasing the pH of the media would likely increase AphB activity and therefore transcription 
of TcpPH. Additionally, growth in LB media would provide the necessary NRES amino acids for 
full ToxR activity. This results in increased induction of toxT expression, which is compounded 
by the increase in ToxT activity at this lower temperature. To induce expression of virulence 
factors in El Tor strains, they must be grown in AKI conditions (71). Under AKI conditions, 
cultures are grown without aeration for 4 hours and then switched to aerated conditions. During 
the non-aerated growth period, oxygen levels are reduced, theoretically increasing AphB activity 
and therefore tcpPH expression. Differences in virulence gene induction between El Tor and 
classical strains has been linked to a single nucleotide differences in the tcpPH promoter, leading 
to differences in expression of tcpPH, resulting in these two strains responding differently to 
environmental stimulation (43, 72, 73).  
 
Structure and function of ToxR and TcpP: 
 ToxR and TcpP are both transmembrane proteins with cytoplasmic domains homologous 
to the winged helix-turn-helix (w-HTH) family of transcription factors. The majority of w-HTH 
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transcription factors are part of a two-component regulatory system in which phosphorylation of 
an N-terminal regulatory domain of the response regulator protein results in transcriptional 
activation by the w-HTH domain. ToxR and TcpP do not have an N-terminal regulatory domain, 
but instead have a C-terminal periplasmic domain, with no known homology. The periplasmic 
domain of TcpP regulates stability by interaction with TcpH. Upon switching to non-inducing 
conditions, TcpP is proteolytically degraded in a controlled stepwise fashion, starting with the 
periplasmic domain, resulting in down-regulation of virulence gene expression (47, 74). The 
periplasmic domain of ToxR is involved in dimerization, but it is not required for transcriptional 
activation. Truncations of ToxR containing only the cytoplasmic domain are able to activate 
transcription of ompU. Additionally, truncations of ToxR missing the periplasmic domain, but 
leaving the cytoplasmic and transmembrane domains intact are able to activate transcription of 
both ompU and toxT (75). Under certain conditions, ToxR is also able to directly activate 
expression of ctxAB, and this function is dependent upon the periplasmic domain (76). 
Additionally, replacement of the periplasmic domain with alkaline phosphatase, or other 
periplasmic proteins, does not dramatically reduce toxT activation, making its function unclear 
(8, 77, 78). Homology of the w-HTH domain allows us to extrapolate structural and 
functional information about ToxR and TcpP cytoplasmic domains based on studies of other w-
HTH proteins, particularly E. coli OmpR (Fig. 1-2A) and PhoB (Fig. 1-2B) which have been 
well characterized. Although, the overall homology of w-HTH proteins is low, 20-65%, many 
residues and the basic structure are conserved throughout this family (79). When residues of 
ToxR corresponding to conserved critical w-HTH residues were mutated, several of the resulting 
ToxR mutants were no longer able to bind DNA (Fig 1-2C). In particular, E39K, R56L/K, and 
R84K mutations disrupted DNA binding and transcriptional activation (13). These residues 
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Fig 1.2. Structural comparison of w-HTH family members. A) The different regions of the 
w-HTH domain including the N-terminal "-sheet (purple), the #-loop (green), the DNA 
binding helix (red), and the C-terminal wing (blue) are highlighted on the OmpR crystal 
structure (1). B) The w-HTH domain of PhoB is shown based on the NMR structure (3). 
Residues that make base-specific contact with DNA nucleotides based on the NMR and 
crystal structures of PhoB bound to DNA are highlighted in red (3, 4).  Models of the w-HTH 
domain of ToxR (C) and TcpP (D), based on homology with other w-HTH domains, were 
created using I-TASSER (9). C) ToxR residues that are conserved with OmpR/PhoB and 
required for DNA binding are shown in red (13). D) TcpP residues required for DNA (red) 
and DNA binding/ToxR-TcpP interaction (blue) highlight the role of the wing of TcpP in both 
ToxR-TcpP interaction and DNA binding (15, 16). E) Structural alignment of ToxR, TcpP, 
PhoB and OmpR was performed in Chimera.  
!
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correspond to PhoB residues that make contact with the DNA backbone (4). Two other residues 
tested that do not correspond to PhoB DNA binding residues, S55A/T and R65L were not 
required for promoter binding or transcriptional activation (13).  
The w-HTH domain is comprised of an N-terminal "-sheet, 3 #-helixes with a loop 
between #2 and #3, and a C-terminal wing comprised of a "-stranded hairpin (Fig 1-2A). The N-
terminal "-sheet is involved in maintaining the hydrophobic core as well as dimerization (4, 79-
81). This "-sheet may also interact with the N-terminal regulatory domain, thereby governing 
activity of the protein (4). The first and second #-helices are involved in proper positioning of the 
DNA binding helix (#3), which is critical both for proper folding of the protein and for DNA 
recognition (79). The third #-helix is the DNA-binding helix, which sits in the major groove of 
the DNA and interacts directly with the DNA bases, allowing for sequence recognition (3, 4). 
Between the second and third # helix is the #-loop. This #-loop sits to one side of the DNA and 
is proposed to interact directly with RNA polymerase (RNAP). The #-loop can activate 
transcription through interaction with a variety of RNAP subunits including PhoB interaction 
with $70 or OmpR interaction with #-CTD (79). The wing is the most C-terminal feature of the 
w-HTH domain. The wing inserts into the minor groove of the DNA, usually oriented towards 
the basal promoter element (3, 4). In addition to DNA binding, the wing can be involved in 
homodimerization of w-HTH domains (4). 
 DNA binding of w-HTH proteins is primarily mediated through the DNA-binding helix 
(#3) and the wing, although other regions of the protein also make contact with DNA. Multiple 
residues of the DNA-binding helix and wing of PhoB interact with the DNA backbone through 
hydrogen bonding, salt bridges, and Van der Waals interactions (3, 4). Additionally, residues in 
the #1 and #2 helixes and the #-loop interact with the DNA backbone, further stabilizing the 
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interaction between the protein and DNA (3, 4). Seven residues of the DNA-binding helix and 
five residues of the wing of PhoB make contact with the DNA. However, the majority of these 
contacts are with the backbone of DNA, and only 2-4 residues of the PhoB DNA binding helix 
and one to two residues of the wing interact directly with the bases (3, 4). Although the PhoB 
recognition sequence is 11 base pairs (bp), only three to four of these nucleotides are involved in 
base-specific contacts (3, 4), indicating that the positioning of the DNA-binding helix and the 
wing may provide additional sequence specificity. The wing of TcpP appears to be particularly 
critical for DNA binding, as mutations in several residues abolish DNA binding (Fig 1.2 D)(15, 
16). 
The dimerization of w-HTH proteins as well as the orientation of the wing relative to the 
DNA-binding helix results in a distinct DNA binding pattern. w-HTH proteins recognize binding 
sites consisting of two direct repeats of nucleotides oriented on the same face of the DNA helix. 
Between these conserved nucleotides is an A/T rich spacer that allows both recognition sites to 
sit on the same face of the DNA. For example, the TcpP-binding site consists of two TcpP-
binding boxes with the consensus sequence TGTAA separated by an A/T rich 6 nucleotide 
spacer (82). This A/T richness provides flexibility to the DNA to allow for insertion of the wing 
into the minor groove. Binding by a w-HTH protein can induce a bend into the DNA due to the 
structural constraints of inserting the DNA-binding helix and the wing into the major and minor 
grooves (4). There are often multiple sets of these binding sites on the promoter, allowing the w-
HTH transcription factors either work cooperatively or antagonistically. For example there are 3 
pairs of Pho boxes, which are recognized by PhoB in V. cholerae. When PhoB binds to the most 
promoter proximal and promoter distal binding sites transcription is activated. Whereas, binding 
of PhoB to the middle site is inhibitory (83). On the ompU promoter, ToxR has multiple binding 
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sites from -238 to -24, again demonstrating the cooperative nature of w-HTH proteins binding to 
the promoter (28). Cooperative binding between two different w-HTH transcription factors is 
required to activate the toxT promoter. On the toxT promoter, TcpP binds to a promoter proximal 
region from -53 to -38 relative to the transcription start site (82) and ToxR binds further 
upstream (from -100 to -68) (16), but binding of both transcription factors is required for full 
transcriptional activation (16). 
One important feature for activation of w-HTH proteins is dimerization. In w-HTH 
proteins with an N-terminal regulatory domain, such as OmpR and PhoB, the regulatory domain 
often initiates and regulates dimerization. In many cases, this domain may influence both 
whether dimerization occurs and the orientation of dimerization (84, 85). However, many w-
HTH domains can still dimerize strongly when the regulatory domain is deleted (4, 81, 86). The 
w-HTH domain of OmpR can also bind DNA as a monomer, and will subsequently dimerize 
weakly on the promoter in different orientations depending on the orientation of the recognition 
sequences (87). When w-HTH proteins are analyzed bound to DNA, they are commonly found in 
a head-to-tail orientation with the C-terminal wing of the promoter distal w-HTH domain 
interacting with the N-terminal "-sheet of the promoter proximal w-HTH. PhoB dimers 
crystallized on DNA are oriented in this head-to -tail fashion (4). Additionally, when orientation 
of OmpR on the promoter was analyzed by copper phenanthroline cleavage, OmpR appeared to 
be oriented in similar head-to-tail dimers on the promoter (88). However, crosslinking studies 
indicate that w-HTH proteins can also form functional head-to-head dimers with the dimerization 
interface along the N-terminal "-sheets. Crosslinking between several residues in the N-terminal 
"-sheet of OmpR was enhanced in the presence of DNA, and the resulting dimer was able to 
activate transcription indicating that this head-to-head orientation is functional (81). In 
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Mycobacterium tuberculosis, PhoP has its greatest DNA-binding affinity when the proteins are 
dimerized such that the N-terminal "-sheets of the w-HTH domain interact in a head-to-head 
mechanism despite binding to a direct repeat (86). It is also possible for w-HTH proteins to 
dimerize through their C-terminal wings orienting the dimeric w-HTH proteins tail-to-tail, 
although this mechanism appears to be less common. HSF, from the yeast Kluyveromyces lactis, 
appears to function in a novel mechanism in which the C-terminal wing does not participate in 
DNA binding, but instead is involved in dimerization in a tail-to-tail orientation (89). 
Dimerization, although critical for activity of many w-HTH proteins, may be dependent on a 
variety of factors including, but not limited to, binding site orientation, mediation by regulatory 
domains, and the structure of the w-HTH domain. Interaction of ToxR and TcpP as both 
heterodimers and homodimers has been observed and is likely important for activity (15, 90), but 
the orientation of these dimers and the interaction faces involved is still unknown.  
Neither ToxR nor TcpP have the N-terminal regulatory domain, which can regulate 
dimerization, but they still interact (15). Evidence that ToxR acts as a dimer comes from the 
demonstration that ToxR can dimerize the N-terminal DNA-binding domain of %-repressor (90). 
The periplasmic domain, in conjunction with ToxS enhances dimerization of the w-HTH domain 
(45). ToxR activity and dimerization is maintained when the periplasmic C-terminus is replaced 
with a dimeric protein such as PhoA (77, 91). In some systems replacement of the periplasmic 
domain with a monomeric protein (MalE or Bla) does not reduce activity or dimerization of 
ToxR (77, 78). Based on this evidence it is believed that ToxR operates as a dimer and the 
periplasmic domain enhances, but is not required for, dimerization. Dimerization of ToxR is so 
robust that it can be used to test dimerization of other proteins (92). ToxR and TcpP also have 
been shown to interact by crosslinking (15) indicating that ToxR and TcpP form either 
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heterodimers or oligomers. Residues in the wing of TcpP are particularly critical for ToxR-TcpP 
interaction (15) indicating that ToxR and TcpP likely interact either in a head-to-tail orientation 
(like PhoB) or a tail-to-tail orientation (like HSF). 
 
Models of transcriptional activation of toxT: 
 Although, both ToxR and TcpP can function as direct activators of transcription, ToxR is 
believed to play a co-activation role on the toxT promoter, assisting in toxT transcriptional 
activation by TcpP. The location of the TcpP binding site at -53 to -38 indicates it is likely the 
transcription factor that interacts with RNAP and the direct activator of toxT transcription (16, 
82). Additionally, when TcpP is overexpressed from a plasmid, it is able to activate transcription 
of the toxT promoter in the absence of ToxR (6, 15). ToxR alone is unable to activate expression 
of toxT, even when overexpressed, despite being able to bind to the promoter in the absence of 
TcpP (5, 16). Because TcpP binds weakly to the toxT promoter, it has been hypothesized that 
ToxR acts as a co-activator by enhancing TcpP recruitment to the promoter via ToxR-TcpP 
protein-protein interaction.  
One model for ToxR co-activation of toxT is the “hand-holding” model (Fig 1-3A). In 
this model ToxR and TcpP interact on the promoter, stabilizing the complex on the DNA. The 
main evidence for this model is that ToxR and TcpP interact, and that this interaction can 
compensate for TcpP DNA binding defects. Specifically, a TcpP mutant, TcpP-H93L, in the 
wing of TcpP, results in no significant defect in ToxR-TcpP interaction, but a severe defect in 
DNA binding (15, 16). Over-expressed TcpP-H93L is no longer able to activate toxT 
transcription in the absence of ToxR, However, the presence of ToxR rescues this mutant, 
returning toxT activation to around 60% of wild-type (16). Several other mutations in the wing of 
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Fig 1.3. Models of ToxR co-activation of toxT. A) “Hand-holding model” in which ToxR-
TcpP interaction holds TcpP in position on the toxT promoter allowing for transcriptional 
activation. B) “Catch and release model” in which ToxR-TcpP interaction recruits TcpP to the 
promoter, but upon DNA binding by ToxR, TcpP is released, allowing ToxR and TcpP bind 
to the promoter independently and at a distance from eachother. C) “Promoter modification 
model” in which ToxR enhances TcpP binding to the toxT promoter through relieving H-NS 
repression, bending the DNA to make the TcpP binding site more accessible, and bringing the 
toxT promoter to the membrane. In this model transcriptional activation of toxT is 
independent of ToxR-TcpP interaction. 
!
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TcpP resulted in a defect in both DNA binding and ToxR-TcpP interaction. None of these 
mutants were able to activate toxT transcription, even in the presence of ToxR, indicating a role 
for ToxR-TcpP interaction in rescuing TcpP DNA-binding mutants (15). If ToxR-TcpP 
interaction is critical for ToxR co-activation of toxT, a system can be envisioned where ToxR 
binds strongly to the toxT promoter, and due to the ToxR-TcpP interaction, ToxR brings TcpP to 
the promoter as well. An additional non-canonical ToxR-binding site is found between the ToxR 
and TcpP binding sites, indicating a possible ToxR-binding site directly adjacent to the TcpP 
binding site (16). Due to the strong interactions between ToxR and the promoter and ToxR and 
TcpP, TcpP is held in place on the promoter allowing for transcriptional activation. 
A second model for ToxR dependent co-activation of the toxT promoter is the “catch and 
release” model (Fig 1-3B). This model, like the previous model, is dependent on ToxR-TcpP 
interaction to recruit TcpP to the promoter. However, in this model the ToxR-TcpP interaction is 
released upon DNA binding allowing ToxR and TcpP to bind to the promoter independently. 
One of the rationales behind this model is the potential involvement of the wing of ToxR and 
TcpP both in protein-protein interaction and DNA binding (15, 16, 45). Several residues in the 
wing of TcpP have been shown to be critical for both ToxR-TcpP interaction and DNA binding 
(15, 16), possibly indicating that ToxR-TcpP interaction and DNA binding do not occur 
simultaneously. Additionally, this model allows for more flexibility in the spacing of the ToxR 
and TcpP binding sites on the promoter since DNA footprinting analysis indicates that there is a 
space between the ToxR and TcpP binding sites (16). The “catch and release” model therefore 
combines the ability of ToxR-TcpP interaction to compensate for TcpP binding defects with the 
idea that the wing plays dual roles in DNA binding and transcriptional activation and the 
possibility that ToxR and TcpP are not directly adjacent to each other on the toxT promoter. 
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The third model for ToxR dependent co-activation is the “promoter alteration” model 
(Fig 1.3 C), which encompasses several mechanisms. In this model ToxR-TcpP interaction is not 
required for toxT activation; instead, the role of ToxR is to enhance TcpP binding to the 
promoter through changes in the promoter architecture. One way that ToxR may enhance TcpP 
binding is by relieving H-NS repression. H-NS binds to the toxT promoter and represses 
transcriptional activation (56, 63). In the absence of H-NS, endogenous TcpP is able to enhance 
transcriptional activation of toxT, even in the absence of ToxR (56). However, the presence of 
ToxR in the &hns strain further increases toxT expression, indicating that ToxR likely aids in 
activation in additional ways. A second way that ToxR could enhance activation is by bringing 
the promoter to the plasma membrane. ToxR membrane localization is required for 
transcriptional co-activation of toxT, but not for direct activation of ompU (75). One explanation 
for this it is that ToxR binds to the promoter, bringing it to the membrane, where TcpP is then 
able to bind. A third mechanism of ToxR-mediated promoter alteration that facilitates toxT 
activation is that when ToxR binds to the toxT promoter, it bends the DNA, making the TcpP 
binding site more accessible. w-HTH proteins often bend the promoter upon binding (4, 93). 
Furthermore, based on footprinting analysis, upon ToxR binding to the toxT promoter, a 
hypersensitivity site is exposed at the TcpP-binding site (16, 82). This hypersensitivity site 
indicates that the TcpP-binding site is more accessible when ToxR is bound to the promoter, 
presumably due to DNA bending. Together, these findings indicate that ToxR may prepare the 
toxT promoter in multiple ways, thereby enhancing TcpP-mediated activation of toxT 
transcription.  
The main goal of my research is to expand our understanding of how toxT expression is 
co-activated by ToxR and TcpP. By testing these models, we can determine what the role of 
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protein-protein interactions has on toxT transcriptional activation and use this information to 
determine which of the 3 models best describes the system. It is also possible that ToxR co-
activation of toxT is achieved by a combination of the “promoter alteration” model and either the 
“hand-holding” or the “catch and release” models. To address these models I will investigate the 
location of ToxR binding sites on the toxT promoter in order to better understand how ToxR 
binds to the promoter relative to TcpP. Additionally, I will examine critical residues in ToxR in 
order to better define the regions of ToxR required for direct activation (as with ompU) vs. co-
activation (as with toxT) and how these residues affect DNA binding, transcriptional activation, 
and protein-protein interactions. As well as helping to understand how virulence factor 
production is induced in V. cholerae, this research may also provide insight into how w-HTH 
proteins cooperate to activate transcription in a variety of systems.  
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ToxR facilitates TcpP-mediated activation of the toxT promoter in Vibrio cholerae, initiating a 
regulatory cascade that culminates in cholera toxin secretion and toxin co-regulated pilus 
expression. ToxR binds a region from -104 to -68 of the toxT promoter, from which ToxR 
recruits TcpP to the TcpP-binding site from -53 to -38. To precisely define the ToxR-binding site 
within the toxT promoter, promoter derivatives with single base pair transversions spanning the 
ToxR-footprinted region were tested for transcription activation and DNA binding. Nine 
transversions between -96 to -83, reduced toxT promoter activity three-fold or greater, and all 
nine reduced the relative affinity of the toxT promoter for ToxR at least two-fold, indicating 
activation defects were largely due to reduced binding of ToxR to the toxT promoter. 
Nucleotides important for ToxR-dependent toxT activation revealed a consensus sequence of 
TNAAA-N5-TNAAA extending from -96 to -83, also present in other ToxR-regulated 
promoters. When these consensus nucleotides were mutated in the ompU, ompT or ctxA 
promoters, ToxR-mediated regulation was disrupted. Thus, we have defined the core ToxR-
binding site present in numerous ToxR-dependent promoters and we have precisely mapped the 
binding site for ToxR to a position three helical turns upstream of TcpP in the toxT promoter. 
 
Introduction 
The gastrointestinal disease cholera is primarily due to the secretion of cholera toxin (CT) by 
ingested Vibrio cholerae and is facilitated by TCP (the toxin co-regulated pilus)(10). The 
expression of CT and TCP, encoded by the ctx and tcp operons, are both positively and 
negatively regulated at the transcriptional level. Positive regulation of ctx and tcp requires ToxT 
(9, 11), the expression of which is initiated by the combined actions of ToxR and TcpP at the 
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toxT promoter (3, 4, 12, 13). While toxR expression is generally considered to be constitutive, 
tcpP expression is regulated by AphA, AphB, CRP and HapR according to environmental 
conditions (15-20). Moreover, TcpP is degraded under non-inducing conditions (23, 24). Thus, 
positive regulation of the transcription cascade culminating in CT secretion and TCP production 
is mediated by the sensing and integration of environmental signals by AphA, AphB and CRP at 
the tcpPH promoter and possible additional signals sensed by ToxR/ToxS and TcpP/TcpH. 
Furthermore, activity of the downstream regulator, ToxT, responds to the presence of bile and 
bicarbonate (25, 26) and ToxT itself is degraded in order to shut down virulence gene expression 
under non-inducing conditions (27). Negative regulation of CT and TCP expression is mediated 
by H-NS, which binds and represses the activities of the ctxAB, tcpA and toxT promoters (2, 28), 
and by the CRP-cAMP complex, which plays a role in HapR activation. HapR in turn represses 
aphA and tcpPH expression (18-20, 29).  
TcpP and ToxR are inner membrane proteins with C-terminal periplasmic domains lacking 
homology to other proteins and N-terminal cytoplasmic domains with strong homology to the 
OmpR/PhoB family of winged helix-turn-helix transcriptional activators (31). The DNA-binding 
domains of OmpR/PhoB family proteins generally interact as dimers with direct repeat DNA 
sequences (32, 33), suggesting these domains dimerize in a head to tail configuration. We have 
recently shown TcpP also binds an RNA polymerase-proximal direct repeat element from -53 to 
-38 on the toxT promoter (8). However, the specific ToxR-binding site is undefined. 
toxT expression requires that membrane-localized ToxR be co-expressed with TcpP (4, 12, 
13, 21, 36), and we hypothesize that ToxR recruits TcpP to what appears to be a weak TcpP-
binding site (relative to ToxR binding affinity, (4, 37)). Once recruited to the toxT promoter, 
TcpP activates toxT transcription (7). The ability of ToxR to facilitate TcpP-mediated toxT 
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activation requires that ToxR bind a poorly defined DNA-binding site containing sequences from 
an inverted repeat element that lies upstream of the TcpP-binding site (Fig. 2-1A, (3, 4)). ToxR-
dependent recruitment of TcpP to the promoter may increase the local concentration of TcpP, 
facilitating TcpP binding to its weak binding site. This could occur while maintaining a 
ToxR/TcpP interaction, or ToxR may release TcpP upon DNA binding to allow TcpP to bind its 
adjacent binding site. Finally, it is possible that although ToxR and TcpP can establish a protein-
protein interaction (7, 37), the main role of ToxR is to simply recruit the toxT promoter to the 
membrane where membrane-localized TcpP has easier access to its toxT promoter-binding site. 
Although there are a large number of genes comprising the ToxR regulon (39), only a select 
few are known to be directly regulated by ToxR. In addition to facilitating the TcpP-dependent 
activation of the toxT promoter, ToxR directly activates the ompU promoter and represses the 
ompT promoter (35, 38). Furthermore, when overexpressed, ToxR can directly activate the ctxA 
promoter (40)), although under physiological conditions the ctxA promoter is activated by ToxT 
(6, 9, 11, 28, 41). The binding sites for ToxR at the ompU, ompT, ctxA and toxT promoters have 
been defined by DNAse I footprinting (4, 35, 38), however comparisons of these footprinted 
regions has not identified a clear consensus ToxR-binding sequence found at all ToxR-
footprinted promoters.  
At the toxT promoter, the ToxR footprint spans the region from -104 to -68, partially 
overlapping an inverted repeat sequence (Fig. 2-1A, black arrows, (3) (4)). Plasmid-born lacZ 
fusion and mobility shift studies using toxT promoter deletion derivatives indicate that at least 
some sequences important for ToxR-binding and ToxR-dependent promoter activation lie 
between –114 and –73 (3). Subsequently, a screen for toxT promoter mutants defective in ToxR-
dependent activation identified single nucleotide substitutions in the toxT promoter at positions  
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–86 and –84 in the upstream half of the inverted repeat sequence that reduced both ToxR-
dependent promoter activation and the affinity of the toxT promoter for ToxR (3). Moreover, 
substitutions at positions -67 and -65 within the downstream half of the inverted repeat that are 
complementary to the -86 and -84 substitutions in the upstream half of the inverted repeat had 
little affect on ToxR-dependent fusion activity (3). These results suggest that the inverted repeat 
sequence does not represent a symmetrical binding site for ToxR at the toxT promoter. Thus, 
some other sequence motif containing nucleotides -86 and -84 is likely to strongly influence 
ToxR binding or ToxR-dependent recruitment of TcpP to the toxT promoter.  
In this report, systematic transversion mutagenesis of the ToxR-footprinted region of the toxT 
promoter was used to identify nucleotides that were critical for promoter activation. These 
studies defined the sequence TNAAA-N5-TNAAA from -96 to -83 as the ToxR-binding site in 
the toxT promoter. Transversions altering these critical nucleotides reduced the affinity of the 
promoter for ToxR and defined a minimal region of the toxT promoter that was essential for 
ToxR-dependent toxT activation. Furthermore, mutation of this repeat element in the ompU, 
ompT and ctxA promoters resulted in loss of ToxR-responsiveness by those promoters as well. 
 
Results 
Specific mutations in the ToxR-binding region of toxT disrupt ToxR-dependent promoter 
activation. The ToxR-binding site within the toxT promoter has been defined previously by 
DNAse I footprinting analysis as extending from -104 to -68 (4), however the specific 
nucleotides within the ToxR-protected region important for toxT activation have not been 
systematically determined. To identify these nucleotides, a collection of toxT promoter 




Figure 2-1. DNA sequence of the V. cholerae classical strain O395 promoter-proximal 
region of the toxT promoter and ToxR-dependent activation of single base pair 
substitutions. (A) Nucleotides are numbered relative to the toxT transcription start site (3). The 
region of ToxR-dependent DNAse I protection is indicated above the DNA sequence (4). The 
solid gray arrows above the sequence indicated the position of the 5’-TNAAA-N5-TNAAA-3’ 
direct repeat motif important for ToxR binding. An inverted repeat sequence (3, 5) is indicated 
by the black convergent arrows between -93 and -58. A promoter-proximal degenerate ToxR-
binding site is indicated by dashed gray arrows from -69 to -56. The boxed nucleotides indicate 
the pentameric direct repeat motif recognized by TcpP (8). Single nucleotide substitutions 
generated within the toxT promoter region from –100 to -57 are indicated on the bottom line in 
italics. (B) Effects of ToxR-binding site mutations on toxT-lacZ activity in wild-type V. cholerae 
strain O395. Strains carrying a plasmid-born wild type toxT-lacZ fusion (-172 to +45), single 
base pair substitution toxT promoter mutants, promoter deletion derivatives, or empty vector 
(promoterless lacZ vector, pTG24) were assessed for !-galactosidase activity. The positions of 
substitutions and endpoints are indicated relative to the toxT transcription start site. Error bars 
represent the standard deviation for each data set. * p< 0.005 as assessed using the students' t-
test, n=6 or more measurements. 
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(Fig. 2-1A). Transversions were generated using the toxT promoter region from -172 to +45 
fused to a promoterless lacZ reporter gene (8, 34). In O395 (V. cholerae classical strain), 13 
transversions reduced toxT promoter activity greater than two-fold, and 12 of 13 mutations affect 
nucleotides in the region from -97 to -82 (Fig. 2-1B). Likewise, a previously identified A[–84]T 
substitution (42) also dramatically reduced fusion activity (Fig. 2-1B). Of the transversions in the 
region from –81 to –57, only that at A(-74)C reduced the activity of the fusion greater than 
twofold (Fig. 2-1B). Thus, nucleotides important for toxT-lacZ fusion activity were clustered 
within the promoter-distal portion of the ToxR-footprinted region while nucleotides in the 
promoter-proximal portion of the footprint contribute little to promoter activity. 
Transversions that reduced toxT promoter activity most dramatically identified the nucleotide 
sequence 5’-CTNAAAAAANNTNAAA-3’ (-97 to -82) as critical for ToxR-dependent toxT 
activation. Within this sequence is a direct repeat motif of (5’-TNAAA-N5-TNAAA-3’) 
composed of two half-sites that are centered one turn of the DNA helix apart. These features are 
consistent with the notion that two ToxR monomers bind in a head to tail configuration to two 
5’-TNAAA-3’ half-sites. Thus, the motif 5’-TNAAA-N5-TNAAA- may represent a minimally 
defined ToxR-binding site.  
 
toxT promoter transversion mutations do not affect ToxR-independent toxT activation by 
overexpressed TcpP. To rule out the possibility that transversion-dependent changes in toxT 
expression are due to defects in TcpP interaction with the toxT promoter, the wild type toxT-lacZ 
fusion and mutant derivatives in the region from -100 to -80 were moved into an O395 
!toxR!tcpP/pEK41 background (EK459/pEK41) to assess the effects on ToxR-independent toxT 
activation in response to TcpP overexpression (pEK41 encodes an HSV epitope-tagged version 
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of TcpP in vector pMMB207, (4)). Previous studies have shown overexpressed TcpP can 
efficiently activate the toxT promoter, even in the absence of ToxR (4, 12).  
In the EK459/pEK41 background, all 22 transversion mutants tested had less than a 30% 
decrease in TcpP-mediated toxT activation (Fig. 2-2A, black bars). More importantly, none of 
the tranversions in the TNAAA-N5-TNAAA putative ToxR-binding site had more than a 20% 
decrease in toxT activation (Fig. 2-2A). Thus, the effects of these promoter mutations on toxT 
activation are most likely due to defects in ToxR-dependent toxT activation.  
Consistent with the interpretation that the TNAAA-N5-TNAAA direct repeat element 
responds to ToxR, introduction of the toxT promoter mutants into a wild type O395 strain 
(ToxR+) overexpressing TcpP (+pEK41) results in a strain with 50% higher levels of "-
galactosidase expression (~30,000 Miller units, Fig. 2-2B), but this level drops to the level of 
activation mediated by overexpressed TcpP alone, when mutations in the TNAAA-N5-TNAAA 
repeat element are encountered (Fig. 2-2B). Thus, the maximal level of toxT activation afforded 
by ToxR and overexpressed TcpP are not achieved when the ToxR-binding site is mutated.  
In an EK459/pMMB207 background (O395 !toxR!tcpP + empty vector), the transversions 
did not dramatically alter the basal activity of the toxT-lacZ fusion (Fig. 2-2A, white bars).  
 
Mutations in the putative ToxR binding-site of toxT disrupt ToxR/toxT interactions. To 
determine whether mutations in the TNAAA-N5-TNAAA putative ToxR-binding site disrupt 
ToxR binding to the toxT promoter, electrophoretic mobility shift assays were performed. 32P-
labeled toxT promoter targets were mixed with increasing concentrations of ToxR-containing V. 






Figure 2-2. ToxR-binding site mutations do not affect toxT activation by overexpressed 
TcpP. (A) toxT-lacZ fusions with toxT promoter transversions from -100 to -80 were tested in a 
strain lacking ToxR (EK459 = O395 !toxR!tcpP), but overexpressing TcpP from plasmid 
pEK41. Strains were grown for 4 hrs at 30° pH=6.5 in the presence of 1 mM IPTG and "-
galactosidase activities were determined for strains carrying either a promoterless lacZ fusion 
vector (vector), or its derivatives carrying either the wild type toxT-lacZ fusion (wt) or single 
base pair substitutions. Black bars represent a !toxR!tcpP background carrying the TcpP 
overexpression plasmid, pEK41. White bars represent a !toxR!tcpP background carrying the 
empty vector expression plasmid, pMMB207. (B) Enhanced activation by co-expression of 
ToxR and overexpressed TcpP is lost when mutations in the ToxR-binding site are present. toxT-
lacZ activation was measured in the !toxR!tcpP strain EK459 harboring the TcpP-expressing 
vector pEK41 (black bars, same data as in Fig. 2-2A) or wild-type O395 (ToxR+) harboring 
pEK41 (gray bars). Error bars represent the standard deviation. * p<0.05, ToxR+ strains are 
significantly higher than ToxR- strains. # p< 0.0001, the ToxR+ strain is significantly lower than 
the ToxR- strain. All assessed using the students' t-test. n=6 or more measurements. 
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In the presence of 0.77 mg/ml ToxR-containing membranes, approximately half of the input 
wild-type toxT promoter probe was shifted (Fig. 2-3, Panel D, lanes 1 and 25), while probes 
bearing mutations in the putative ToxR-binding site (TNAAA-N5-TNAAA, from -96 to -83) 
were shifted with 10-30% efficiency (Fig. 2-3, Panel D, lanes 2 to 23). Thus, mutation of the 
putative ToxR-binding site led to a defect in ToxR binding, confirming the identity of the ToxR-
binding site. Experiments with increasing concentrations of ToxR-containing membranes (Fig. 2-
3, Panels B to H) were used to determine the concentration leading to an ~50% shift for each 
toxT promoter mutant probe (Table 2-1 and Fig. 2-3). toxT promoter probes bearing 
transversions in the ToxR-binding site, required two to five-fold more ToxR protein to reach 
50% shifting (Table 2-1). Comparison of transversion-dependent effects on relative affinity and 
toxT-lacZ fusion activation indicates that reductions in relative affinity correlate well with 
reductions in promoter activation. The fact that the C(-95)A mutation at the N position of 
TNAAA consensus, had no significant defect in transcription (Fig. 2-1B) or ToxR binding 
(Table 2-1, Fig. 2-3), supports the conclusion that this nucleotide position is not recognized by 
ToxR.   
Finally, further evidence that the TNAAA-N5-TNAAA sequence from -96 to -82 represents 
the ToxR-binding site within the toxT promoter is that a double-stranded oligonucleotide from 
that region can compete with the full-length toxT promoter for ToxR-mediated gel shifting 
activity and mutations within the TNAAA-N5-TNAAA consensus binding site within these 
oligonucleotides disrupts inhibition activity (data not shown). 
In the presence of 4.4 mg/ml negative control membranes (lacking ToxR), less than 50% of 
the target promoters were shifted (Fig. 2-4), while a few targets shifted greater than 50% in the 
presence of 5.6 mg/ml negative control membranes (Fig. 2-3, panel I, Fig. 2-4), indicating that at 
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Figure 2-3. Mutations in the putative ToxR-binding site disrupt ToxR binding to the toxT 
promoter. For toxT promoter electrophoretic mobility shift assays, the 32P-end-labeled toxT 
promoter targets used for most panels carry the wild type promoter (-172 to +45, lanes 1 and 25), 
single-transversion derivatives with mutations at positions -100 to -80 (lanes 2 to 22, 
respectively), -60 (lane 24), the A[–84]T substitution (lane 23) or the -100 to +45 deletion 
derivative (lane 26) are indicated at the top of the figure. For lanes 1 to 26, the DNA-binding 
solutions containing end-labeled DNA targets were mixed with membrane buffer only (Panel A), 
ToxR-containing membranes at either 0.29 mg/ml (Panel B), 0.58 mg/ml (Panel C), 0.77 mg/ml 
(Panel D), 1.2 mg/ml (Panel E), 2.3 mg/ml (Panel F), 4.6 mg/ml (Panel G), 9.3 mg/ml (Panel H) 
or the negative control ToxR-negative membrane preparation at 5.6 mg/ml (Panel I) as indicated 
on the right side of the figure. The positions of free and shifted end-labeled DNA target 
migration through the gel are indicated on the left side of the figure. DNA bound by membrane-
localized ToxR is retained in the well of the gel. The % shifted values given below the free target 
band for each sample indicate the percentage of shifted signal, relative to the sum of free and 
shifted signals, as quantified by densitometry. 
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Figure 2-4: Assessment of 50% gel shifting activity of various toxT promoter mutants. The 
% of target shifted, as presented in Fig. 2-3, was plotted as a function of ToxR+ (TG129) 
membrane protein concentration. The binding curves were used to determine the concentrations 
of ToxR-containing membrane required for a 50% shift of each target. Data are split between 
two different binding curves for clarity, as having too many overlapping binding curves obscured 
the data.  
 
 42 
Table 2-1. Relative affinities of toxT promoter mutants for membranes containing (ToxR+) 
or lacking (ToxR-) ToxR. 




ToxR+ ToxR–  
wild type (wt) 
(-172 to +45) 
0.76 > 5.6 1.0 
T[-100]G 0.57 > 5.6 0.8 
A[-99]C 0.96 > 5.6 1.3 
T[-98]G 0.74 > 4.2 1.0 
C[-97]A 0.99 > 5.6 1.3 
T[-96]G 1.55 > 5.6 2.0 
C[–95]A 0.44 > 5.6 0.6 
A[-94]C 2.01 > 5.6 2.6 
A[-93]C 2.33 > 5.6 3.1 
A[-92]C 2.02 > 5.6 2.7 
A[-91]C 2.12 > 5.6 2.8 
A[-90]C 1.83 > 5.6 2.4 
A[-89]C 1.48 > 5.6 1.9 
C[-88]A 0.77 > 4.2 1.0 
A[-87]C 0.74 > 5.6 1.0 
T[-86]G 3.42 > 5.6 4.5 
A[-85]C 1.23 > 5.6 1.6 
A[-84]C 4.12 > 5.6 5.4 
A[-83]C 1.98 > 5.6 2.6 
A[-82]C 1.39 > 5.6 1.8 
T[-81]G 0.67 > 4.2 0.9 
A[-80]C 0.74 > 4.2 1.0 
T[-60]G 0.83 > 5.6 1.1 
A[-84]T 2.39 > 4.2 3.1 
toxT -100 to +45 0.74 > 5.6 1.0 
a Numbers represent the position of the promoter mutation or the endpoints of deletions, relative 
to the toxT transcription start site. Italicized and bold nucleotides indicate the position of the 
ToxR-binding site direct repeat TNAAA-N5-TNAAA (-96 to -82). 
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high membrane concentrations, one begins to detect increased background binding to toxT 
promoter probes. 
 
The region from -82 to -68 of the toxT promoter, while containing a partially-conserved 
ToxR binding site, does not contribute to toxT activation. Now that we had identified the 
ToxR-binding site in the toxT promoter, we recognized that the toxT promoter also contains an 
imperfect ToxR-binding site (ANAAA-N4-TNAAG) from -56 to -69 on the opposite strand from 
our recently defined ToxR-binding site (from -96 to -83). Thus, we sought to determine whether 
this imperfect ToxR binding site (Fig. 2-1A, dashed gray arrow) supported any detectable ToxR 
binding or ToxR-dependent toxT activation.  
In O395, the activity of the wild type fusion was not altered by deletion of toxT promoter 
sequences upstream of -100 (Fig. 2-1B), indicating that the region from -172 to -101 does not 
significantly contribute to toxT promoter activation. In contrast, the deletions removing 
sequences upstream of -81 (or -47) reduced fusion activity by about ten-fold (Fig. 2-11B), 
indicating that the region from -100 to -82 strongly contributes to toxT promoter activity, as 
expected since this region contains the ToxR-binding site TNAAA-N5-TNAAA. Previous studies 
by Higgins et al also demonstrated that while toxT promoter truncations lacking sequences from 
-172 to -114 maintained wild-type levels of activation, deleting the region from -114 to -73 
resulted in a toxT promoter with just 10% activation (3). A toxT promoter fragment from -73 to 
+45 was also not bound by ToxR (3).  
Since there is an imperfect ToxR-binding site from -69 to -56 of the toxT promoter, we 
assessed whether that region of the promoter has the potential for ToxR-dependent activation. As 
both our results with the -81 to +45 toxT-lacZ reporter construct and the -73 to +45 reporter 
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construct described previously (3) showed ToxR could not activate these promoter fragments, we 
hypothesized that the imperfect ToxR repeat from -69 to -56 of the toxT promoter may have a 
low affinity ToxR-binding site. Thus, we tested the ability of overexpressed ToxR to restore 
activation to the -81 to +45 toxT-lacZ reporter plasmid. Even overexpression of toxR (from 
pVJ21, (30)) was unable to restore activation to this promoter, as it showed "-galactosidase 
levels only slightly above O395 expressing the empty vector (Fig. 2-5A). This low level of ToxR 
responsiveness is similar to the negative control -46 to +45 reporter construct, which lacks the 
imperfect ToxR-binding site (Fig. 2-5A). Overexpressed ToxR in the !toxR strain EK307 was 
able to activate the full-length toxT promoter construct from -172 to +45 (Fig. 2-53A). Gel-shift 
analysis also indicated that ToxR is largely unable to bind this imperfect repeat element as a toxT 
promoter fragment from -81 to +45 showed nearly undetectable ToxR binding (Fig. 2-5B). 
These data indicate ToxR binds the imperfect ToxR-binding site from -69 to -56 in the toxT 
promoter poorly and that this specific DNA sequence does not contribute to ToxR-dependent 
toxT activation. This conclusion is also supported by the fact that the ToxR-footprinted region of 
the toxT promoter only extends to -68(4). 
 
Spacing of ToxR DNA binding site relative to TcpP DNA binding site is not critical for toxT 
activation. To further investigate the importance of positioning of ToxR relative to TcpP on the 
toxT promoter, constructs were made in which the ToxR binding site was moved either 2 helical-
turns closer or 2 helical-turns further from the TcpP DNA binding site. Activation of both of 
these promoters with altered spacing still required both ToxR and TcpP (Fig. 2-6). Moving the 
ToxR binding site so that it is adjacent to the TcpP binding site or so that it is an additional two 
helical turns from the TcpP binding site resulted in around a 25% decrease in transcriptional 
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Figure 2-5. ToxR fails to bind or activate a toxT-lacZ derivative containing the degenerate 
ToxR-binding site from -69 to -56. A) toxT promoter derivatives driving lacZ expression were 
tested for activation in wild-type V. cholerae (O395) or the toxR mutant strain EK307 with or 
without overexpression of ToxRS from plasmid pVJ21. n=6 B) Electrophoretic mobility shift 
analysis of full length (-172 to +45), -100 to +45, -81 to +45 and -46 to +45 toxT derivatives with 
increasing concentrations of ToxR-containing membranes shows the degenerate ToxR-binding 
site from -69 to -56 has weak ToxR-binding capacity. Negative control gel shifting with 
membranes lacking ToxR (ToxR-) were also tested and showed minimal background. DNA 
bound by membrane-localized ToxR is retained in the well of the gel. % shifting by membranes 
is indicated under each lane as determined by ImageJ. 
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Figure 2-6. ToxR binding site location is not critical for transcriptional activation of 
toxT. The ToxR binding site was moved two helical-turns either upstream or downstream of 
the original binding site, placing it either adjacent to or 5 helical-turns away from the TcpP-
binding site. Transcriptional activation, as measured by !-galactosidase assay only occurred 
in the V. cholerae strain expressing both ToxR and TcpP (O395)(black bars). Movement of 
the ToxR binding site resulted in a slight decrease in transcriptional activation. Deletion of 
either ToxR or TcpP (EK307 and RY1, respectively) resulted in background levels of 
activation (grey and white bars, respectively) for all promoters tested.  
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activation of the promoter (Fig 2-6). Moving the ToxR and TcpP binding sites so that they are 
adjacent, theoretically allowing for ToxR-TcpP interaction on the promoter, does not appear to 
enhance or dramatically reduce activation. Furthermore, deletion of the degenerate ToxR binding 
site from -69 to -56 by moving of the ToxR binding site adjacent to the TcpP binding site does 
not adversely affect activation. There is a slight, but significant defect in transcriptional 
activation of the toxT promoter when the spacing between the ToxR binding site and the TcpP 
binding site is altered, indicating that the positioning of these two transcription factors relative to 
each other contributes to, but is not critical for, transcriptional activation. 
 
The newly identified ToxR-binding site in the toxT promoter is also required for ToxR-
mediated activation of ompU and ctxA and repression of ompT.  In addition to 
facilitating TcpP-mediated activation of the toxT promoter, ToxR can directly activate the ompU 
promoter and repress the ompT promoter (35, 38). Furthermore, while ctxA activation is usually 
accomplished by ToxT (11, 28, 41), when ToxR is expressed at high levels it can directly 
activate the ctxA promoter (9, 40). Thus, we examined the promoter sequences of the ompU, 
ompT and ctxA genes for elements similar to the TNAAA-N5-TNAAA sequence identified in the 
toxT promoter. In the ompU promoter, we identified a similar sequence, 5’ TNAAA-N5-TNAAT 
3’, located from -51 to -37 relative to the transcription start site (on the opposite strand from the 
ToxR binding site in the toxT promoter), a position appropriate for direct activation of the ompU 
promoter by ToxR (Fig. 2-7A).  
Transversion mutations introduced at positions -50, -49, -47, -40, -39 and -37 (conserved 
nucleotides) all resulted in a >10-fold decrease in ompU-lacZ activation, with promoter proximal 
mutations at -40, -39 and -37 resulting in ~100-fold decreases in promoter activity (Fig. 2-7B). 
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Figure 2-7. The ToxR consensus-binding site is required for ToxR-mediated activation of 
the ompU. A) Location of consensus ToxR-binding sites in the ompU promoters. Nucleotides 
comprising potential ToxR-binding sites are in bold, while the opposite strand sequences, 
matching the toxT promoter consensus ToxR-binding site, are shown in gray. Those nucleotides 
targeted for mutagenesis are highlighted in gray and underlined. B) Effects of transversion 
mutations on ToxR-mediated activation of the ompU promoter in wild-type V. cholerae or the 
toxR mutant strain, EK307. * p<0.05, ** p<0.001 relative to the wild-type promoter. # p<0.001 
relative to the ompT-lacZ T(-47)G mutant. All assessed using the students' t-test, n=6 or more 
measurements. C) V. cholerae membranes containing (pSK-ToxR-HA) or lacking ToxR (pSK) 
were mixed at increasing concentrations with radioactively labeled probes from wild-type or 
mutated ompU promoters. Due to the fact that there are multiple ToxR-binding sites in the ompU 
promoter, no clear defect in DNA binding was observed with the mutated promoter probe.  
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These decreases were not due to disruption of the RNA polymerase binding site as activity of 
these promoters in the absence of ToxR was comparable to the wild-type ompU-lacZ promoter 
(Fig. 2-7B, white bars). Thus, the TNAAA-N5-TNAA element in the ompU promoter contributed 
to ToxR-dependent activation as it did in the toxT promoter, confirming this as a minimal ToxR-
responsive element of V. cholerae. Transversion mutation of the non-consensus nucleotide at 
position -48, T(-48)G also had an effect on ompU promoter activation, although it was the least 
defective (8-fold decrease) of all the mutations tested (Fig. 2-7B). 
 The ctxA promoter has an architecture made up of heptad repeats of TTTTGAT upstream 
of the basal promoter element. As such, it also contains a TNAAA repeat (on the opposite 
strand), but the spacing of this element does not provide the typical spacing, 10-11 base-pairs, 
corresponding to one turn of the DNA helix. We hypothesize this may explain why high levels of 
ToxR are required for activation of the ctxA promoter by ToxR. To assess ToxR-mediated ctxA-
lacZ activation, we used a !toxT strain, VJ740 (9), overexpressing ToxRS from plasmid pVJ21 
(30). When the most promoter-proximal ToxR-binding site in the ctxA promoter (-60 to -57, Fig. 
2-8A) is mutated by transversion mutagenesis, ctxA-lacZ promoter activity is reduced three to 
five-fold (Fig. 2-8B), indicating this sequence in the ctxA promoter is ToxR-responsive, like in 
toxT and ompU. We also mutated the non-consensus nucleotide G(-58)C in the ctxA promoter 
and found it to have no effect on ToxR-mediated activation (Fig. 2-8B). Finally, as the ctxA 
promoter is typically directly activated by the ToxT protein, rather than ToxR (28, 41), we tested 
the effect of these promoter mutations on ToxT-mediated ctxA-lacZ activation in the wild-type 
strain, O395. The activation defects in O395 (ToxT-dependent) were inversely related to those in 
the !toxT mutant strain VJ740 overexpressing ToxR (EK3166, Fig. 2-8B). Thus, ToxR and 




Figure 2-8. The ToxR consensus-binding site is required for ToxR-mediated activation of 
the ctxA promoter. A) Location of consensus ToxR-binding sites in the ctxA promoter with 
nucleotides comprising potential ToxR-binding sites in bold, while the opposite strand 
sequences, matching the toxT promoter consensus ToxR-binding site, are shown in gray. Those 
nucleotides targeted for mutagenesis are highlighted in gray and underlined. B) Effect of 
mutations in the consensus ToxR-binding site within the promoter-proximal heptad repeat of the 
ctxA promoter. ctxA-lacZ expression was measured in a !toxT strain overexpressing ToxR 
(ToxR-dependent) or wild-type V. cholerae O395 (ToxT-dependent). * p<0.05, ** p<0.001 
relative to the wild-type promoter. # p<0.001 relative to the ompT-lacZ T(-47)G mutant. All 
assessed using the students' t-test, n=6 or more measurements. C) V. cholerae membranes 
containing (pSK-ToxR-HA) or lacking ToxR (pSK) were mixed at increasing concentrations 
with radioactively labeled probes from wild-type or mutated ctxA promoter. Due to the fact that 
there are multiple ToxR-binding sites in the ctxA promoter, no clear defect in DNA binding was 
observed with the mutated promoter probe. 
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 Finally, the ompT promoter, which is repressed by ToxR, also contains two consensus 
ToxR-binding sites, one from -78 to -66, the other from -47 to -33 (Fig. 2-9A). Since mutation of 
the promoter proximal ToxR-binding half-site would likely also affect RNAP binding, we 
mutated the promoter distal ToxR-binding half-site of the ompT promoter from -47 to -43 (Fig. 
2-9A). Transversion mutation of nucleotides, -47, -46, -45 and -43 representing the TTTNA 
consensus binding site (opposite strand relative to toxT) resulted in loss of ToxR-mediated ompT 
repression, as ompT expression in the presence of ToxR increased 8 to 12-fold (Fig. 2-9B). 
Alternatively, mutation T(-44)G in the non-consensus nucleotide resulted in a <3-fold increase in 
ompT expression (Fig. 2-9B). 
 Thus, all promoters directly regulated by ToxR contain a consensus TTTNA-N5-TTTNA 
ToxR-binding site (or near consensus) and mutation of that ToxR-binding site in each promoter 
leads to loss of ToxR responsiveness. 
 The ompU, ctxA and ompT promoters all contain multiple ToxR-binding sites (Fig. 2-7A, 
2-8A, and 2-9A). Thus, while mutations of promoter-proximal ToxR-binding site nucleotides 
affected gene expression (Fig. 2-7B, 2-8B, and 2-9B), they did not affect ToxR binding to the 
promoter, as these mutations did not affect binding to the more promoter-distal ToxR-binding 
sites (2-7C, 2-8C, and 2-9C).  
 
Discussion 
The purpose of this study was to define nucleotides within the ToxR-binding site of the toxT 
promoter that influence ToxR-dependent toxT promoter activation. Using plasmid-based toxT-
lacZ fusion vectors, nine transversions in the region of -96 to -83 reduced toxT promoter activity 
three-fold or greater, with those at -90, -86, -84 and -83 reducing this activity more than six-fold 
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Figure 2-9. The ToxR consensus-binding site is required for ToxR-mediated repression of 
the ompT promoter. A) Location of consensus ToxR-binding sites in the ompT promoter. 
Nucleotides comprising potential ToxR-binding sites are in bold, while the opposite strand 
sequences, matching the toxT promoter consensus ToxR-binding site, are shown in gray. Those 
nucleotides targeted for mutagenesis are highlighted in gray and underlined. B) Effects of ompT 
transversion mutations on ToxR-mediated repression of the ompT promoter in wild-type V. 
cholerae or the toxR mutant strain, EK307. * p<0.05, ** p<0.001 relative to the wild-type 
promoter. # p<0.001 relative to the ompT-lacZ T(-47)G mutant. All assessed using the students' 
t-test, n=6 or more measurements. C) V. cholerae membranes containing (pSK-ToxR-HA) or 
lacking ToxR (pSK) were mixed at increasing concentrations with radioactively labeled probes 
from wild-type or ompT promoter. Due to the fact that there are multiple ToxR-binding sites in 
the ompT promoter, no clear defect in DNA binding was observed with the mutated promoter 
probe. 
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(Fig. 2-1B). Transversions that altered promoter activity three-fold or greater were located within 
the ToxR-footprinted region (-104 to -68, (4)), and led to the identification of a TNAAA-N5-
TNAAA consensus ToxR-binding site. Nucleotides within the second pentameric repeat from -
86 to -82 may represent the more critical ToxR recognition site as mutations in three of four 
conserved nucleotides resulted in a greater than six-fold decrease in transcription activity 
whereas none of the mutations in the ToxR recognition site from -96 to -92 had such strong 
effects on toxT activation (Fig. 2-1B). 
Substitutions at -86 and -84, which were found to strongly affect ToxR-mediated toxT 
promoter activation, were previously identified in a screen for the loss of ToxR-mediated toxT 
promoter activation (Fig. 2-1B, (42)). Furthermore, transversion mutations at these two 
nucleotides resulted in the greatest reduction in ToxR binding affinity (Table 2-1 and Fig. 2-3 
and 2-4). Substitutions at -67 and -65 (the complementary nucleotides of -86 and -84 in an 
inverted repeat within the toxT promoter) had little influence on ToxR-mediated promoter 
activation both in this report and a previous report (Fig. 2-1B, (42)). Thus, substitutions 
occupying symmetrical positions with respect to that inverted repeat within the toxT promoter 
have differential effects on toxT activation, demonstrating that nucleotides critical to ToxR-
mediated toxT promoter activation are not defined by the inverted repeat, but rather by the 
TNAAA-N5-TNAAA direct repeat element overlapping the upstream half of the inverted repeat 
(Fig. 2-1A). As read-through transcription is known to occur from the upstream tcpA promoter, 
transversions within the region from -100 to -60 can alter the sequence of the inverted repeat 
within the mRNA initiated from the tcpA promoter and may influence transcription attenuation 
in the tcpF-toxT intergenic region in the context of a chromosomally-located toxT promoter, 
imposing an additional layer of control on toxT transcription levels (6, 42). 
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Based on ToxR-mediated DNA mobility shift experiments in this study, several 
transversions within the -96 and -83 region reduced the relative affinity of the toxT promoter for 
ToxR at least two-fold, with those at -86 and -84 reducing this affinity more than four-fold, again 
supporting the hypothesis that the -86 to -82 ToxR recognition site is more critical for ToxR 
interaction and toxT activation (Table 2-1 and Fig. 2-3 and 2-4). It is notable that several 
adenosine nucleotides in the N5 spacer region were also required for efficient activation (Fig. 2-
1B) and two, A[-91C] and A[-90]C reduced ToxR binding affinities more than two-told (Table 
2-1). Thus, the N5 spacer region also contributes to ToxR binding, possibly through wing 
domain/DNA interactions (32). This leads us to propose a modified (asymmetric) ToxR binding 
site on the toxT promoter of TNAAAAA-N3-TNAAA. Alternatively, as poly-A tracts have been 
shown to induce bends in the DNA helix (43), it is possible that A to C transversions within the 
linker region alters the spatial orientation of the two ToxR-binding half-sites, indirectly altering 
its interactions with the ToxR molecules. Thus, the motif 5’-TNAAA-N5-TNAAA-3’ represents 
a minimally defined ToxR-binding site, with nucleotides between the two half-sites providing 
structural information or potentially, direct interactions with ToxR.  
Transcription activation assays on truncated toxT promoter fragments demonstrated that the 
ToxR-binding site from -96 to -82 is required for binding and toxT activation, and that deletion 
of this region from our -81 to +45 promoter derivative or the previously described -73 to +45 
derivative results in a promoter with greatly reduced transcription activation (Fig. 2-1B and Fig. 
2-5A, (3)). Gel shift analysis with the -81 to +45 toxT promoter construct also demonstrated 
nearly undetectable levels of binding by ToxR (Fig. 2-5B), in agreement with previous studies 
using a truncated promoter from -73 to +45 (3). Thus, the promoter-proximal degenerate ToxR-
binding site from -69 to -56 with two substitutions and altered spacing between the repeats 
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(ANAAA-N4-TNAAG, hashed gray arrows in Fig. 2-1A) is unable to support efficient ToxR 
binding or toxT promoter activation. One surprising finding with the -81 to +45 toxT promoter 
construct lacking the ToxR-binding site was that activation by overexpressed TcpP was 
dramatically impeded if ToxR was co-expressed along with this promoter truncation (Fig. 2-2B). 
Since ToxR binds poorly to this promoter fragment (Fig. 2-5B), we propose this loss of 
activation is due to a previously established ToxR-TcpP interaction (7, 37) and diversion of TcpP 
away from the toxT promoter (perhaps towards the ompU and ompT promoters) by ToxR. 
Alternatively, the weak ToxR-binding activity of the -81 to +45 toxT promoter fragment 
observed in Fig. 2-5B may be sufficient to allow ToxR binding inside bacterial cells and this 
binding may interfere with TcpP binding to its binding site from -53 to -38. According to this 
second hypothesis, binding of ToxR to its consensus ToxR-binding site from -96 to -82, would 
displace the weakly bound ToxR from the -81 to +45 region. This would be similar to PhoB 
repression of the phoBR promoter and de-repression by PhoB binding to a neighboring upstream 
PhoB binding site (44).  
The ToxR binding site from -96 to -82 is 3 helical-turns upstream of the TcpP binding site 
from -53 to -38. This places ToxR and TcpP on approximately the same face of the DNA. This 
would place one face of the toxT promoter facing the membrane where it can be bound by both 
ToxR and TcpP, which are both transmembrane transcription factors. The orientation of these 
two binding sites on the same face could allow ToxR to bind to the toxT promoter, recruiting it to 
the membrane in the proper orientation for TcpP binding. The degenerate ToxR binding site 
from -69 to -56 is approximately 1/2 of a helical-turn from the TcpP binding site and therefore 
opposite face of the DNA. This would make it difficult for this site to be bound by ToxR 
simultaneously with TcpP or with ToxR bound at the -96 to -83 site. The positioning of the ToxR 
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binding site three helical-turns upstream of the TcpP binding site could make it difficult for the 
DNA binding domains of ToxR and TcpP proteins to interact while these proteins are bound to 
the promoter. The ToxR binding site can be moved adjacent to the TcpP binding site (two 
helical-turns downstream) or two helical turns further upstream without disrupting transcriptional 
activation (Fig 2-6). If the ToxR and TcpP DNA binding domains were interacting while ToxR 
and TcpP were bound to the toxT promoter, movement of these sites relative to each other would 
likely disrupt that interaction. Therefore, it is likely that although the DNA binding domains of 
ToxR and TcpP do interact (7, 37), they do not interact when these proteins are bound to the 
promoter. Although the exact spacing of these two binding sites is not critical, a slight (25%) 
defect in transcriptional activation of the toxT promoter is observed when the ToxR binding site 
is moved (Fig. 2-6). This could be due to disruption of the DNAse I hypersensitivity site that is 
revealed when ToxR binds the toxT promoter (4). 
The motif 5’-TNAAA-N5-TNAAA-3’, or its complement (5’-TTTNA-N5-TTTNA-3’), 
occurs three times in the ToxR-footprinted region of the V. cholerae ompU promoter, (35), twice 
in the ToxR-footprinted region of the V. cholerae ompT promoter (38), and within a heptad 
repeat element (TTTTGAT) in the ctxA promoter (45) (Fig. 2-7A, 2-8A, and 2-9A). Mutation of 
the promoter-proximal ToxR-binding site in both the ompU and ctxA promoters dramatically 
reduced ToxR-dependent activation (Fig. 2-7B and 2-8B), and similar mutation in the ompT 
promoter prevented ToxR-mediated repression of the ompT expression (Fig. 2-9B). These results 
provide more evidence that we have identified the consensus ToxR-binding site that controls 
numerous ToxR-regulated promoters in V. cholerae. A recent study by Dittmer et al using 
different point mutations in the ctxA promoter indicated some nucleotides within the TNAAA 
ToxR consensus-binding site may also contribute to ToxT binding (46). Differences in our 
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results regarding nucleotides required for ToxT responsiveness of the ctxA promoter may reflect 
differences in the specific mutations tested, the way in which the cells were grown prior to 
assaying ctxA-lacZ expression or other factors. 
These studies provide us with a working model of toxT promoter activation that involves the 
binding of two ToxR molecules to the region from -96 to -83, allowing ToxR to displace H-NS 
(Fig. 2-10A, (2)) and recruit two molecules of TcpP to bind the region from -53 to -38 (8). 
Whether ToxR releases TcpP upon DNA binding so TcpP can engage its binding site 30 
nucleotides closer to the RNA polymerase binding site (“catch and release” model, Fig. 2-10C) 
or ToxR and TcpP maintain interaction while bound to the toxT promoter ("hand-holding" 
model, Fig. 2-10B), remains to be determined. The argument against the "hand-holding" model 
is that the ToxR-binding site is three helical turns of the DNA upstream of TcpP, a distance that 
would require dramatic DNA-bending to maintain this protein-protein interaction. Furthermore, 
the ToxR-binding site can be moved an additional two helical turns upstream from the TcpP-
binding site and maintain strong ToxR and TcpP-dependent toxT activation (Fig. 2-6).  
In an alternative activation model, ToxR binding to the toxT promoter may alter the promoter 
architecture such that TcpP binding is facilitated, even without any direct contact between ToxR 
and TcpP ("promoter alteration" model, Fig. 2-10D). This could be due to ToxR removing the 
repressor H-NS from the toxT promoter and/or ToxR inducing DNA bending that allows TcpP 
better access to its DNA binding site (Fig. 2-10D). Although, removal of H-NS alone does not 
account for full toxT activation as in an H-NS mutant, toxT is expressed to just 20% of the level 
expressed under ToxR and TcpP-induced conditions (2). Evidence supporting the "promoter 
alteration" model comes from the fact that when ToxR binds the toxT promoter, a DNAse I 
hypersensitivity site is revealed overlapping the TcpP-binding site (4, 8). This suggests ToxR 
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Figure 2-10. Models for the role of ToxR in TcpP-mediated toxT activation. A) As previously 
described, the toxT promoter in repressed by H-NS (2). B) In the "hand-holding" model ToxR and 
TcpP interact in the inner membrane of V. cholerae as previously described (7), then ToxR escorts 
TcpP to the toxT promoter where ToxR relieves H-NS repression and maintains interaction with 
TcpP while TcpP stimulates transcription. C) In the "catch and release" model, ToxR also interacts 
with TcpP and recruits TcpP to the toxT promoter, but upon DNA-binding by ToxR, H-NS is 
displaced and ToxR releases TcpP so TcpP can bind the TcpP-binding site 30 nucleotides 
downstream of the ToxR-binding site (8). D) In the "promoter alteration" model interaction 
between ToxR and TcpP is not required for toxT activation, rather ToxR binding to the toxT 
promoter displaces H-NS and alters the toxT promoter architecture such that a normally weak 
TcpP-binding site is altered in some way to facilitate enhanced TcpP binding, thus allowing TcpP-
mediated activation of the toxT promoter. E) In the "membrane recruitment" model, again 
interaction between ToxR and TcpP is not required, but the role of ToxR is to simply recruit the 
toxT promoter to the membrane where TcpP has easier assess to its DNA-binding site. This model 
takes into account the fact that TcpP binding to the toxT promoter requires higher concentrations 
of V. cholerae membranes than ToxR binding (4) and the fact that membrane localization was 
previously shown to be required for ToxR to facilitate TcpP-mediated toxT activation (21). 
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binding results in DNA bending or unwinding that might allow TcpP better access to its toxT 
promoter-binding site. However, this role alone cannot be sufficient for promoting TcpP-
mediated activation, as a soluble form of ToxR that binds the same DNA-binding site, does not 
facilitate TcpP-mediated toxT activation (21). Finally, it is possible that the main role of ToxR is 
to recruit the toxT promoter to a membrane-proximal location where TcpP can more efficiently 
interact with its relatively weak DNA-binding site ("membrane recruitment" model, Fig. 2-10E, 
(4, 8)). According to this model, ToxR should be able to facilitate TcpP-mediated toxT activation 
from a considerable distance (so long as it still displaces H-NS binding), a model to be tested in 
the future. Most likely, aspects from several of these models contribute to how ToxR facilitates 
activation of the toxT promoter including: membrane recruitment, H-NS displacement, 
alterations to the promoter architecture and possibly ToxR-TcpP interaction. 
This study defines a minimal ToxR-responsive site, TNAAA-N5-TNAAA, in the toxT, 
ompU, ompT and ctxA promoters. Based on the direct repeat nature of this ToxR-binding site, we 
hypothesize two ToxR molecules bind this repeat element in a head-to-tail fashion, consistent 
with the structure determined for the E. coli PhoB-DNA co-crystal (32). The fact that the ToxR-
binding site in the toxT promoter is in the opposite orientation from the promoter-proximal 
ToxR-binding sites of other ToxR-regulated promoters (ompU, ctxA and ompT; Fig. 2-1A, 2-7A, 
2-7A, and 2-8A) suggests ToxR favors this inverted orientation when playing a supporting role 
in TcpP-mediated toxT activation. 
By defining the ToxR-binding site we can compare the recognition sequences for a number 
of OmpR/PhoB family regulators in V. cholerae including, ToxR, TcpP and PhoB. All three 
proteins have very similar recognition sequences TTTNA-N5-TTTNA (ToxR), TGTAA-N6-
TGTAA (TcpP, (8)) and TGTCA-N6-TGTCA (PhoB, (44)). This raises the question of how V. 
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cholerae avoids cross-talk among these closely related binding sites and what determines 
sequence specific recognition of DNA within each protein. Previous studies on winged-HTH 
proteins suggest that rather than differences in residues in the #3 DNA recognition helix, 
sequence specificity may be dictated by the preceding #2 helix and loop domain which influence 
the positioning of the #3 helix relative to the rest of the molecule (47, 48)). Future experiments 
will test whether this hypothesis holds true for ToxR and TcpP in V. cholerae as well. 
 
Materials and Methods 
Bacterial strains and plasmids. All V. cholerae used in this study are derived from O1 serotype 
Classical biotype strain O395 (1). V. cholerae, E. coli and plasmids used in this study are listed 
in Table 2-2. Strains were routinely grown in LB medium containing 10 g/L NaCl at 37°C or Vc 
LB containing 5 g/L NaCl. Unless otherwise indicated, antibiotics were used at the following 
concentrations: streptomycin 100 "g/ml; ampicillin 100 "g/ml; chloramphenicol 25 "g/ml; and 
kanamycin 30 "g/ml.  
DNA manipulations. Cloning procedures and transformation of E. coli strains were carried out 
using standard protocols (49). pTG24-based fusion plasmids were transferred to V. cholerae by 
electroporation (2.2 kV) using an E. coli Pulsor (Bio-Rad) and pMMB207-based plasmids were 
transferred to V. cholerae by triparental mating using mobilization plasmid pRK2013 (22).  
Generation of promoter mutants. The wild type toxT promoter, !"#$%&"!"#$%"$&'()*)+,"-%)./"
'-0)*)+,"'() *+",-&.-)%10$)."2345"6708&8%8&$("9:;"$%" 1+&'($1+!" 17+" !"#$%&") -<=>"/.0?@"
$.," !"#$%&") +45" 1*"A@" '0)&+0%" BC$D(+" >E3F" $.," 17+" Expand High Fidelity PCR system 
(Roche)G"C7+"$&'()*)+,"9:;"*0$/&+.1"#$%"/+("'-0)*)+,!",)/+%1+,"#)17"EcoRI and BamHI, and 
ligated into EcoRI/BamHI-digested pBluescript SK(+), generating pTG3. Nucleotide 
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Table 2-2. Strains and plasmids 
 
Name  Description Source 
V. cholerae    
O395 Wild type, StrR    (1) 
RY6  (O395 toxT!pro) (6) 
EK307 O395 !toxR (4) 
EK459 O395 !toxR !tcpP (4) 
TG128 EK459/pBluescript SK(+)/pMMB207 This study 
TG129 EK459/pSK-toxR-HA/pMMB207 This study 
EK3124 O395 + pTL61T  
EK3122 O395 + pTL61T-ompU(-211 to +22)  
EK3139 EK307 +  pTL61T  
EK3137 EK307 + pTL61T-ompU(-211 to +22)  
VJ740 O395 toxT!HTH (9) 
EK3165 VJ740 + pACYC184-TetS (CmR) This study 
EK3166 VJ740 + pVJ21 (CmR) This study 
EK3177 O395 + pTL61T-ctxA (-83 to +63) This study 
EK3178 O395 + pTL61T-ctxA (-21 to +63) This study 
EK3183 EK3165 + pTL61T-ctxA (-83 to +63) This study 
EK3184 EK3165 + pTL61T-ctxA (-21 to +63) This study 
EK3189 EK3166 + pTL61T-ctxA (-83 to +63) This study 
EK3190 EK3166 + pTL61T-ctxA (-21 to +63) This study 
SM1544 O395 + pTL61T-ompT (-323 to +104) This study 
SM1550 EK307 + pTL61T-ompT (-323 to +104) This study 
E. coli    
DH5#   supE44 !lacU169(F80lacZDM15) hsdR17 recA1 endA1 
gyrA96 thi-1 relA1 
Laboratory 
collection 
Plasmids   
pBluescript SK(+) ApR, high copy number cloning vector  Stratagene 
pMMB207 IPTG-inducible expression vector, CmR,  
lacIq, tacP 
(14) 
pEK41 pMMB207-tcpP-HSV (4) 
pRK2013 ColE1::RK2 tra+ ori–, KmR  (22) 
pSK-toxR-HA pBluescript SK(+)::toxR-HA (8) 
pTG3 pBluescript SK(+)::toxT promoter (–172 to +45) as an 
EcoRI-BamHI fragment 
This study 
pTG24 ApR, promoterless lacZ fusion vector derived from 
pTL61T 
(8) 









Name  Description Source 
pTG228 pTG24:: toxT promoter (-81 to +45) This study 
pVJ21 pACYC184-toxRS (30) 
pACYC184-TetS pACYC184 cut with BamHI, Klenow filled and religated 
to disrupt tetracycline resistance 
This study 
pTL61T promoter-less lacZ fusion vector (34) 
pTL61T-ompU (-
211 to +22) 
lacZ fusion vector containing the ompU promoter from -
211 to +22 
(35) 
pTL61T-ctxA 
(-83 to +63) 









323 to +104) 
lacZ fusion vector containing the ompT promoter from (-





Table 2-3: Oligonucleotides used in this study 
primer name purpose sequence 5’ to 3’ 
toxT D-100 forw mutagenesis cgggatcctatctcaaaaaacataaaataacatgagttac 
 toxT D-82 forw mutagenesis cgggatcctaacatgagttactttatgtttttcttatg 
 toxT D-47 forw mutagenesis gcgcggatcccgtctgtaacttgttcttatgtctg 
 toxT -57 forw mutagenesis catgagttactttatgtttttattatgtaatacgtctgtaact 
 toxT -57 rev mutagenesis agttacagacgtattacataataaaaacataaagtaactcatgttat 
 toxT -58 forw mutagenesis acatgagttactttatgttttgcttatgtaatacgtctgtaac 
 toxT -58 rev mutagenesis gttacagacgtattacataagcaaaacataaagtaactcatgttatt 
 toxT -59 forw mutagenesis aacatgagttactttatgtttctcttatgtaatacgtctgtaa 
 toxT -59 rev mutagenesis ttacagacgtattacataagagaaacataaagtaactcatgttattttatgtt
ttttgag 
 toxT -60 forw mutagenesis gagttactttatgttgttcttatgtaatacg 
 toxT -60 rev mutagenesis cgtattacataagaacaacataaagtaactc 
 toxT -61 forw mutagenesis tgagttactttatgtgtttcttatgtaatac 
 toxT -61 rev mutagenesis gtattacataagaaacacataaagtaactca 
 toxT -62 forw mutagenesis atgagttactttatggttttcttatgtaata 
 toxT -62 rev mutagenesis tattacataagaaaaccataaagtaactcat 
 toxT -63 forw mutagenesis catgagttactttatttttttcttatgtaat 
 toxT -63 rev mutagenesis attacataagaaaaaaataaagtaactcatg 
 toxT -64 forw mutagenesis acatgagttactttaggtttttcttatgtaa 
 toxT -64 rev mutagenesis ttacataagaaaaacctaaagtaactcatgt 
 toxT -65 forw mutagenesis aacatgagttactttctgtttttcttatgta 
 toxT -65 rev mutagenesis tacataagaaaaacagaaagtaactcatgtt 
 toxT -66 forw mutagenesis taacatgagttacttgatgtttttcttatgt 
 toxT -66 rev mutagenesis acataagaaaaacatcaagtaactcatgtta 
 toxT -67 forw mutagenesis ataacatgagttactgtatgtttttcttatg 
 toxT -67 rev mutagenesis cataagaaaaacatacagtaactcatgttat 
 toxT -68 forw mutagenesis aataacatgagttacgttatgtttttcttat 
 toxT -68 rev mutagenesis ataagaaaaacataacgtaactcatgttatt 
 toxT -69 forw mutagenesis aaataacatgagttaatttatgtttttctta 
 toxT -69 rev mutagenesis taagaaaaacataaattaactcatgttattt 
 toxT -70 forw mutagenesis aaaataacatgagttcctttatgtttttctt 
 toxT -70 rev mutagenesis aagaaaaacataaaggaactcatgttatttt 
 toxT -71 forw mutagenesis taaaataacatgagtgactttatgtttttct 
 toxT -71 rev mutagenesis agaaaaacataaagtcactcatgttatttta 
 toxT -72 forw mutagenesis ataaaataacatgaggtactttatgtttttc 
 toxT -72 rev mutagenesis gaaaaacataaagtacctcatgttattttat 
 toxT -73 forw mutagenesis cataaaataacatgatttactttatgttttt 
 toxT -73 rev mutagenesis aaaaacataaagtaaatcatgttattttatg 
 toxT -74 forw mutagenesis acataaaataacatgcgttactttatgtttt 
 toxT -74 rev mutagenesis aaaacataaagtaacgcatgttattttatgt 
 toxT -75 forw mutagenesis aacataaaataacattagttactttatgttt 
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primer name purpose sequence 5’ to 3’ 
 toxT -75 rev mutagenesis aaacataaagtaactaatgttattttatgtt 
 toxT -76 forw mutagenesis aaacataaaataacaggagttactttatgtt 
 toxT -76 rev mutagenesis aacataaagtaactcctgttattttatgttt 
 toxT -77 forw mutagenesis aaaacataaaataacctgagttactttatgt 
 toxT -77 rev mutagenesis acataaagtaactcaggttattttatgtttt 
 toxT -78 forw mutagenesis aaaaacataaaataaaatgagttactttatg 
 toxT -78 rev mutagenesis cataaagtaactcattttattttatgttttt 
 toxT -79 forw mutagenesis aaaaaacataaaataccatgagttactttat 
 toxT -79 rev mutagenesis ataaagtaactcatggtattttatgtttttt 
 toxT -80 forw mutagenesis caaaaaacataaaatcacatgagttacttta 
 toxT -80 rev mutagenesis taaagtaactcatgtgattttatgttttttg 
 toxT -81 forw mutagenesis atctcaaaaaacataaaagaacatgagttactttatg 
 toxT -81 rev mutagenesis cataaagtaactcatgttcttttatgttttttgagat 
 toxT -82 forw mutagenesis tatctcaaaaaacataaactaacatgagttactttat 
 toxT -82 rev mutagenesis ataaagtaactcatgttagtttatgttttttgagata 
 toxT -83 forw mutagenesis ttatctcaaaaaacataacataacatgagttacttta 
 toxT -83 rev mutagenesis taaagtaactcatgttatgttatgttttttgagataa 
 toxT -84 forw mutagenesis atctcaaaaaacatacaataacatgagttac 
 toxT -84 rev mutagenesis gtaactcatgttattgtatgttttttgagat 
 toxT A[-84]T forw mutagenesis atctcaaaaaacatataataacatgagttac 
 toxT A[-84]T rev mutagenesis gtaactcatgttattatatgttttttgagat 
 toxT -85 forw   mutagenesis tcttatctcaaaaaacatcaaataacatgagttactt 
 toxT -85 rev mutagenesis aagtaactcatgttatttgatgttttttgagataaga 
 toxT -86 forw mutagenesis atcttatctcaaaaaacagaaaataacatgagttact 
 toxT -86 rev mutagenesis agtaactcatgttattttctgttttttgagataagat 
 toxT -87 forw mutagenesis tatcttatctcaaaaaacctaaaataacatgagttac 
 toxT -87 rev mutagenesis gtaactcatgttattttaggttttttgagataagata 
 toxT -88 forw mutagenesis ttatcttatctcaaAaaaaAtaaaataacaTGAgtta 
 toxT -88 rev mutagenesis taactcatgttattttattttttttgagataagataa 
 toxT -89 forw mutagenesis gttatcttatctcaaAaaccataaaataacaTGAgtt 
 toxT -89 rev mutagenesis aactcatgttattttatggtttttgagataagataac 
 toxT -90 forw mutagenesis tgttatcttatctcaaAaCacataaaataacaTGagt 
 toxT -90 rev mutagenesis actcatgttattttatgtGttttgagataagataaca 
 toxT -91 forw mutagenesis ctgttatcttatctcaaACaacataaaataacaTgag 
 toxT -91 rev mutagenesis ctcatgttattttatgttGtttgagataagataacag 
 toxT -92 forw mutagenesis gctgttatcttatctcaaCaaacataaaataacatga 
 toxT -92 rev mutagenesis tcatgttattttatgtttGttgagataagataacagc 
 toxT -93 forw mutagenesis ggctgttatcttatctcacaaaacataaaataacatg 
 toxT -93 rev mutagenesis catgttattttatgttttgtgagataagataacagcc 
 toxT -94 forw mutagenesis Tggctgttatcttatctccaaaaacataaaataacat 
 toxT -94 rev mutagenesis Atgttattttatgtttttggagataagataacagcca 
 toxT -95 forw mutagenesis gctgttatcttatctaaaaaaacataaaata 
 toxT -95 rev mutagenesis tgttattttatgtttttttagataagataacagccacgaatgtggc 
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 toxT -96 forw mutagenesis cgtggctgttatcttatcgcaaaaaacataaaataac 
 toxT -96 rev mutagenesis gttattttatgttttttgcgataagataacagccacg 
 toxT -97 forw mutagenesis tggctgttatcttatatcaaaaaacataaaa 
 toxT -97 rev mutagenesis ttttatgttttttgatataagataacagcca 
 toxT -98 forw mutagenesis ttcgtggctgttatcttagctcaaaaaacataaaata 
 toxT -98 rev mutagenesis tattttatgttttttgagctaagataacagccacgaa 
 toxT -99 forw mutagenesis attcgtggctgttatcttctctcaaaaaacataaaat 
 toxT -99 rev mutagenesis attttatgttttttgagagaagataacagccacgaat 
 toxT -100 forw mutagenesis cattcgtggctgttatctgatctcaaaaaacataaaa 
 toxT -100 rev mutagenesis ttttatgttttttgagatcagataacagccacgaatg 
 toxTp -172 BamHI  cloning 
primer 
gcgcggatccgtatagcaaagcatattcagagaac 
 toxTp +45 EcoRI  cloning 
primer 
gcgcgaattcaaataaacgcagagagccatcc 




















 toxT + 2 turns TOP mutagenesis atgagttactttatgagataacagccacattcgtggtttttcttatgtaat 
 toxT + 2 turns 
BOTTOM 
mutagenesis attacataagaaaaaccacgaatgtggctgttatctcataaagtaactcat 
 toxT – 2 turns TOP mutagenesis aaaacataaaataactatgtaatacgtctg 
 toxT -2 turns BOTTOM mutagenesis cagacgtattacatagttattttatgtttt 
ompU T(-50)G TOP mutagenesis gtgttcataagttggagttatatcattttactaac 
ompU T(-50G BOTTOM mutagenesis gttagtaaaatgatataactccaacttatgaacac 






















primer name purpose sequence 5’ to 3’ 




ctxA T(-60)G TOP mutagenesis gatttttgatttGtgatttcaaataatacaaatttatttac 
ctxA T(-60)G BOTTOM mutagenesis gtaaataaatttgtattatttgaaatcaCaaatcaaaaatc 
ctxA T(-59)G TOP mutagenesis gatttttgattttGgatttcaaataatacaaatttatttac 
ctxA T(-59)G BOTTOM mutagenesis gtaaataaatttgtattatttgaaatcCaaaatcaaaaatc 
ctxA G(-58)C TOP mutagenesis gatttttgatttttCatttcaaataatacaaatttatttac 
ctxA G(-58)C BOTTOM mutagenesis gtaaataaatttgtattatttgaaatGaaaaatcaaaaatc 
ctxA A(-57)C TOP mutagenesis gatttttgatttttgCtttcaaataatacaaatttatttac 
ctxA A(-57)C BOTTOM mutagenesis gtaaataaatttgtattatttgaaaGcaaaaatcaaaaatc 






















substitutions within the ToxR-binding region of the toxT promoter region were generated by a 
one-step process in which the entire plasmid is amplified using complementary mutagenic 
primers, pTG3 as template and Pfu Turbo DNA polymerase (Stratagene), followed by DpnI 
cleavage for enrichment for PCR-amplified plasmids or the two-step SOEing PCR amplification 
technique (50) using complementary mutagenic primers, the exterior primers !"#$%&") -<=>"
/.0?@" $.," !"#$%&") +45" 1*"A@" '0)&+0%" BC$D(+" >E3F! pTG3 as template and Expand High 
Fidelity PCR System (Roche)!" *8((8#+," DH" IJA" '08,-61" '-0)*)6$1)8.!" ,)/+%1)8."#)17"1*"A@"
$.,"/.0?@!"$.,"()/$1)8."into EcoRI/BamHI-digested pBluescript SK(+). Deletion derivatives of 
!"#$%&")#+0+"/+.+0$1+,"-%)./"IJA"$&'()*)6$1)8."-%)./"'CK3"$%" 1+&'($1+!" 17+" !"#$%&" +45"
1*"A@"'0)&+0"$.,"+)17+0"17+"!-<L<"/.0?@!"!-M>"/.0?@"80"!-N="/.0?@"primer (Table 2-3). 
The DNA sequences of all PCR-generated V. cholerae DNA fragments were determined at The 
University of Michigan Core sequencing facility to verify the mutations and confirm the absence 
of additional nucleotide changes. DNA fragments carrying the wild type, deleted and substituted 
toxT promoters were excised from pBluescript-based constructs as NotI/SalI fragments and 
recloned promoters were excised from pBluescript-based constructs as NotI/SalI fragments and 
recloned into NotI/SalI-digested pTG24 (8), generating lacZ transcriptional fusions.  
ompU promoter DNA from -211 to +22 relative to the transcription start site was PCR amplified 
in plasmid pBluescript SK(+)-ompU using mutagenic primer pairs listed in Table 2-3. Following 
DpnI digestion and DH5# transformation, candidate ompU mutants were confirmed by 
sequencing prior to excision with EcoRI and BamHI and ligation into the promoter-less lacZ 
vector pTL61T (34). 
ctx-lacZ fusions published previously (28), were PCR amplified using mutagenic primers listed 
in Table 2-3, DpnI digested and transformed into DH5#. Candidate ctxA promoter mutants were 
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confirmed by sequencing. Previously described ompT-lacZ fusions (38) were PCR amplified 
using mutagenic primers listed in Table 2-3, DpnI digested and transformed into DH5#. 
Candidate ompT promoter mutants were confirmed by sequencing. 
Measurement of lacZ fusion activity. Cultures of toxT-lacZ reporter strains carrying both 
pTG24 and pMMB207 or their derivatives were grown overnight in Luria-Bertani (LB) broth 
containing 5 g/L NaCl (Vc LB) at 30° C, diluted 1:50 in LB broth which had been adjusted to an 
initial pH of 6.5 and supplemented with chloramphenicol, ampicillin, streptomycin and 1mM 
isopropyl-"-D-thiogalactopyranoside (IPTG) where required. After incubation for 4 hr at 30°C 
(ToxR-inducing conditions), the OD600 of the cultures were determined and 5 to 100 µl samples 
were used in a standard !-galactosidase assay (51). For ompU-lacZ fusion constructs, !-
galactosidase activity was measured on overnight cultures of V. cholerae grown at 30°C in Vc 
LB pH=7. For ctxA-lacZ and ompT-lacZ fusions, !-galactosidase assays were performed on 
overnight cultures grown at 30°C in Vc LB pH=6.5. 
Mobility shift assays. DNA gel mobility shift assays were performed essentially as previously 
described (8) using membrane preparations obtained either from V. cholerae strains TG128 
(ToxR-) and TG129 (ToxR+, O395 !toxR!tcpP expressing HA-tagged ToxR from the plasmid 
pSK-toxR-HA, Table 2-2) grown in Vc LB broth supplemented with 1 mM IPTG, streptomycin, 
chloramphenicol and ampicillin. Protein concentrations were determined using the Quick-Start 
Bradford Dye reagent (Bio-Rad). DNA fragments carrying the either the entire region from -172 
to +45, relative to the toxT transcription start site, or upstream deletion derivatives thereof, were 
excised from pBluescript clones using NruI and SalI, gel purified and end-labeled by Klenow 
DNA polymerase (Invitrogen) in the presence of [#-32P]-dCTP or [#-32P]-dATP (MP 
Biomedicals) as previously described (8). Increasing amounts of membrane preparations were 
 69 
mixed with the end-labeled DNA targets in a solution containing 10 mM Tris (pH 7.4), 1 mM 
EDTA, 5 mM NaCl, 50 mM KCl, 50 "g/ml BSA and 10 "g/ml sheared salmon sperm DNA. 
Binding reactions were performed at 30°C for 30 min and the free and membrane-associated 
DNA targets samples were separated by electrophoresis on a 6% polyacrylamide/TBE gel prerun 
with 5% thioglycolic acid as previously described (8). After electrophoresis, the gels were dried, 
the extents of DNA migration were recorded by autoradiography and in some cases the relative 
intensities of the recorded signals were determined using a Biospectrum image analyzer (UVP, 
LLC) or using ImageJ (http://rsbweb.nih.gov/ij/). 
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Notes: I replicated all of the !-galactosidase transcriptional activation assays shown (Fig. 3-1 and 
Tables 3-1, 3-2, and 3-3) for all of the ToxR mutants. I created all of the strains for the BACTH 
assay, validated the BACTH assay for ToxR-TcpP interaction, and performed all of the BACTH 
assays shown (Fig. 3-7). Additionally, I created the models shown in Figures 3-2 and 3-8. 
 
Summary 
ToxR of Vibrio cholerae directly activates the ompU promoter, but requires a second activator, 
TcpP to activate the toxT promoter. ompU encodes a porin, while toxT encodes the transcription 
factor, ToxT, that activates V. cholerae virulence genes including cholera toxin and the toxin co-
regulated pilus. Using an ompU-sacB transcriptional fusion, toxR mutant alleles were identified 
that encode ToxR molecules defective for ompU promoter activation. Many toxR mutants 
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defective for ompU activation affected residues involved in DNA binding. Mutants defective for 
ompU activation were also tested for activation of the toxT promoter. ToxR-F69A and ToxR-
V71A, both in the "-loop of ToxR, were preferentially defective for ompU activation, with 
ToxR-V71A nearly completely defective. Six mutants from the ompU-sacB selection showed 
more dramatic defects in toxT activation than ompU activation. All but one of the affected 
residues map to the wing domain of the winged-helix-turn-helix of ToxR. Some ToxR mutants 
preferentially affecting toxT activation had partial DNA-binding defects, and one mutant, ToxR-
P101L, had altered interactions with TcpP. These data suggest that while certain residues in the 
"-loop of ToxR are utilized to activate the ompU promoter, the wing domain of ToxR contributes 
to both promoter binding and ToxR/TcpP interaction facilitating toxT activation. 
 
Introduction 
Vibrio cholerae is the causative agent of the diarrheal disease cholera, a disease estimated 
to affect 18 million people each year worldwide (11). V. cholerae lives in aquatic environments 
year-round, but during seasonal outbreaks the bacterium is ingested by humans in contaminated 
food or water. Following ingestion, V. cholerae senses the changes in environmental conditions 
and responds by activating a number of genes whose products are required for effective 
colonization and pathogenesis in human hosts. These include the genes encoding cholera toxin 
and the toxin co-regulated pilus among others (13-16). Activation of these virulence genes is 
dependent upon two inner membrane localized transcription factors ToxR and TcpP (17-20). 
Both ToxR and TcpP have C-terminal periplasmic domains with the potential to sense 
environmental signals as well as N-terminal DNA-binding and transcription activation domains 
similar to the winged helix-turn-helix (winged-HTH) family of transcription factors (22). ToxR 
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and TcpP stimulate virulence gene expression by combining to activate the toxT promoter (1, 19, 
23). ToxT then activates various virulence genes directly (24-26).  
DNAse I footprinting studies, toxT promoter mutations and analysis of a series of tcpP 
mutants have suggested that TcpP directly interacts with RNA polymerase at the toxT promoter 
while ToxR serves an accessory role from a position further upstream of the basal promoter 
elements (1, 5, 27). Furthermore it has been demonstrated that TcpP and ToxR physically 
interact and that this interaction may contribute to the activity of ToxR on the toxT promoter (5). 
In fact, a mutant derivative of TcpP that is deficient in toxT promoter binding (TcpP-H93L) is 
still functional for toxT activation if ToxR is co-expressed (1). TcpP binds a pentameric direct 
repeat element TGTAA-N6-TGTAA from -53 to -38 relative to the start site of toxT transcription 
(27). Within this repeat element, the central nucleotide of both repeats is critical for TcpP-
mediated toxT activation, even in the presence of ToxR (27). These data lead to a model in which 
ToxR binds a region upstream of the TcpP-binding site and facilitates toxT promoter recognition 
and activation by TcpP (27). 
While both ToxR and TcpP are required for toxT activation (19, 28, 29), ToxR is able to 
regulate other promoters in a TcpP-independent fashion. One such promoter, ompU, controls 
expression of the outer membrane porin OmpU. ToxR directly activates ompU (30) and represses 
expression of the alternative porin, OmpT (31). Proper regulation of outer membrane protein 
synthesis is critical as expression of OmpT leads to greater sensitivity to bile and other related 
detergents (32).  
 Given that ToxR directly activates ompU yet plays an accessory role in toxT activation, 
we hypothesized that the molecular mechanism by which ToxR regulates these two promoters 
may be different and we might be able to isolate point mutations in toxR that affect activation of 
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ompU or toxT specifically. Identification of such mutants would strengthen the hypothesis that 
different regions of ToxR are more critical for one type of activation or the other, and based on 
homology to the winged-HTH family of transcription factors, the position of mutant substitutions 
may direct us to the function of certain domains of ToxR. Precedent for such differential 
activation of the ompU and toxT promoters comes from the fact that toxT expression requires that 
ToxR be membrane-localized, while ompU can be efficiently activated by a soluble form of 
ToxR (Crawford et al., 2003). 
 In this study we identified residues in the "-loop of ToxR, especially V71, as being 
critical for ompU promoter activation, while several ToxR mutants had preferential defects in 
toxT promoter activation, including six in the wing domain of ToxR. 
 
Results 
We hypothesized that since ToxR appears to function by different mechanisms at the ompU and 
toxT promoters, we might be able to isolate toxR mutants that affect ompU transcription, but not 
toxT. Identification of such mutants would indicate which domain(s) of ToxR is critical to 
directly activate transcription at the ompU promoter. 
 
Isolation of toxR alleles defective for ompU activation. To isolate toxR mutants defective for 
ompU activation, an ompU-sacB transcriptional fusion strain was constructed in which an ompU-
sacB fusion was inserted at the lacZ locus of the #toxR classical V. cholerae strain EK307 
(EK406 derived from EK307; Table 3-4). The #toxR ompU-sacB selection strain is able to grow 
on 5% sucrose, however, upon introduction of a wild-type copy of toxR on a plasmid, this strain 
becomes sensitive to 5% sucrose. To isolate toxR mutants, three pools of mutagenized toxR 
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alleles were introduced into EK406 by electroporation. Transformants were plated on LB plates 
containing 5% sucrose and colonies capable of growing on 5% sucrose were isolated. The toxR 
encoding plasmids were sequenced, and selected mutants were studied further. 
 In the course of constructing the toxR allele for PCR mutagenesis, a C-terminal 
(periplasmic) HA-epitope tag was added to the toxR coding sequence to allow assessment of 
protein stability and translation with an anti-HA tag antibody (Materials and Methods).  
 
Quantification of ompU activation defects. Once candidate sucrose-resistant toxR alleles were 
identified that were defective for ompU activation, their protein stability was assessed by anti-
HA epitope tag Western blot analysis (data not shown) and alleles encoding full-length ToxR 
derivatives were introduced into a V. cholerae #toxR ompU-lacZ reporter strain (EK410) to 
quantify ompU activation defects. Like the ompU-sacB selection strain the ompU-lacZ reporter 
was inserted at the lacZ locus of V. cholerae (9). The various plasmid-encoded ToxR derivatives 
were tested for their ability to activate ompU as compared to wild-type ToxR or an empty vector 
control (pSK). Only mutants harboring a single amino acid substitution were studied further. If a 
sequenced toxR allele defective for ompU activation contained two or more mutations, the 
mutations were separated by allelic exchange of a restriction fragment into the parental plasmid 
pSK-toxR-HA or by site-directed mutation. Following these reconstructions, 13 mutants from the 
randomly mutagenized pools were studied. !-galactosidase assays were performed and Miller 
Units for wild-type ToxR were set at 100% and all mutant derivatives were expressed relative to 
100%. 
 Of these 13 ToxR derivatives, seven showed little or no ability to activate the ompU 
promoter (<3% wild type activity); ToxR-W64R, ToxR-V71A, ToxR-Q78R, ToxR-L83P, ToxR-
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T99K, ToxR-T99R and ToxR-G104S, although ToxR-L83P was somewhat less stable than the 
other mutants (Fig. 3-1). The remaining six mutants retained 24-79% activity relative to wild-
type ToxR.  
 
Effect of ToxR substitutions on toxT activation. While the ToxR mutants were isolated based 
on their reduced activation of the ompU promoter, we were also interested in whether any 
mutants showed a differential effect on toxT activation. If the mechanism of ompU and toxT 
activation differs, we expected to find some mutants that were defective for ompU activation to 
be less affected for toxT activation.  
 To examine the effect of ToxR substitutions on toxT activation, the various plasmid-
borne alleles were introduced into the #toxR toxT-lacZ reporter strain EK1072 (Table 3-4). Of 
the seven ToxR mutants that showed little or no ompU-lacZ expression, all but mutant ToxR-
V71A showed little or no activity for toxT-lacZ expression as well (Fig. 3-1). While many of 
these mutants may be affected in their DNA-binding activity (see below), ToxR-V71A seemed to 
be particularly interesting since it showed only 3% activity on the ompU promoter, but 
maintained 15% activation of the toxT promoter (Fig. 3-1). This suggests the ToxR-V71A 
mutation affects a region of ToxR that is especially important for ToxR to directly activate the 
ompU promoter, but less critical when ToxR plays an accessory role with TcpP to activate the 
toxT promoter. Based on homology with other winged-HTH proteins, residue V71 of ToxR lies 
within the "-loop that is proposed to directly interact with RNA polymerase to activate 
transcription of target promoters (Fig 3-2A & B). Thus, some mutations in this region of ToxR 
would be predicted to affect the direct activation mechanism of ToxR at the ompU promoter 
more than the accessory role at the toxT promoter. 
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Figure 3-1. Activation of ompU-lacZ or toxT-lacZ chromosomal reporter constructs in V. 
cholerae by various ToxR mutant derivatives. #toxR V. cholerae strains were complemented 
with HA-tagged wild-type ToxR, the empty vector pSK Bluescript, or various ToxR mutant 
proteins. !-galactosidase activity was measured after a 3-4 hour induction with 100mM IPTG at 
30°C.  Miller units were expressed as percent, relative to activation seen with wild-type ToxR-
HA. Data shown are from at least two experiments performed in triplicate. ToxR-HA from the 





Figure 3-2. Modeling of the N-terminal DNA-binding/transactivation domain of ToxR 
(residues 1-114) using threading of the ToxR sequence onto structurally related winged-
HTH family members.  A) labeling of putative domains of interest within the ToxR 
transcription activation and DNA-binding domain, model assembled using I-TASSER (2-4) B) 
homology modeling of residues within ToxR that affect ompU promoter activation more 
dramatically than toxT promoter activation.  C) homology modeling of residues within ToxR that 
affect toxT promoter activation more dramatically than ompU promoter activation. 
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In addition to identifying mutant ToxR-V71A that affects ompU activation more 
dramatically than toxT, six of the ToxR mutants isolated were more strongly attenuated for toxT 
activation than ompU. While this phenotype was not necessarily expected from our selection 
strategy, we were excited to identify such differential ToxR mutants. Again, such mutants 
suggest that activation of ompU and toxT by ToxR have different specific requirements within 
the transcription activator ToxR. Five of six mutants lie just N-terminal to or within the putative 
wing domain of the ToxR winged-HTH structure; ToxR-D89E, ToxR-K92E, ToxR-S93P, ToxR-
P101L, and ToxR-R103G (Fig. 3-2A & C). The wing domain of winged-HTH proteins can 
perform different functions including DNA binding and protein-protein interaction, depending 
on the activator protein (5, 33-35).  
When the ToxR sequence is threaded onto the structures of related winged-HTH activator 
proteins (Fig. 3-2A), five of the amino acid substitutions preferentially affecting toxT expression 
are predicted to lie on a distinct face of ToxR (Fig. 3-2C) from amino acids required for efficient 
ompU activation in the "-loop (Fig. 3-2B). We did identify one "-loop mutant, ToxR-R65Q, in 
the ompU-sacB screen that was preferentially defective for toxT activation, but it was the least 
preferential (<2-fold differential, Fig. 3-1 and 3-2C).  
 
DNA binding activity of ToxR mutant derivatives. Six of the 13 isolated ToxR 
mutants were severely defective for activation of both the ompU and toxT promoters. These 
include, ToxR-W64R, ToxR-Q78R, ToxR-L83P, ToxR-T99K, ToxR-T99R and ToxR-G104S. 
One simple explanation for the defect in activation by these mutants is that they fail to recognize 
either promoter. In fact, two of the seven mutants lie within the putative DNA-recognition helix 
("3, Fig. 3-1 & 3-2A) of ToxR (ToxR-Q78R and ToxR-L83P). 
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We first assessed binding to the ompU promoter. V. cholerae lacking endogenous copies 
of toxR and tcpP (strain EK459, Table 3-4) was transformed with the pSK-toxR-HA plasmid 
encoding each toxR mutant allele. Membranes were prepared from these strains (18) and used in 
a gel mobility shift assay with a radiolabeled fragment of the ompU promoter from -211 to +22 
relative to the transcription start site. This fragment has been shown previously to contain ToxR-
binding sites (30). 
 ompU promoter probes were mixed with 0.05 or 0.25mg/ml of total membrane proteins. 
While negative control membranes (pSK, vector alone) gave some shifting of the probe in the 
absence of ToxR (Fig. 3-3A, asterisk), ToxR-mediated binding could be distinguished because 
ToxR causes retention of the probe in the well (membranes are retained in the well in this assay, 
Fig. 3-3A). This experiment demonstrated that the six ToxR derivatives severely defective for 
both ompU and toxT activation were unable to bind the ompU promoter. These include ToxR-
W64R, ToxR-Q78R, ToxR-L83P, ToxR-T99K, ToxR-T99R and ToxR-G104S. To confirm that 
sufficient amounts of ToxR were available to bind the ompU promoter, Western blot analysis 
was performed to determine the relative amount of each ToxR derivative present in each gel-shift 
reaction. Levels of all 14 ToxR proteins (including wild-type) were similar (Fig. 3-3A). As a 
negative control probe for these experiments we used a fragment of the toxT promoter lacking a 
ToxR-binding site (from -46 to +45). 
 Most ToxR derivatives that demonstrated an intermediate ompU activation defect (Fig. 3-
1) showed either modest or no DNA-binding defect for the ompU promoter (Fig. 3-3A). While 
ToxR-R65Q, ToxR-V71A and ToxR-K92E were clearly not as efficient as wild-type ToxR for 
ompU promoter binding (even with ToxR-K92E being present at higher protein levels than wild-
type ToxR), ToxR-P101L and ToxR-R103G were somewhat less obvious in their DNA-binding 
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Figure 3-3. Gel-shift assays to assess promoter recognition by various ToxR mutant 
proteins identified in a random mutagenesis ompU-sacB selection strategy.  V. cholerae 
membranes prepared from a #toxR#tcpP V. cholerae strain (EK459) expressing each mutant 
ToxR derivative (or wild-type ToxR-HA) were mixed at 0.05 and 0.25 mg/ml (two lanes for 
each sample) with radiolabeled ompU promoter DNA (A) or 0.1 and 0.5 mg/ml with toxT 
promoter DNA (B) prior to running samples in a non-denaturing PAGE. 
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defects. Finally, ToxR-D89E and ToxR-S93P bind the ompU promoter similar wild-type ToxR, 
although ToxR-S93P does not retain all of the ompU probe in the well (some smearing).  
Since the ToxR derivatives with intermediate ompU activation defects all have 
differential effects on toxT activation (Fig. 3-1), we examined whether these ToxR derivatives 
have differential defects in toxT promoter binding as compared to the ompU promoter. A toxT 
promoter probe (from -172 to +45) containing the ToxR-binding site was radiolabeled and used 
in a gel-shift assay with the same membranes used for the ompU promoter gel-shift assays (Fig. 
3-3B). The six mutants defective for both ompU and toxT activation (ToxR-W64R, ToxR-Q78R, 
ToxR-L83P, ToxR-T99K, ToxR-T99R and ToxR-G104S) were also defective for toxT promoter 
binding.  
The two "-loop mutants, ToxR-R65Q and ToxR-V71A showed intermediate defects in 
toxT promoter binding, consistent with their ability to activate the toxT promoter to 15-20% of 
wild-type ToxR activity (Fig. 3-1).  
The five ToxR mutants in the wing domain (or just N-terminal to the wing) had 
intermediate toxT promoter-binding defects (Fig. 3-3B). These wing and wing-proximal mutants 
appear slightly more defective for toxT than ompU promoter binding (Fig, 3-3A vs. 3-3B). 
However, the level of their toxT activation defect is not solely determined by their DNA-binding 
defect. Specifically, ToxR-P101L and ToxR-R103G have similar toxT promoter DNA-binding 
defects, yet ToxR-R103G is 3-fold more defective for toxT activation than ToxR-P101L. Thus, 
this region may perform a role in addition to DNA binding that affects toxT transcription 
activation. While ToxR-K92E maintains some (albeit modest) DNA-binding activity on the 
ompU and toxT promoters (Fig. 3-3), it has a much stronger defect in toxT activation than ompU 
activation (Fig. 3-1). This could reflect a critical role for residue K92 in toxT activation or the 
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fact that toxT promoter activation is more sensitive to ToxR mutations affecting DNA-binding 
affinity. Finally, mutant ToxR-D89E showed nearly wild-type binding to both the ompU and 
toxT promoters, with a very slight defect in toxT binding (Fig. 3-3). This mutant can only 
activate the toxT promoter to about 30% the level of wild-type ToxR, while ompU activation 
shows 79% of wild-type activity. This suggests this conservative amino acid substitution is 
particularly detrimental to ToxR/TcpP-mediated activation of the toxT promoter either due to a 
slight defect in toxT promoter binding or some other toxT activation function. 
 
Characterization of previously identified ToxR mutant derivatives. Over the years a number 
of ToxR mutant derivatives have been constructed based on homology modeling of specific 
residues with the OmpR/PhoB of transcription activators (7) or isolated from a mutagenesis 
screen that affected the accessibility of ToxR to periplasmic proteases (10). Comparing activities 
of the various mutants has been somewhat complicated by the fact that authors focus on different 
promoters for assessing ToxR activity such as ctx-lacZ fusions (7, 10, 36-38), a promoter that is 
now thought to be directly activated by ToxT rather than ToxR in V. cholerae (25, 26, 28). In 
other cases, ompU promoter activity was based on the levels of OmpU or OmpT protein as 
measured in a semi-quantitative fashion on Coomassie gels. Thus, to standardize comparison of 
the activities of these various ToxR derivatives, we constructed several of these mutants in our 
ToxR-HA expression system and tested them for activation of our ompU-lacZ and toxT-lacZ 
reporters. In this way we could directly compare activation levels with !-galactosidase assays 
and determine protein levels by anti-HA Western blots. 
 Results for various constructed ToxR-HA mutants are presented in Table 3-1. The initial 
set of ToxR-HA mutants tested were based on studies by Ottemann et. al. (7) where several 
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Table 3-1: Activation phenotypes of ToxR derivatives from various mutagenesis studies 
     
ToxR derivative location ompU-lacZ toxT-lacZ 
Controls 
ToxR-HA wild-type -  100% + 5.6        100% + 6.9 
pSK -     0.3% + 0.03         1.6% + 0.1 
Ottemann mutants 
ToxR-E39K-HA !1  18.6% + 1.2    104.5% + 8.2 
ToxR-S55A-HA "5  94.6% + 2.4    111.8% + 3.3 
ToxR-R56K-HA !2    1.2% + 0.2        2.0% + 0.1 
ToxR-R56L-HA !2        0.3% + 0.009        1.8% + 0.1 
ToxR-R65L-HA !-loop  39.4% + 0.9      32.3% + 1.9 
ToxR-R84K-HA !3/DNA-binding domain      0.3% + 0.03        1.9% + 0.1 
ToxR-R84L-HA !3/DNA-binding domain        0.3% + 0.03          1.8% + 0.04 
ToxS-blind mutants 
ToxR-K85E-HA !3/DNA- binding domain      0.3% + 0.02          2.0% + 0.05 
ToxR-D89N-HA between !3 & wing domain        1.0% + 0.02        2.4% + 0.1 
ToxR-T99M-HA wing domain     0.4% + 0.04        2.1% + 0.1 
toxT-lacZ white mutants 
ToxR-R84C-HA !3/DNA- binding domain     0.3% + 0.02          2.0% + 0.05 
ToxR-D89Y-HA between !3 & wing domain     0.5% + 0.09        2.1% + 0.2 
ToxR-K98E-HA wing domain 65.7% + 6.8      25.8% + 1.2 
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ToxR residues conserved in OmpR were targeted for mutagenesis. These mutants had been 
tested previously for their ability to activate a ctx-lacZ fusion in E. coli, to alter outer membrane 
protein profiles from OmpU to OmpT in V. cholerae and for the ability to direct cholera toxin 
production in V. cholerae (presumably via the TcpP-dependent activator, ToxT). One should 
note that since the studies by Ottemann et. al., Pfau and Taylor mapped the N-terminus of the 
ToxR protein and it begins at the second ATG predicted start codon (39), thus we have 
renumbered the reconstructed ToxR-HA mutants to represent the position of the mutation. 
Ottemann et. al. noted previously that ToxR-E39K (E51K, by their numbering system) 
failed to activate a ctx-lacZ fusion in E. coli and showed an altered OmpU/OmpT profile 
suggesting ToxR-E39K was defective for transcription activation of ompU, but maintained ompT 
repression indicating DNA-binding was unaffected. Our studies confirm that ToxR-E39K has 
only 19% activity at the ompU promoter, yet it still maintains wild-type levels (105%) activity at 
the toxT promoter. Our findings suggest this mutation affects the direct activation of ompU, 
while having no effect on TcpP-dependent activation of toxT. This further emphasizes the 
different mechanism used by ToxR for activation of these two promoters. DNA-binding studies 
with the ToxR-E39K mutant suggest it is partially defective for DNA binding (Fig. 3-4). 
Homology modeling of the ToxR-E39K mutant places it in the first a helix ("1) of the 
PhoB/OmpR-type DNA-binding and transcription activation domain (Fig. 3-2). This region does 
not directly bind DNA, but is a scaffolding helix that is packed against helix 3 (the DNA-
recognition helix) and the more C-terminal wing domain (33, 40, 41). As such, the ToxR-E39K 
mutation may affect proper orientation of these two domains as well as the orientation of the 
transactivating "-loop. Alternatively, portions of the E39 side-chain may directly contact RNA 





Figure 3-4.  Gel-shift assays to assess promoter recognition by various ToxR mutant 
proteins identified previously (7, 10) or in a random mutagenesis toxT-lacZ blue-white 
screen (this study).  V. cholerae membranes prepared from a #toxR#tcpP V. cholerae strain 
(EK459) expressing each mutant ToxR derivative (or wild-type ToxR-HA) were mixed at 0.05 
and 0.25 mg/ml with radiolabeled ompU promoter DNA (A) or 0.1 and 0.5 mg/ml with toxT 
promoter DNA (B) prior to running samples in a non-denaturing PAGE. 
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Four toxR mutants that Ottemann et. al. showed to have little or no activity on the ompU 
or ctx promoter and led to almost no cholera toxin (CT) production (ToxR-R56K, ToxR-R56L, 
ToxR-R84K and ToxR-R84L; (7)) showed no activity at either the ompU or toxT promoters 
using our lacZ reporter strains (Table 3-1). DNA-binding assays demonstrated three out of four 
derivatives (ToxR-R56L, ToxR-R84K and ToxR-R84L) lack DNA-binding activity for both 
promoters even though the proteins were stably expressed in the membrane of V. cholerae (Figs. 
S1A & B). One mutant derivative, ToxR-R56K, had weakly detectable binding to the ompU and 
toxT promoters (Fig. 3-4). However, ToxR-R56K failed to activate either promoter. Thus, the 
level of DNA-binding observed with the ToxR-R56K mutant is insufficient for promoter 
activation.  
The final mutant that we reconstructed from Ottemann’s studies was ToxR-R65L which 
was shown previously to have a partial defect for ompU activation based on outer membrane 
protein profiles and was 2 to 3-fold decreased for CT production. We also found that ToxR-
R65L was partially defective for both ompU and toxT activation with activation levels of 39% 
and 32% of wild-type, respectively (Table 3-1). This mutation lies within the putative "-loop and 
behaves similarly to our previously generated alanine mutant at this position (ToxR-R65A, Table 
2) and mutant ToxR-R65Q from our random mutagenesis and sucrose selection (Fig. 3-1). 
ToxR-R65L (Table 3-1), ToxR-R65A (Table 3-2) and ToxR-R65Q (Fig. 3-3) had modest DNA-
binding defects that may explain their partially impaired abilities to activate both the ompU and 
toxT promoters (Fig. 3-5, 3-4 and 3-1, respectively). 
In addition to the mutants generated by Ottemann et. al. we also reconstructed three 
ToxR mutants that were originally isolated from a screen for ToxR derivatives that were 
susceptible to periplasmic cleavage (resulting in increased activity of an alkaline phosphatase 
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fusion domain) even in the presence of ToxS, that normally protects ToxR from degradation in 
E. coli (10). Such “ToxS-blind” alleles were mapped to the cytoplasmic domain of ToxR (10). 
All three ToxS-blind derivatives of ToxR tested (ToxR-K85E, ToxR-D89N and ToxR-T99M) 
were severely defective for ompU and toxT activation (Table 3-1). DNA-gel shift assays revealed 
that while the proteins are stably expressed, one ToxR derivative (ToxR-K85E) is completely 
defective for DNA binding activity and derivatives ToxR-D89N and ToxR-T99M maintain only 
weak binding to the ompU promoter (Fig. 3-4A) and negligible binding to the toxT promoter 
(Fig. 3-4B).  
 
Characterization of three mutants isolated based on decreased activation of a toxT-lacZ 
fusion reporter. The last group of mutants generated in this study was isolated from a randomly 
mutagenized pool of pSK-toxR-HA alleles for their inability to active a toxT-lacZ fusion in V. 
cholerae. For these studies we used a blue/white screen to identify random ToxR mutant 
derivatives that were defective for activation of the toxT promoter. Three mutants were identified 
in an initial screen that affected toxT activation, ToxR-R84C, ToxR-D89Y and ToxR-K98E. 
ToxR-R84C and ToxR-D89Y were both completely defective for both toxT and ompU activation 
(Table 3-1), whereas ToxR-K98E maintained some activation of both promoters, yet showed a 
preferential defect (26% activation vs. 66%) for toxT activation as opposed to ompU. Like other 
mutants from our ompU-sacB selection that showed preferential toxT activation defects, ToxR-
K98E affects a residue in the putative wing domain of ToxR (Fig. 3-2C). 
 Mutant derivatives ToxR-R84C and ToxR-D89Y were unable to bind either the toxT or 
ompU promoters (Fig. 3-4), thus explaining their inability to activate these promoters. Residue 
K98 clearly plays a role in DNA-binding (Fig. 3-4), as would be expected by its location in the 
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wing domain (33). However, based on its preferential defect in toxT activation as opposed to 
ompU activation, it may also play a role in TcpP-mediated activation of the toxT promoter. 
 
The role of !-loop residues on ompU and toxT activation by ToxR. Since we found one 
ToxR residue essential for ompU expression in the "-loop of ToxR, ToxR-V71 (Fig. 3-1), we 
performed alanine-scanning mutagenesis of the entire the putative "-loop (R65-S75). Mutations 
were constructed in the pSK-toxR-HA vector and expressed in the either the ompU-lacZ (EK410) 
or toxT-lacZ (EK1072) reporter strains to assess transcription activation activity. 
 One additional mutant ToxR protein, ToxR-F69A, showed a >two-fold preferential 
defect for ompU expression. It activated ompU-lacZ to 35% of wild-type levels and toxT-lacZ to 
92% of wild-type (Table 3-2). Three mutants, ToxR-R65A, ToxR-G68A and ToxR-S74A, 
showed decreases in both ompU and toxT expression, ToxR-G68A and ToxR-S74A being 
slightly more defective for ompU than toxT activation (Table 3-2). One mutant protein, ToxR-
S75A, showed little or no activation of either ompU or toxT. This residue approaches the 
predicted DNA-binding helix of ToxR and disrupts the DNA-binding activity of ToxR (see 
below).  
 One alanine mutant in the "-loop, ToxR-D73A, showed a more dramatic defect on toxT 
(41% of wild-type) than on ompU (93% of wild-type) expression. When residue D73 of ToxR is 
modeled onto homologous winged-HTH transcription factor structures, ToxR residues F69 and 
V71 are oriented away from the "-loop in one direction, while residue D73 is predicted to be 
oriented in the opposite direction, toward residues P101 and R103 (Fig. 3-2C). Our random 
mutagenesis selection identified mutations in these latter two residues, ToxR-P101L and ToxR- 
R103G, that are also more dramatically affected for toxT expression than ompU. Thus, this face 
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Table 3-2. Activation phenotypes of ToxR !-loop mutants. Miller Units measured in strains 
EK410 (O395 #toxR ompU-lacZ) and EK1072 (O395 #toxR toxT-lacZ). Data are from one 
representative experiment performed in triplicate. 
 
 
ToxR derivative location ompU-lacZ toxT-lacZ 
ToxR-HA wild-type - 100.0% + 5.6 100.0% + 6.9  
pSK (vector) -     0.3% + 0.03     1.6% + 0.1 
ToxR-R65A "-loop   51.3% + 2.9   43.1% + 1.4 
ToxR-E66A "-loop 103.3% + 4.6 106.4% + 2.0 
ToxR-Q67A "-loop 101.4% + 3.6 164.5% + 3.9 
ToxR-G68A "-loop   12.0% + 0.9   19.2% + 2.3 
ToxR-F69A "-loop   35.2% + 1.1   91.6% + 3.0 
ToxR-E70A "-loop   79.5% + 3.4   91.7% + 3.1 
ToxR-D72A "-loop 102.8% + 2.5 118.0% + 9.5 
ToxR-D73A "-loop   92.9% + 0.6   40.8% + 15.3 
ToxR-S74A "-loop   47.4% + 5.1   63.1% + 6.7 




of the ToxR molecule appears to play a critical role in toxT activation in conjunction with TcpP, 
while V71 and F69 of the "-loop are more important for ompU activation by ToxR. 
 These alanine mutant studies also revealed that the preferential defect of ToxR-R65Q on 
toxT activation (Fig. 3-1) was largely side-chain dependent since the ToxR-R65A mutant had 
more similar defects in both ompU and toxT activation (albeit still slightly more defective for 
toxT activation, Table 3-2). 
 
Promoter recognition by !-loop alanine mutants. Since some of our "-loop ToxR alanine 
mutants have activation defects, we assessed the DNA-binding activity of the various mutant 
proteins. Membranes were isolated from a V. cholerae #toxR#tcpP mutant (EK459) expressing 
various ToxR derivatives and the membrane preparations were used in gel-shift assays on the 
ompU (Fig. 3-5A) or toxT (Fig. 3-5B) promoter.  
 While wild-type ToxR shifted about 50-75% of the ompU probe at the lower membrane 
concentration (Fig. 3-5A), three mutant proteins partially defective for ompU activation (ToxR-
R65A, ToxR-G68A, and ToxR-S74A; Table 3-2) had somewhat weaker binding to the ompU 
promoter. ToxR-S75A is unable to activate either the ompU or toxT promoter (Table 3-2) and is 
severely defective for DNA-binding (Fig. 3-5). Thus, it may define the first residue of the DNA-
binding helix of ToxR. Finally, ToxR-F69A maintains wild-type levels of binding to the ompU 
promoter (Fig. 3-5A) and displays slightly reduced binding to the toxT promoter (Fig. 3-5B). 
However, ToxR-F69A is preferentially defective for ompU activation (Table 3-2). Thus, residue 
F69 (like V71 identified in our original random mutagenesis selection) appears to be particularly 




Figure 3-5. Gel-shift assays to assess promoter recognition by putative !-loop site-directed 
ToxR mutant proteins.  V. cholerae membranes prepared from a #toxR#tcpP V. cholerae strain 
(EK459) expressing each mutant ToxR derivative (or wild-type ToxR-HA) were mixed at 0.05 
and 0.25 mg/ml with radiolabeled ompU promoter DNA (A) or 0.2 and 1.0 mg/ml with toxT 
promoter DNA (B) prior to running samples in a non-denaturing PAGE. 
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Effect of specific ToxR wing residue substitutions on differential promoter activation. Since 
alanine scanning mutagenesis of the "-loop indicated some preferential defects were side-chain 
dependent (R65Q vs. R65A, Fig. 3-1 and Table 3-2), we determined whether the preferential 
toxT activation defects of certain ToxR wing mutants were due to the specific side-chain 
substitutions, each residue was mutated to alanine (ToxR-D89A, ToxR-K92A, ToxR-S93A, 
ToxR-K98A, ToxR-P101A and ToxR-R103A). These ToxR derivatives were then tested for 
ompU and toxT activation in V. cholerae. While the absolute levels of ompU and toxT activation 
changed in the alanine mutants relative to the original side-chain substitution mutants, five of six 
wing mutants tested maintained preferential defects in toxT activation; ToxR-K92A, ToxR-S93A 
ToxR-K98A, ToxR-P101A and ToxR-R103A (Table 3-3), indicating these toxT-specific defects 
were not side-chain dependent.  
The ToxR-D89A mutant was completely defective for both ompU and toxT activation 
(Table 3-3) whereas the original conservative mutant, ToxR-D89E, maintained some activation 
of ompU and toxT (although it was preferentially toxT-defective, Fig. 3-1). All six alanine wing 
mutants were stably expressed similar to wild-type ToxR (data not shown). 
 
Mutant ToxR-P101L in the putative wing domain of ToxR is deficient in ToxR-TcpP 
crosslinking. Given that ToxR appears to play a supporting role for activation of the toxT 
promoter by assisting direct activation by TcpP (5), we tested our various ToxR wing domain 
mutants that were preferentially affected for toxT-lacZ activation, for their ability to interact with 
TcpP in the membrane of V. cholerae. We used a crosslinking capture ELISA protocol described 
previously (5) for assessing the interaction of a number of ToxR mutant derivatives with wild 
type TcpP. For these experiments a V. cholerae #tcpP strain (RY1) was first modified to harbor 
each toxR allele of interest on the chromosome at the toxR locus. The resulting strains 
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Table 3-3. Affect of side chain substitutions in the wing domain on promoter activation. 
Miller Units measure in strains EK410 (O395 #toxR ompU-lacZ) and EK1072 (O395 #toxR 
toxT-lacZ). * Data same as that shown in Fig. 3-1. ** Data same as that shown in Table 3-1. Data 
are from at least two experiments performed in triplicate. 
 
ToxR derivative ompU-lacZ  (% wild-type) toxT-lacZ  (% wild-type) 
ToxR-HA wild type 100.0 + 3.5 100.0 + 5.0 
pSK (vector)     0.3 + 0.04      1.4 + 0.07 
 
   ToxR-D89E-HA *   78.9 + 4.7   29.8 + 11.1 
ToxR-D89A-HA     1.2 + 0.23     1.7 + 0.1 
 
  ToxR-K92E-HA *   36.9 + 5.2     2.8 + 0.1 
ToxR-K92A-HA   73.8 + 15.6   33.4 + 3.9 
 
   ToxR-S93P-HA *   33.9 + 4.6     8.1 + 0.6 
ToxR-S93A-HA 104.0 + 6.9   21.4 + 3.4 
 
   ToxR-K98E-HA **   37.3 + 7.3   17.0 + 0.5 
ToxR-K98A-HA   74.1 + 6.6   18.0 + 1.0 
 
  ToxR-P101L-HA *   34.0 + 11.8   11.2 + 0.8 
ToxR-P101A-HA   52.2 + 16.0   10.3 + 0.4 
 
   ToxR-R103G-HA *   24.0 + 4.5     3.9 + 0.1 




Figure 3-6. Assessment of TcpP protein interaction by various ToxR mutant proteins that 
preferentially affect toxT transcription.  V. cholerae membranes from cells expressing each 
ToxR mutant derivative were assessed for their ability to interact with wild-type TcpP-HSV or 
TcpP-K101E.  ToxR mutant proteins were expressed from the chromosomal toxR locus while 
TcpP-HSV was expressed from the IPTG-inducible plasmid pEK41 in a #tcpP V. cholerae 
background.  TcpP-HSV was captured to 96-well microtiter plates using an anti-HSV 
monoclonal antibody. TcpP capture was assessed by probing the wells with an anti-TcpP 
polyclonal antibody (5, 6), while ToxR co-capture was assessed by probing parallel wells with an 
anti-ToxR polyclonal antibody. Levels of each ToxR mutant protein and TcpP-HSV were 
assessed by Western blot on the same protein extracts used for crosslinking. Statistical 
comparisons were made using the students’ t-test and compare samples relative to a strain 




were transformed with an HSV epitope-tagged version of TcpP (encoded on pEK41, (1)). The 
interaction between ToxR and TcpP-HSV was assessed using V. cholerae membranes harvested 
after a six-hour IPTG induction step to allow for TcpP-HSV expression and membrane insertion.  
We tested the ability of seven ToxR mutant proteins with preferential defects in toxT 
activation to interact with wild-type TcpP: ToxR-D73A, ToxR-D89E, ToxR-K92E, ToxR-S93P, 
ToxR-K98E ToxR-P101L, and ToxR-R103G (six of which lie adjacent to or in the putative wing 
domain). As a negative control we assessed the levels of interaction between wild-type ToxR and 
a TcpP mutant protein, TcpP-K101E, shown previously to be defective for ToxR interaction (5). 
 Of the ToxR mutants tested, only ToxR-P101L (located at the tip of the wing domain) 
showed reduced levels of interaction with TcpP, with about 15% of wild-type levels of 
interaction (Fig. 3-6). The level of ToxR-P101L interaction with TcpP was as low as the 
previously characterized weak interaction between ToxR and TcpP-K101E, although ToxR-
P101L was somewhat less stable than wild-type ToxR and this may contribute to the reduced 
level of ToxR/TcpP interaction (Fig. 3-6). One other mutant, ToxR-D89E, showed a trend 
towards decreased TcpP interaction, but the defect did not reach statistical significance (Fig. 3-6, 
p=0.07). All other ToxR mutants maintained wild-type (or in some cases increased) levels of 
TcpP interaction (Fig. 3-6), despite their reduced levels of toxT-lacZ activation (Fig. 3-1, Tables 
3-1 & 3-2) 
As the ToxR/TcpP capture assay is dependent upon lysine-mediated crosslinking, we 
established a second assay for ToxR/TcpP interaction, a membrane-bound ToxR and TcpP 
bacterial two-hybrid reporter system. This system is based on the reconstitution of a split 
adenylate cyclase enzyme of Bordetella pertussis, which upon ToxR/TcpP interaction brings the 
 99 
Figure 3-7. Assessment of ToxR/TcpP interaction by various ToxR and TcpP mutants 
using an adenylate cyclase-based membrane-anchored bacterial two-hybrid system. A) 
Interaction between wild-type TcpPH fused to the cya25 fragment of B. pertussis CyaA and 
ToxRS fused to the cya18 fragment of CyaA were assessed in strain BTH101. Interaction was 
determined by measuring "-galactosidase activity produced as a result of reconstitution of a 
functional adenylate cyclase enzyme.  Known non-interacting mutants of TcpP were fused to 
cya25 as controls.  As additional controls cya18-ToxR and cya25-TcpP alone were tested B) 
Western blot analysis of ToxR mutant derivatives fused to cya18.  C) Western blot analysis of 
wild-type ToxR and EpsM fused to cya18. D) Western blot analysis of TcpP fused to cya25. All 
western blots were probed with rabbit anti-CyaA antibodies (Santa Cruz Biotechnology). 
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two Cya fragments together leading to cAMP generation and increased !-galactosidase 
production in E. coli (12, 42). Unlike the crosslinking assay described above, this assay does not 
rely upon primary amines for DSP-mediated crosslinking. Using the bacterial two-hybrid system 
we were unable to detect a significant defect in ToxR-P101L interaction with TcpP (Fig. 3-7), 
suggesting the defect in interaction in the crosslinking assay may be due to alterations in the 
orientation of lysines in the vicinity of P101. 
These data indicate that ToxR-P101L maintains interaction with TcpP, but in an altered 
form as compared to wild-type ToxR. It should be noted that the bacterial two-hybrid assay is 
performed using plasmids expressing ToxR and TcpP in E. coli and the levels of ToxR-P101L 
may be higher than was achieved in V. cholerae when ToxR-P101L was expressed from its 
normal chromosomal locus. None of the other ToxR wing domain mutants tested had a defect in 
the bacterial two-hybrid assay (Fig. 3-7). 
Two previously characterized TcpP mutants, TcpP-L96S and TcpP-I97T, that failed to 
interact with ToxR in the capture assay (5), were completely defective for ToxR/TcpP interaction 
in the bacterial two-hybrid assay (Fig. 3-7A), while a third TcpP mutant, TcpP-K101E, 
completely defective for ToxR crosslinking (Fig. 3-6, (5)), was only partially defective in the 
bacterial two-hybrid assay (Fig. 3-7A; p=0.035). This mutant may have lost some level of 
crosslinking in the capture assay (Fig. 3-6) due to substitution of the lysine, which carries a 
primary amine group. While TcpP-L96S and TcpP-I97T were less stable than wild-type TcpP in 
this system, it should be noted that some ToxR mutants (ToxR-S93P and ToxR-K98E) were 





 This manuscript set out to address the differential roles for ToxR at two distinct V. 
cholerae promoters, ompU and toxT. Using an ompU-sacB fusion-based selection strategy, we 
identified a number of residues in ToxR required for full activation of the ompU promoter (Fig. 
3-1). While several of these mutations severely affected ompU promoter binding, those in the 
putative "-loop of ToxR (Fig. 3-2) had less dramatic DNA-binding defects (Fig. 3-3A). One 
particular "-loop mutant, ToxR-V71A, was nearly completely defective for ompU activation (3% 
of wild-type) while it maintained intermediate levels of toxT activation (15% of wild-type, Fig. 
3-1). Thus, this residue in the "-loop may be particularly critical for engagement of the RNAP 
machinery at the ompU promoter. The fact that one other "-loop mutant, ToxR-R65Q, had an 
ompU promoter-binding defect similar to ToxR-V71A (Fig. 3-3A), yet maintained 35% ompU 
activation also supports the hypothesis that V71 has a specific role in ToxR-mediated ompU 
activation. The importance of residues in the "-loop in ompU activation was reiterated with the 
generation of site-directed "-loop mutations in which one additional "-loop alanine substitution, 
ToxR-F69A, led to a defect in ompU activation (Table 3-2), but had no effect on ompU promoter 
binding (Fig. 3-5A). Residue E39 in the neighboring helix "1 (Fig. 3-2A and B) also appears to 
contribute specifically to ompU activation (Table 3-1) and may be part of an RNAP interaction 
patch for ompU activation (Fig. 3-8). 
It should be noted that some mutations in the "-loop affected both ompU and toxT 
activation (ToxR-R65A, ToxR-G68A and ToxR-S74A) and two mutants, ToxR-R65Q and 
ToxR-D73A, affected toxT activation preferentially over ompU (Fig. 3-1 & Table 3-2). Thus the 
"-loop is not exclusively important for ompU activation. However, the ToxR-V71A mutant 
indicates this residue is particularly important for ompU activation as no other "-loop mutant 
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Figure 3-8. Model for differential activation of the ompU and toxT promoters of V. cholerae 
by ToxR.  A) ToxR directly activates the ompU promoter in the absence of TcpP using residues 
F69 and V71 of the "-loop, and possibly E39 of "3, to stimulate RNA polymerase transcription.  
B) ToxR activates the toxT promoter in conjunction with TcpP by facilitating the ability of TcpP 
to interact with RNA polymerase.  At the toxT promoter, ToxR and TcpP may interact via wing-
wing contacts between the proteins. Thus, in this model, ToxR is inverted in its binding 
orientation on the DNA relative to the ompU promoter to present the wing face of ToxR to TcpP. 
Both promoters are shown from a backside view to allow easier visualization of the side chains 
that contribute preferentially to ompU (magenta) or toxT (orange) activation. The DNA template 
used is from the structure of PhoB bound to DNA (8). 
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tested had a comparable toxT activation defect (97% defective). Other members of the 
OmpR/PhoB family of winged-HTH activators also have activation-specific mutations identified 
in their "-loops (43, 44). In some cases, suppressor mutations in the gene encoding a component 
of RNA polymerase can rescue the activation-defective OmpR/PhoB family member (45).  
Eight ToxR substitution mutants with intermediate defects in ompU-lacZ expression 
(ToxR-R65Q, ToxR-D73A, ToxR-D89E, ToxR-K92E, ToxR-S93P, ToxR-K98E, ToxR-P101L 
and ToxR-R103G) showed preferential defects in toxT-lacZ expression relative to ompU-lacZ 
expression. Six of eight substitutions affect residues adjacent to or within the putative wing 
domain of the winged-helix-turn-helix (winged-HTH) domain of ToxR. The wing domain in this 
family of proteins has been shown in some instances to be involved in DNA-binding, while in 
other cases it plays a role in protein-protein interactions (5, 8, 33, 35). When involved in DNA-
binding, the wing binds the minor groove of the DNA helix while the DNA-recognition "-helix 
("3, Fig. 3-2A) recognizes the major groove (8, 33). Our findings suggest the wing domain of 
ToxR is involved in DNA binding (Fig. 3-3) and may also play a role in TcpP interaction (Fig. 3-
6). We hypothesize that ToxR interaction with TcpP allows ToxR to facilitate activation of the 
toxT promoter. One ToxR wing mutant that affected toxT activation preferentially, ToxR-P101L, 
was defective for this ToxR/TcpP interaction as assessed by a crosslinking assay, with ToxR-
P101L expressed from its chromosomal locus (Fig. 3-6). On the other hand, a plasmid-based 
ToxR/TcpP bacterial two-hybrid assay revealed no significant defect for ToxR-P101L/TcpP 
interaction (Fig. 3-7). It was notable that wild-type ToxR consistently generated high levels of 
cAMP in the bacterial two-hybrid assay, resulting in lacZ expression levels ranging from 898-
2922 Miller Units over 42 measurements, while ToxR-P101L gave more variable lacZ 
expression levels, ranging from 195-2975 Miller Units over 27 measurements (Fig. 3-7A). 
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Together we take these data to indicate that the ToxR-P101L mutant likely presents a slightly 
altered conformation of the ToxR wing domain that affects the ToxR/TcpP crosslinking assay 
more dramatically than the bacterial two-hybrid assay. We hypothesize that in the former assay, 
this altered wing conformation affects the presentation of a neighboring lysine residue, which is 
involved in ToxR/TcpP crosslinking.  
Because no other wing mutants tested had a significant defect in TcpP interaction by 
either assay, the toxT-preferential defects of the other ToxR wing substitutions may reflect their 
slightly greater defects in toxT promoter binding as compared to ompU binding (Fig. 3-3 and 3-
4) and/or some other aspect of promoter interaction required for full toxT activation. ToxR may 
have a lower affinity for the toxT promoter than the ompU promoter, thus the reduced DNA-
binding activity of these ToxR wing mutants may largely explain their preferential defects in 
toxT activation. Modest reductions in DNA-binding affinity may also preferentially affect toxT-
lacZ expression in V. cholerae relative to ompU-lacZ since ToxR must displace the global 
regulator H-NS bound to the toxT promoter (46). Alternatively, by affecting the wing domain, 
these mutants may be altered in their interaction with the minor groove of the DNA in a way that 
slightly changes the orientation of ToxR on the DNA rather than leading to a major defect in 
DNA-binding affinity. This could adversely affect the ability of ToxR to efficiently function with 
TcpP to facilitate toxT expression. It remains less clear why the ToxR "-loop mutant derivatives, 
ToxR-R65Q and ToxR-D73A, showed toxT-specific activation defects (Fig. 3-1 & Table 3-2), 
but their toxT activation defects were <2-fold of their ompU activation defects, making them the 
least dramatic of the toxT-specific defects. The ToxR-D73 side chain is predicted to be oriented 
towards the wing domain when modeled on other winged-HTH transcription factors (Fig. 3-2C), 
although assignment of side-chain orientation in loop regions is tentative. If oriented towards the 
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wing domain, D73 may function along with wing residues of ToxR to enhance TcpP-mediated 
toxT activation. R65 maintains some toxT-specific defects even when changed to alanine or 
leucine (Tables 3-1 & 3-2), although the preference diminishes with these other side-chain 
substitutions. When bound to the toxT promoter with "3 in the major groove it is possible that 
R65 can contribute to functions specific for TcpP-dependent activation as this side chain is 
predicted to extend to the edge of the "-loop (Fig. 3-2C) and potentially participate in 
interactions primarily involving the face of ToxR containing the wing domain. Our modeling of 
ToxR bound to DNA and results with other PhoB/OmpR family members (8, 33) indicate that 
the "-loop sits “side saddle” on the DNA (Fig. 3-8) and interacts with RNAP from that position. 
Thus, residues that extend in one direction from the "-loop like F69 and V71 (Fig. 3-2B) may 
interact with RNAP while those that extend in the other direction, like R65 and D73 may interact 
with other components of the activation complex. 
Over the past several years a number of ToxR mutant derivatives have been generated 
with various affects on transcription and DNA binding. These studies were performed in various 
bacterial backgrounds including E. coli, Salmonella typhimurium and V. cholerae (1, 7, 9, 18, 23, 
36-39, 47, 48). The promoter used in many of these studies was the cholera toxin (ctx) promoter, 
a promoter now believed to be directly activated by the AraC-like transcription factor, ToxT (10, 
25, 26, 28). We reconstructed a number of these mutants from various studies using our pSK 
Bluescript expression vector with a C-terminal HA epitope tag to assess their activation using 
our ompU-lacZ and toxT-lacZ V. cholerae reporter strains. These two promoters represent those 
known to be directly activated by ToxR in V. cholerae.  
In previous work, Ottemann et al reported a number of conserved residues in the DNA-
binding and transactivation domain of ToxR were required for ctx-lacZ activation in E. coli, 
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OmpU and CT production in V. cholerae and ctxA promoter binding (7). Our findings using 
toxT-lacZ fusions (a promoter activated prior to CT production) and ompU-lacZ fusions in V. 
cholerae were largely in agreement with the previous findings. One difference we found was that 
ToxR-E39K had an intermediate defect on ompU-lacZ expression, but had little effect on toxT-
lacZ expression (Table 3-1). Ottemann et al reported this mutant to be strongly defective for ctx-
lacZ activation in E. coli and CT production in V. cholerae (7). It is unclear why we saw little to 
no effect on toxT-lacZ activation. It is possible that even in V. cholerae, there is a role for ToxR 
in direct ctxAB activation, and this mutation specifically affects ctxAB activation, while not 
affecting toxT activation. One other difference we found in our studies was that the ToxR-R84L 
mutation had no DNA-binding activity for either the ompU or toxT promoters (Fig. 3-4). 
Ottemann et al reported this mutant (ToxR-R96L by their numbering system) to maintain DNA-
binding activity, yet be unable to activate transcription (7). Their gel shift assays were performed 
on ctxA promoter fragments, whereas ours used ompU and toxT promoter fragments. It is appears 
this mutation affects binding to the three promoters tested differently. Our data are in agreement 
that ToxR-R84L is unable to activate transcription. 
Regarding the previous findings of DiRita et al where they identified a number of ToxS-
blind alleles of toxR that failed to allow ToxR-ToxS interactions in the periplasm, the three 
mutants we constructed for testing, ToxR-K85E, ToxR-D89N and ToxR-T99M, behaved much 
like the mutants previously described (10). All three mutants were unable to activate both ompU-
lacZ and toxT-lacZ fusions in V. cholerae (Table 3-1). We also showed that all three mutants 
were defective for ompU (Fig. 3-4A) and toxT promoter binding (Fig. 3-4B). In the case of 
ToxR-T99M, this is similar to the defect seen with two mutants identified in our original 
randomly-mutagenized pools affecting the same amino acid residue, ToxR-T99K and ToxR-
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T99R. The defect of ToxR-D89N is much more severe than the ToxR-D89E mutant identified in 
our random screen. Thus, the nature of the side-chain substitution has a great effect on activity of 
ToxR substitutions at this position. Our randomly isolated ToxR-D89E derivative is a very 
conservative change, thus it is not surprising that it retains more activity than ToxR-D89N. 
Given that asparagine (N) is also closely related to aspartate (D), this further suggests the 
negative charge of residue D89 (which would also be present in the D89E substitution) plays an 
important role in transcription activation. Finally, ToxR-K85E is a substitution within the DNA-
binding helix ("3) of ToxR. By changing a positively charged lysine to a negatively charged 
glutamate, DNA-binding is completely disrupted and the protein no longer activates 
transcription. A conservative ToxR-K85R mutation at this position has no effect on transcription 
activation (data not shown). Thus, all three tested “ToxS-blind” mutants disrupted DNA-binding. 
Why these substitutions affected the ability of ToxR to interact with ToxS in the periplasm 
remains unclear. It is possible that DNA-binding facilitates ToxR dimerization and dimerization 
enhances ToxS interaction. Alternatively, ToxS may act as a chaperone for ToxR until it finds a 
ToxR dimerization partner (39, 49). If ToxR is unable to bind DNA, then once it is released from 
ToxS it may not stably interact with its ToxR binding partner, rendering the periplasmic domain 
of ToxR susceptible to protease cleavage. 
 One last ToxR mutant to discuss is ToxR-K98E. This residue is predicted to lie in the 
first !-strand of the wing domain (Fig. 2C) and has an intermediate defect in DNA binding to the 
ompU and toxT promoters (Fig. 3-4). This mutation was isolated from a screen for ToxR 
derivatives with reduced toxT-lacZ activation capacity. ToxR-K98E mediates 26% of wild-type 
activation for the toxT promoter and 66% activation for ompU (Table 3-1). One possibility for 
the preferential defect of ToxR-K98E on toxT activation could be an impaired ability to interact 
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with TcpP. However, capture assay analysis and bacterial two-hybrid analysis demonstrated that 
ToxR-K98E had no defect in interaction with TcpP (Figs. 3-6 and 3-7). Thus, while this mutation 
negatively affects DNA binding, it maintains TcpP interaction. Since the crosslinker used in 
these studies, DSP, reacts with primary amines, this indicates crosslinking relies upon other 
lysines of ToxR. This could indicate that K98 and the wing domain of ToxR are not directly 
involved in ToxR/TcpP interactions, or other neighboring lysines (such as K92 or K102) can also 
facilitate ToxR/TcpP crosslinking.  
In all, these studies define residue V71 of the "-loop of ToxR as being critical for 
activation of the ompU promoter and F69 playing a supporting role in ompU activation. Residues 
adjacent to and within the wing domain of ToxR also affect ompU activation, but in a number of 
cases more strongly affect toxT activation. Why some of these ToxR mutations affect toxT more 
dramatically than ompU remains to be determined. In at least one case, ToxR-P101L, 
presentation of the wing domain for ToxR/TcpP interaction was affected (Fig. 3-6). For the 
remainder of the ToxR derivatives preferentially defective for toxT activation, there was no 
statistically significant defect in TcpP interaction. Thus, the wing domain of ToxR appears to 
play a role on both ompU and toxT activation, but perhaps a dual role in toxT activation, DNA 
binding and TcpP interaction. It is notable that the mutation affecting ToxR/TcpP crosslinking 
was ToxR-P101L, which is predicted to perturb the structure of the wing domain by eliminating 
the proline turn residue at the tip of the wing. Mutations in the wing domain of TcpP (also an 
OmpR/PhoB family member) have been shown previously to affect ToxR interaction (5). Thus, 
we present a model where the wing domains of ToxR and TcpP are oriented towards each other 
on the toxT promoter (Fig. 3-8). ToxR binds the toxT promoter at a direct repeat three helical-
turns upstream of the TcpP binding site (50). Thus, we model ToxR on the toxT promoter as a 
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head-to-tail dimer with its wing domain oriented toward TcpP (Fig. 3-8B). At the ompU 
promoter, we orient the promoter proximal ToxR molecule with residues F69 and V71 of the "-
loop oriented towards the promoter for interaction with RNA polymerase (Fig. 3-8A). 
Orientation of the remaining ToxR molecules on the ompU promoter is speculative and future 
experiments will test the model we propose for ToxR binding throughout the ompU promoter 
(30, 31). 
 
Materials and Methods 
Bacterial strains and plasmids. A list of bacterial strains and plasmids is provided as Table 3-4. 
V. cholerae were grown in modified LB (with 5g/L NaCl rather than 10g/L) with 100 µg/ml 
streptomycin and 100 µg/ml ampicillin or 25 µg/ml chloramphenicol as appropriate.  
Construction of an HA-epitope tagged toxR allele. toxR from V. cholerae strain O395 was 
PCR amplified from chromosomal DNA using a primer with a BamHI restriction site and 
including the toxR ribosomal binding site (primer 5’ ToxR-HA) and a 3’ XhoI restriction site 
(primer 3’ ToxR-HA) to allow in-frame ligation into the HA-tagging vector pcDNA3-HA (51)). 
The resulting C-terminally HA-tagged toxR allele was confirmed to encode wild-type toxR by 
sequencing. The toxR-HA allele was then liberated from pcDNA3-HA by BamHI and ApaI 
digestion and ligated into the expression vector pSK Bluescript (Invitrogen) for expression in V. 
cholerae. Primers for these studies are listed in Table 3-5. 
Isolation of sucrose-resistant toxR alleles using an ompU-sacB selection. The toxR-HA allele 
was subjected to random Taq polymerase-mediated mutagenesis by standard PCR amplification 
for 20 rounds of amplification using primers 5’ ToxR-HA and 3’ HA-tag ApaI. (Table 3-5). The 
toxR-HA mutant pool was cut with BamHI and ApaI and ligated into fresh pSK 
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Table 3-4. Strains and plasmids. 
 
V. cholerae strain    Source 
EK307  O395 #toxR   (1) 
EK406  EK307 ompU-sacB  this study 
EK410  EK307 ompU-lacZ  (9) 
EK459  O395 #toxR#tcpP  (1) 
EK816  O395 #toxRS toxT-lacZ this study 
EK1072 EK307 toxT-lacZ  this study 
 
E coli  strain 
DH5a      lab strain 
DHM1      (12) 
BTH101     (21) 
 
plasmids 
 random mutants from ompU-sacB  
pSK-toxR-HA wild-type   this study    
pSK-toxR-HA-W64R    this study  
pSK-toxR-HA-R65Q    this study 
pSK-toxR-HA-V71A    this study 
pSK-toxR-HA-Q78R    this study 
pSK-toxR-HA-L83P    this study 
pSK-toxR-HA-D89E    this study 
pSK-toxR-HA-K92E    this study 
pSK-toxR-HA-S93P    this study 
pSK-toxR-HA-T99K    this study 
pSK-toxR-HA-T99R    this study 
pSK-toxR-HA-P101L    this study 
pSK-toxR-HA-R103G    this study 
pSK-toxR-HA-G104S    this study 
pSK-toxR-HA-L107S    this study 
 "-loop mutants 
pSK-toxR-HA-R65A    this study 
pSK-toxR-HA-E66A    this study 
pSK-toxR-HA-Q67A    this study 
pSK-toxR-HA-G68A    this study 
pSK-toxR-HA-F69A    this study 
pSK-toxR-HA-E70A    this study 
pSK-toxR-HA-D72A    this study 
pSK-toxR-HA-D73A    this study 
pSK-toxR-HA-S74A    this study   




Ottemann reconstructed mutants (7) 
pSK-toxR-HA-E39K (formerly E51K) this study 
pSK-toxR-HA-R56K    this study 
pSK-toxR-HA-R56L    this study 
pSK-toxR-HA-R65L    this study 
pSK-toxR-HA-R84K    this study 
pSK-toxR-HA-R84L    this study 
  
DiRita ToxS-blind mutants  (10) 
pSK-toxR-HA-K85E    this study 
pSK-toxR-HA-D89N    this study 
pSK-toxR-HA-T99M    this study 
 
random mutants (toxT-lacZ)   
pMMB66EH-toxR     this study 
pSK-toxR-HA-R84C    this study 
pSK-toxR-HA-D89Y    this study 
pSK-toxR-HA-K98E    this study 
 
bacterial two-hybrid plasmids 
pKT25      (21) 
pUT18c     (21) 
pUT18c-EpsM    this study 
pUT18c-ToxRS    this study 
pUT18c-ToxRS-D73A   this study 
pUT18c-ToxRS-D89E   this study 
pUT18c-ToxRS-K92E    this study 
pUT18c-ToxRS-S93P    this study 
pUT18c-ToxRS-K98E   this study 
pUT18c-ToxRS-P101L   this study 
pUT18c-ToxRS-R103G   this study 
pKT25-TcpPH    this study 
pKT25-TcpPH-L96S    this study 
pKT25-TcpPH-I97T    this study 




Table 3-5.  Primers used in this study. 
 
primer name sequence 5’ to 3’ purpose 
5’ ToxR-HA gggggatcctcaaaagagatatcgatgag cloning toxR into pcDNA-HA and 
pSK Bluescript 
3’ ToxR-HA ggggggctcgagctcacacactttgatggc cloning toxR into pcDNA-HA 
3’ HA-tag ApaI cctgacgggcccactagcgaattcatctagaagcg  cloning toxR into pSK Bluescript 
toxR K85R TOP catttcgactctgcgcagaatgctcaaagattcg separation of double mutants 
toxR K85R BOTTOM cgaatctttgagcattctgcgcagagtcgaaatg separation of double mutants 
toxR D89E TOP caaaatgctcaaagagtcgacaaagtccccac separation of double mutants 
toxR D89E BOTTOM gtggggactttgtcgactctttgagcattttg separation of double mutants 
toxR R65A catgactttgtttgggctgagcaaggttttgaagtc !-loop mutant construction 
toxR E66A gactttgtttggcgagcccaaggttttgaagtcgat !-loop mutant construction 
toxR Q67A ctttgtttggcgagaggctggttttgaagtcgatgat !-loop mutant construction 
toxR D72A caaggttttgaagtcgctgattccagcttaacc !-loop mutant construction 
toxR D73A ggttttgaagtcgatgcttccagcttaacccaag !-loop mutant construction 
toxR S74A gttttgaagtcgatgatgccagcttaacccaagc !-loop mutant construction 
toxR S75A gaagtcgatgattccgccttaacccaagccatttc !-loop mutant construction 
toxR D72A BOTTOM ggttaagctggaatcagcgacttcaaaaccttg construction of chromosomal mutants 
toxR D73A BOTTOM cttgggttaagctggaagcatcgacttcaaaacc construction of chromosomal mutants 
toxR K92E TOP cgcaaaatgctcaaagattcgacagagtccccacaatacgtca
aaacggt 
construction of chromosomal mutants 
toxR K92E BOTTOM accgttttgacgtattgtggggactctgtcgaatctttgagcatttt
gcg 
construction of chromosomal mutants 
toxR S93P TOP caaagattcgacaaagcccccacaatacgtc construction of chromosomal mutants 
toxR S93P BOTTOM gacgtattgtgggggctttgtcgaatctttg construction of chromosomal mutants 
toxR K98E TOP cccacaatacgtcgaaacggttccgaagcgc construction of chromosomal mutants 
toxR K98E BOTTOM gcgcttcggaaccgtttcgacgtattgtggg construction of chromosomal mutants 
toxR P101L TOP cgtcaaaacggttctgaagcgcggttacc construction of chromosomal mutants 
toxR P101L BOTTOM ggtaaccgcgcttcagaaccgttttgacg construction of chromosomal mutants 
toxR R103G TOP caaaacggttccgaagggcggttaccaattgatc construction of chromosomal mutants 
toxR R103G BOTTOM gatcaattggtaaccgcccttcggaaccgttttg construction of chromosomal mutants 
ToxR XbaI Fwd ggggtctagagatgagtcatattggtactaaattcattc construction of BACTH system 
ToxS BamH1 Rev ggggggatccttaagaattactgaacagtacggtag construction of BACTH system 
TcpP XbaI Fwd ggggtctagagatggggtatgtccgcgtga construction of BACTH system 
TcpH BamH1 Rev ggggggatccctaaaaatcgctttgacaggaa construction of BACTH system 
EpsM XbaI Fwd ggggtctagagatgatgaaagaattattggctcc construction of BACTH system 
EpsM EcoRI Rev gggggaattctcagcctccacgcttcag construction of BACTH system 
tcpP L96S top gatgaacataagacgtcgatcgaaaatgtaaag construction of BACTH system 
tcpP L96S bottom ctttacattttcgatcgacgtcttatgttcatc construction of BACTH system 
tcpP I97T top gaacataagacgttgaccgaaaatgtaaagttac construction of BACTH system 
tcpP I97T bottom gtaactttacattttcggtcaacgtcttatgttc construction of BACTH system 
tcpP K101E top gttgatcgaaaatgtagagttacaaggttatc construction of BACTH system 





Bluescript digested with BamHI and ApaI. Three pools of ~300-400 clones were generated and 
used to transform the V. cholerae #toxR ompU-sacB strain, EK406. Transformants were plated 
onto LB plates containing 5% sucrose, 100 µg/ml streptomycin and 100 µg/ml ampicillin (to 
select for pSK Bluescript) and 100mM IPTG to induce toxR-HA expression. Within the three 
pools, the percentage of mutant pSK-toxR-HA alleles that resulted in sucrose resistance in strain 
EK406 was, 2.5%, 4.5% and 6.25%, respectively. About 160 colonies from the three pools were 
picked and screened individually for ToxR-HA expression by Western blot analysis after growth 
of the strain for 3hrs in 3mls LB + 100mM IPTG (data not shown). Those that expressed 
significant amount of full-length ToxR-HA as assessed by anti-HA antibody, were studied 
further. This amounted to about 25-35% of the total sucrose-resistant clones analyzed. Those 
mutants defective for ompU-sacB activation, that expressed full length ToxR-HA, were sent for 
sequencing at the University of Michigan Sequencing Core. 
Isolation of ToxR mutants defective for activation of a toxT-lacZ fusion. A small pool of 
toxR mutants (about 130) expressed from the IPTG-inducible plasmid pMMB66EH (52) were 
screened for their ability to activate a toxT-lacZ reporter in V. cholerae, strain EK816 (Table 3-
4). After transforming EK816 with the mutant pool, cells were grown for 1 hr in LB prior to 
plating on LB Agar supplemented with 10 µM IPTG, 100 µg/ml ampicillin (to select for the 
plasmid pMMB66EH-toxR) and 40 µg/ml X-gal at 30°C overnight. 24 white colonies were 
picked and analyzed for expression of full length ToxR protein by Western blot analysis using an 
anti-ToxR antibody. Plasmids expressing full-length protein were subjected to sequencing 
analysis at the University of Michigan Sequencing Core. Mutants of interest were removed from 
plasmid pMMB66EH-toxR and cloned into pcDNA3-HA and then pSK Bluescript as described 
for mutants from the sucrose selection strategy. 
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Measuring transcriptional activation activity of ToxR-HA derivatives. pSK-toxR-HA 
derivatives encoding various toxR-HA alleles were transformed into the V. cholerae #toxR 
ompU-lacZ reporter strain EK410 and the #toxR toxT-lacZ reporter strain EK1072. The latter is a 
#toxR derivative of a previously constructed O395 toxT-lacZ strain, a kind gift from Dr. Claudia 
Häse (19). Reporter strains harboring the various ToxR-HA derivatives were grown in triplicate 
overnight at 30°C and then diluted 1:50 and grown for 3-4 hrs at 30°C in the presence of 100 
µg/ml streptomycin, 100 µg/ml ampicillin and 100 µM IPTG. Cells were harvested and 20 µl or 
100 µl were used in a standard !-galactosidase assay (53). Measurements of ompU and toxT 
activation for each ToxR-HA mutant derivative were assessed in at least two separate 
experiments.  
DNA gel mobility shift assays. Promoter-binding assays were performed essentially as 
described previously (1). The membranes used were from strain EK459 (#toxR#tcpP) carrying 
each pSK-toxR-HA allele and induced for 4-5 hours at 30°C in 500ml LB pH=6.5 with 100 µM 
IPTG. Increasing concentrations of membrane were mixed with either an ompU promoter probe 
extending from -211 to +22 relative to the transcriptional start site, a toxT promoter probe 
extending from -172 to +45 or a negative control toxT promoter probe extending from -46 to +45 
(lacking the ToxR-binding site, (29)). Probes were labeled by Klenow fill-in of BamHI or SalI 
digested plasmids with "-32P-dCTP and 3000 cpm of labeled probe were used in each reaction. 
Relative levels of each ToxR mutant protein were assessed using anti-HA monoclonal antibody 
(Covance), anti-HA polyclonal antibody (Covance), or anti-ToxR polyclonal antibody. Samples 
normalized to the same relative concentrations used in the gel shift assay were boiled in SDS-
sample buffer and run in a 12% SDS-PAGE gel. 
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ToxR/TcpP-HSV Capture Assay. V. cholerae RY1 with various toxR alleles recombined at the 
normal toxR locus were transformed with plasmids expressing wild-type TcpP-HSV or the 
ToxR-interacting mutant TcpP-K101E. Strains were diluted 1:50 from an overnight culture at 
30°C and grown for 4-6 hrs at 30°C in 500ml LB containing 100 µg/ml streptomycin, 25 µg/ml 
chloramphenicol and 100 µM IPTG. Membranes harboring ToxR and TcpP-HSV proteins of 
interest were prepared (18) and dialyzed into HEPES-buffered saline (HBS, 20mM HEPES 
pH=7.0, 150 mM NaCl). Three to five mg/ml membrane proteins were crosslinked using a 15-
fold molar excess of DSP (Pierce) for 30' at room temp, blocked with 50mM Tris pH=7.4 and 
then solubilized in 1% Triton X-100 (Bio-Rad). The molarity of dialyzed membrane preparations 
was estimated by measuring the protein concentration and assuming a 50kD average protein size 
in the total membrane extract. After sonication on ice (3 x 5 seconds), 50 µl membrane extracts 
were added to microtiter plates coated with mouse anti-HSV antibody (Novagen, coated at 1:500 
dilution in PBS) and binding proceeded overnight at 4°C. After washing five times with PBS, 
wells were incubated with 50 µl a 1:100 dilution of rabbit anti-TcpP antibody or a 1:1000 
dilution rabbit anti-ToxR antibody. Primary antibody incubation proceeded from 3 hrs-overnight 
at 4°C. After five washes with PBS, wells were then incubated with a 1:3000 dilution of goat 
anti-rabbit-AP conjugated secondary antibody (Zymed) and binding was revealed by addition of 
100 µl of the colorimetric substrate PNPP (Sigma) at 4 mg/ml following sequential washing with 
PBS (four times) Tris-buffered saline (100mM Tris pH=8.0, 150mM NaCl, one wash). Plates 
were read at ABS405. Relative levels of each ToxR mutant protein were assessed using an anti-
ToxR polyclonal antibody at a 1:1000 dilution. Relative levels of TcpP-HSV in each strain were 
assessed using an anti-HSV monoclonal antibody (Novagen) at a 1:5000 dilution. The amount of 
TcpP-HSV or ToxR captured is presented as % of wild-type after subtracting out the background 
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signal obtained for each protein in the absence of TcpP-HSV (using the pMMB207 empty 
vector). Samples diluted on the same day to the same relative concentrations used in the capture 
assay were boiled in SDS-sample buffer and run in a 12% SDS-PAGE gel for Western blot 
analysis of protein levels in the extracts. Statistical analysis was performed using the students’ t-
test comparing six or nine measurements relative to the strain expressing wild-type ToxR and 
wild-type TcpP-HSV. 
ToxR/TcpP bacterial two-hybrid system. ToxRS and EpsM were PCR amplified from 
chromosomal DNA and cloned into the pUT18c vector (21) 3’ of the cya18 fragment in DHM1. 
TcpPH was PCR amplified from chromosomal DNA and cloned into the pKT25 vector (21) 3’ of 
the cya25 fragment in DHM1. Point mutations were created in ToxR and TcpP using site-
directed mutagenesis (primers are listed in Table 3-5). Plasmids were transformed into the 
reporter strain BTH101 and grown at 37oC in the presence of 100 µg/ml ampicillin and 30 µg 
/ml kanamycin. Cultures were induced 16 hours at 30oC in LB broth in the presence of 100 
µg/ml ampiclillin, 30 µg /ml kanamycin 0.5 mM and IPTG. 20 µl of culture was used in a 
standard "-galactosidase assay (53) in a minimum of 3 separate experiments with three replicates 
each. Stability of ToxR and TcpP mutants was determined by transforming the cya18-ToxRS 
mutant plasmid with pKT25 or cya25-TcpP mutant plasmid with pUT18c into BTH101. Cultures 
were induced 16 hours at 30°C in LB broth in the presence of 100 µg/ml ampicillin, 30 µg /ml 
kanamycin, 0.5 mM IPTG, and 1 mM cAMP. Samples normalized to the same relative 
concentrations by OD600 were boiled in SDS-sample buffer and run in a 10% SDS-PAGE gel. 
Samples were probed with anti-CyaA rabbit polyclonal antibody (Santa Cruz Biotechnology). 
ToxR mutant modeling. Using a newly developed program I-TASSER (2-4), we threaded the 
ToxR sequence onto winged-HTH family members with solved structures. I-TASSER made a 
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secondary structure sequence prediction for ToxR and threaded that onto to several best matches 
in the PDB, compiling the best matching fragments from each structure. In creating the ToxR 
model, I-TASSER used parts of YycF (from Bacillus subtilis), OmpR (E. coli), MtrA 
(Mycobacterium tuberculosis), RegX3 (M. tuberculosis), ArsR (Helicobacter pylori) and VicRc 
(Enterococcus faecalis) as the top ten threading templates (results at 
http://zhanglab.ccmb.med.umich.edu/I-TASSER/output/S57294/). It then compiled these best fit 
pieces and performed energy/hydrogen bonding optimization. The best fit of the ToxR model is 
to YycF, with 25% sequence identity (with PhoB of E. coli as the third best fit). Using the 
protein structure analysis program Chimera (54), several key residues of ToxR were highlighted 
to show the predicted orientation of their side-chains to gain insights into their potential effects 
on ToxR function.  
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The wing of the ToxR winged helix-turn-helix domain is required for DNA 
binding 
 
Note: All of the strains created and all of the assays performed in this chapter were done either 
by myself or by Emily French under my supervision. 
 
Summary 
 ToxR and TcpP, two winged helix-turn-helix (w-HTH) family transcription factors, 
activate expression of the toxT promoter in Vibrio cholerae. ToxT then directly regulates a 
number of genes required for virulence. In addition to co-activation of toxT, ToxR can directly 
activate the ompU promoter and repress the ompT promoter. Based on a previous study 
suggesting that the wing of ToxR is preferentially involved in toxT co-activation compared to 
ompU direct activation, we employed alanine-scanning mutagenesis to determine which residues 
in the wing of ToxR are required for activation of each promoter. Although several residues in 
the wing were preferentially required for toxT activation when expressed from a plasmid, this 
phenotype was dependent upon overexpression and not observed when the same ToxR mutants 
were expressed from the chromosome. All of the ToxR wing residues tested that were critical for 
transcriptional activation of toxT and/or ompU were also critical for DNA binding. Furthermore, 
none of the ToxR wing residues tested were critical for ToxR-TcpP interaction indicating that the
! "##!
wing of ToxR is likely not required for ToxR-TcpP interaction. Based on these findings we can 
conclude that the primary role of the wing of ToxR is to bind DNA, along with the DNA 
recogition helix of ToxR, and this function is required both for co-activation of toxT and direct 
activation of ompU.  
 
Introduction  
 ToxR and TcpP are transmembrane transcription factors that coordinately activate 
transcription of toxT, the gene encoding the master virulence regulator in V. cholerae. TcpP is 
posited to be the direct activator of toxT, binding to the toxT promoter from -53 to -38, just 
upstream of the -35 element (8). Although, TcpP is able to activate intermediate levels of toxT 
expression when overexpressed (7, 9), ToxR is required for TcpP-mediated expression of toxT 
under native conditions. ToxR binds to the toxT promoter from -96 to -83 (11), approximately 
three helical turns upstream of the TcpP binding site, enhancing TcpP-mediated activation of the 
toxT promoter. In addition to acting as a co-activator of toxT, ToxR is also able to directly 
activate the ompU promoter (13) and repress the ompT promoter (15).  
 ToxR and TcpP both have cytoplasmic domains that are homologous with the w-HTH 
(winged helix-turn-helix) family of transcription factors. Most w-HTH proteins have a N-
terminal regulatory domain and a C-terminal w-HTH domain. However, both ToxR and TcpP 
have an N-terminal w-HTH domain, which is linked to a periplasmic C-terminal domain through 
a single-pass transmembrane domain. The periplasmic domain of ToxR is involved in, but not 
required for, dimerization (16-21). The periplasmic domain of TcpP regulates stability and is 
proteolytically degraded under non-inducing conditions (22, 23). The functions of ToxR and 
TcpP periplasmic domains are enhanced by the periplasmic proteins ToxS and TcpP, 
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respectively (16, 22, 23). The w-HTH domains of ToxR and TcpP bind to the toxT promoter and 
activate transcription. The w-HTH domain consists of an N-terminal !-sheet, three "-helixes 
including the DNA-binding helix ("3) that is inserted into the major groove of the DNA, and a 
C-terminal wing (Fig. 4-1). The N-terminal !-sheet can be involved in protein-protein interaction 
as well as stabilizing the hydrophobic core (24-27). The first two "-helixes form part of the 
hydrophobic core as well as interact with the DNA backbone helping to stabilize protein-DNA 
interactions (3, 24, 28). Between the second "-helix ("2) and the DNA-binding helix ("3) is the 
"-loop. The "-loop of w-HTH proteins is hypothesized to interact with RNA polymerase (25). 
The "-loop of ToxR is critical for direct activation of the ompU promoter while less essential for 
co-activation of the toxT promoter (2). The wing of w-HTH proteins consists of a !-strand 
hairpin, which inserts into the minor grove of the DNA, thereby enhancing binding to the 
promoter (3, 24). The wing of w-HTH proteins is often also involved in dimerization (24, 29, 
30). 
Dimerization is critical for activation of w-HTH transcription factors and can be mediated 
by interactions between w-HTH domains, the N-terminal regulatory domain (of w-HTH proteins 
containing this domain) and the promoter architecture (24, 27, 29, 31, 32). w-HTH proteins have 
been found to dimerize in three different orientations. Both PhoB and OmpR have been shown to 
dimerize in a head-to-tail orientation on the promoter. In this orientation, the wing of the 
upstream w-HTH protein interacts with the !-sheet of the downstream w-HTH (24, 29). 
Alternatively, Mycobacterium tuberculosis PhoP has been shown by crosslinking to dimerize in 
a head-to-head orientation with the two !-sheets interacting (31). OmpR can also be found in 
head-to head orientations (27), although formation of OmpR dimers in head-to-head or head-to-
tail orientation may be primarily dependant on the orientation of the OmpR binding site (32). 
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Figure 4-1. Model of ToxR bound to the promoter. ToxR bound to DNA was modeled using 
the I-TASSER modeling program (http://zhanglab.ccmb.med.umich.edu/I-TASSER/) to 
determine ToxR structure based on the crystal structure of other w-HTH family members (2). 
Binding of ToxR to DNA was modeled using the NMR structure of PhoB bound to DNA (3)!
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Finally, HSF in Kluyveromyces lactis interacts in a tail-to-tail orientation in which the two wings 
interact (30). In this system the wings are only involved in protein-protein interaction and do not 
appear to interact with the DNA (30). Both ToxR and TcpP form homodimers (16-21, 33) as 
well as ToxR-TcpP heterodimers (2, 7). However, the orientation and interface(s) of these dimers 
has not been elucidated.  
 When ToxR is bound to the toxT promoter, a hypersensitivity site is created at the TcpP 
binding site (6) indicating an alteration of the structure of the toxT promoter upon ToxR binding. 
This hypersensitivity site indicates that upon ToxR binding to the toxT promoter, the TcpP-
binding site may become more accessible, allowing for enhanced TcpP binding to the promoter. 
Additionally, the toxT promoter is repressed by H-NS, and deletion of H-NS results in a six-fold 
increase in toxT expression over wild-type in the presence of ToxR and TcpP (1). ToxR is 
particularly critical for toxT activation in the presence of H-NS, as it can increase expression of 
toxT over 1000-fold, whereas, in the absence of H-NS, ToxR only increases expression of toxT 
three-fold (1). Together, this indicates that one of the primary roles of ToxR may be to relieve H-
NS repression, but that ToxR also plays an additional roll(s) in activation beyond relieving H-NS 
repression. ToxR also likely influences the localization of the toxT promoter by recruiting it to 
the membrane thereby enhancing TcpP binding. Although the cytoplasmic domain of ToxR is 
able to activate transcription of ompU, membrane localization is required for ToxR co-activation 
of toxT (5).  
 Another possible role for ToxR in co-activation of TcpP is recruitment of TcpP to the 
toxT promoter through ToxR-TcpP interaction. ToxR-TcpP interaction can be observed by DSP 
crosslinking in V. cholerae membranes (2, 7) and an membrane-localized E. coli bacterial two-
hybrid (BACTH) system (2). ToxR-TcpP interaction likely occurs through the wing of TcpP, 
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since mutations in the wing of TcpP can disrupt ToxR-TcpP interaction resulting in a defect in 
transcriptional activation (7). The wing of TcpP plays a dual role, since residues in the wing of 
TcpP also are required for binding to the toxT promoter (6, 7). The wing of ToxR may also be 
involved in ToxR-TcpP interaction, as ToxR-P101L was preferentially defective for toxT 
activation, relative to ompU activation, and was defective in interaction with TcpP by DSP 
crosslinking (2). ToxR-TcpP interaction could be maintained on the toxT promoter, allowing 
ToxR to stabilize TcpP binding to the promoter and thereby enhancing transcriptional activation. 
Alternatively, ToxR-TcpP interaction could recruit TcpP to the toxT promoter. In this model, 
ToxR-TcpP interaction would be disrupted upon ToxR binding to DNA, allowing each protein to 
bind to the promoter independently.  
The role of the ToxR-wing in co-activation of toxT could be due to DNA binding and/or 
ToxR-TcpP interaction. DNA binding by the wing of ToxR is critical for activation of both toxT 
and ompU since mutations in the wing of ToxR (T99K or G104S) that inhibit DNA binding 
inhibit transcriptional activation of both promoters (2). However, several mutants in the wing 
(P101L, and R103G) as well as mutants in the loop leading from the DNA-binding helix to the 
wing (D89E, K92E, S93P) are preferentially defective for transcription of toxT, compared to 
ompU (2). This could be due to differences in binding to the two promoters, ToxR-TcpP 
interaction, or other as yet unknown factors. The goal of this study was to determine the role of 
each residue in the wing of ToxR in transcriptional activation of both toxT and ompU. The 
requirement of ToxR wing residues for ToxR-TcpP interaction and DNA binding will also be 





The wing of ToxR is required for transcriptional activation of both toxT and ompU. To 
determine the role of each wing residue in ToxR co-activation of toxT and activation of ompU, 
we mutated each wing residue to alanine, including residues in the loop between the DNA-
binding helix ("3) and the wing. Alanine scanning was used because residues in this region of 
ToxR can have different phenotypes depending on the amino acid to which they are mutated (2). 
Each ToxR-wing mutant was expressed from a plasmid and tested for transcriptional activation 
of chromosomal ompU-lacZ (Strain EK410) and toxT-lacZ (Strain EK1072) (Fig. 4-2) (2, 5).  
Of the 25 residues tested, six were preferentially required for toxT co-activation as 
compared to ompU activation (K92, P94, Y96, P101, L107, and I108). Residues preferentially 
required for toxT co-activation were defined by mutation of that residue resulting in a 2-fold 
decrease in toxT co-activation relative to ompU activation and designated Class I mutants (Fig. 
4-2 green). Three of the six residues (Y96, L107, and I108) were required for both toxT co-
activation and ompU activation as mutation of these residues resulted in less than 50% activation 
of ompU. These residues are particularly critical for co-activation of toxT, since mutation of any 
of these residues decreased toxT transcriptional activation to less than 10% of wild-type. These 
residues are clustered at the hinge of the wing adjacent to the !-strands (Fig. 4-3). The two 
prolines present in the wing, P94 and P101, are partially required for ompU activation (50-70% 
activity when mutated), but critical for toxT co-activation (<30% activity when mutated). K92 is 
not required for ompU activation (maintained ~100% activity when mutated), but is involved in 
toxT co-activation (50% activity), similar to what has been previously described for this mutant 
(2). None of the residues were preferentially required for ompU activation relative to toxT 
activation, again highlighting the critical role for the wing of ToxR in co-activation of toxT. 
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Figure 4-2. Requirement of each residue in the ToxR wing on toxT and ompU activation. A) 
ToxR-HA wing mutants were expressed from pBluescriptSK- in the presence of pREP4 to 
regulate expression. The level of activation both the toxT-lacZ and ompU-lacZ chromosomal 
reporters for each mutant was measured by !-galactosidase assay and normalized to wild-type 
ToxR. Mutants were divided into classes based on phenotype. Class I mutants (green) are greater 
than 2-fold defective for toxT activation relative to ompU activation. Class II mutants (purple) 
are not significantly defective for activation of either promoter (P<0.05). Class III mutants (red) 
are required for activation of both toxT and ompU promoters. * indicates ToxR mutants that are 
at least 2-fold more defective for toxT activation than ompU activation. # indicates ToxR mutants 
that were defective for activation of both promoters (< 10% activation). B) Stability of ToxR-HA 
was monitored by Western blot using monoclonal anti-HA. All strains were tested at least six 




Figure 4-3. Location of ToxR wing residues. ToxR w-HTH domain was modeled using I-
TASSER (http://zhanglab.ccmb.med.umich.edu/I-TASSER/)(2). A) Wing residues belonging to 
Class I (green) are preferentially required for activation of toxT when expressed from a plasmid. 
However, this preferential defect was lost when ToxR was expressed from the toxR 
chromosomal locus. B) Class II residues (purple) are not required for transcriptional activation of 
either toxT or ompU. C) Residues belonging to Class III (red) are required for transcriptional 
activation of both toxT and ompU and DNA binding.  
!
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Several residue side chains in the wing region of ToxR are not required for transcriptional 
activation of either promoter (S90, T91, S93, V100, Q106, V111, E112, T113, and V114) and 
were designated Class II. When these residues were mutated to alanine >80% of transcriptional 
activation of both promoters was maintained (Fig. 4-2). The majority of these residues are either 
in the loop between the DNA-binding helix ("3) and the wing or after the !-hairpin of the wing 
(Fig. 4-3). The only two amino acid side-chains in the !-turn of the wing that are not required for 
transcriptional activation of at least one promoter are V100 and Q106, indicating that the !-
hairpin is critical for transcriptional activation. This is expected since many w-HTH proteins 
insert the !-hairpin of the wing into the minor groove of promoter DNA (3, 24). In order to 
compound the effects of mutating these residues a quadruple mutant was constructed (ToxR-
S90A/T91A/Q95A/V100A, designated ToxR-quad), however this mutant was still not defective 
for transcriptional activation of either promoter.  
 As was expected, since the wing of ToxR is involved in DNA binding (2), several 
residues wing of ToxR are required for transcriptional activation of both ompU and toxT (D89, 
V97, T99, K102, G104, Y105). Mutation of these residues, designated Class III, resulted in less 
than 5% activation of either ompU or toxT loci (Fig. 4-2). This results in toxT activation as low 
as the empty vector control (p>0.05). The majority of these residues are predicted to be involved 
in DNA binding, either directly or indirectly, and mutations in T99 and G104 have been 
previously shown to disrupt DNA binding to both promoters (2). All of the residues required for 
transcriptional activation of both promoters are found in the !-hairpin of the wing except D89, 
which is positioned at the end of the DNA-binding helix (Fig. 4-3).  
 Since overexpression can result in altered phenotypes, we analyzed the requirement of 
ToxR wing residues for transcriptional activation using chromosomally expressed ToxR wing 
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Figure 4-4. ToxR wing mutants expressed from the toxR chromosomal locus are not 
preferentially defective for toxT activation. A) Selected ToxR wing mutants representing each 
class of mutant were placed on the chromosome and assayed for transcriptional activation of 
toxT-lacZ and ompU-lacZ by !-galactosidase assay. Class I mutants were at least 2-fold more 
defective for toxT activation tan ompU activation when expressed from a plasmid, but equally 
defective for activation of both promoters when endogenously expressed. Class II mutants are 
not defective for activation of either promoter, and maintained 80% activity even when mutated. 
Class III mutants are defective for activation of both promoters. B) The stability of each ToxR 
wing mutant was monitored by Western blot using anti-ToxR antibodies.  
!
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mutants. Thus, we measured activation of chromosomal toxT-lacZ and ompU-lacZ reporter from 
each class of mutants expressed from the native toxR locus (Fig. 4-4). Three residues 
preferentially required for toxT co-activation under overexpression conditions, Y96, L107, and 
I108, were no longer preferentially required for toxT co-activation when expressed from the 
chromosome. L107 was even slightly more critical for ompU activation than toxT co-activation 
when endogenously expressed (p<0.005), although ToxR-L107A was unstable when expressed 
from the chromosome in the absence of the C-terminal HA tag. Q95 contributed to, but was not 
required for, toxT activation when expressed from a plasmid (59% of wild-type activation), was 
able to activate both toxT and ompU promoters at wild-type levels when chromosomally 
expressed (Fig. 4-2 and 4-4), and as such it was classified as a class II residue. All class II 
residues tested tolerated mutation to alanine and maintained transcriptional activation of both 
toxT and ompU promoters, whether expressed from the native toxR locus or a plasmid. Similarly, 
both of the class III residues tested were still required for transcriptional activation of toxT and 
ompU when expressed from the native locus. These results highlight the importance of 
monitoring transcriptional activation using ToxR expressed from the native locus, particularly 
when looking at subtle phenotypes or comparing activation of different promoters. It is 
particularly critical to note that mutations in ToxR can result in a preferential defect in toxT due 
to overexpression.  
 
The wing of ToxR is not required for ToxR-TcpP interaction. Since one of the hypothesized 
roles for ToxR in facilitating TcpP-mediated toxT transcriptional activation is interaction with 
TcpP and recruitment of TcpP to the toxT promoter, we tested whether the wing of ToxR is 
involved in ToxR-TcpP interaction. Using DSP crosslinking, membranes containing ToxR and 
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Figure 4-5. The wing of ToxR is not required for ToxR-TcpP interaction. Membranes from 
V. cholerae containing ToxR wing mutants and TcpP-HSV were crosslinked by DSP. TcpP-HSV 
was immunoprecipitated using anti-HSV. The amount of TcpP immunoprecipitated was 
monitored by Western blot using anti-TcpP. The amount of ToxR co-immunoprecipitated was 
monitored by Western blot using anti-ToxR. EpsL, a type 2 secretion system protein, which is 
not predicted to interact with ToxR or TcpP was monitored by Western blot as a negative 
control. As an additional control, TcpP-N99D was used which is defective for ToxR-TcpP 
interaction by the capture assay (7). The band intensities were quantified by image J and the % of 
ToxR co-immunoprecipitated by TcpP is denoted under the Western blot after subtracting the 
signal with the empty pMMB207 vector. Representative Western blots and quantification are 
shown from one of at least two independent experiments with similar results. 
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TcpP from V. cholerae expressing TcpP-HSV from a plasmid and chromosomally expressed 
ToxR wing mutants were immunoprecipitated using the HSV tag on TcpP, and the amount of co-
precipitated ToxR was measured by Western blot (Fig. 4-5). EpsL, a transmembrane protein in 
the Type 2 secretion system of V. cholerae, which is not predicted to interact with ToxR or TcpP 
was also assayed as a negative control. 13-17% of ToxR crosslinked to TcpP (Fig. 4-5), which is 
not unexpected as ToxR regulates multiple loci in V. cholerae, independent of TcpP.  
None of the eight stable ToxR wing residues tested (L107A was too unstable for 
quantification) were required for ToxR-TcpP interaction. This indicates that wing residues of 
ToxR that affect toxT transcriptional activation are not required for ToxR-TcpP interaction. As a 
secondary assay for ToxR-TcpP interaction, we employed a membrane localized bacterial two-
hybrid system (BACTH) (2). The requirement of each of the 25 residues in the wing of ToxR for 
ToxR-TcpP interaction was tested using alanine mutants in this system (Fig. 4-6). Mutation of 
several of the residues in the wing of ToxR resulted in reduced ToxR-TcpP interaction by 
BACTH. However, the residue that was the most critical for interaction by BACTH (V97) is not 
required for interaction by co-immunoprecipitation (Fig. 4-5 and 4-6). Furthermore, the quad 
mutant (ToxR-S90A/T91A/Q95A/V100A) was also defective for interaction by BACTH (Fig. 4-
6) but was co-immunoprecipitated by TcpP (Fig. 4-5). This made it difficult to interpret the 
results of the BACTH since it is either not sensitive enough to detect weakened but intact 
interactions between ToxR and TcpP, there are factors in V. cholerae that influence ToxR-TcpP 
interaction and are missing in the BACTH system, or mutation of the wing of ToxR affects the 
ability of the N-terminal and C-terminal fragments of Cya to productively reassemble rather than 
actual ToxR-TcpP interaction.  
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Figure 4-6. ToxR-TcpP interaction as monitored by BACTH varies. pKT25-TcpPH and 
pUT18c-ToxRS were expressed in the BACTH strain BTH101. Reassembly of adenylate cyclase 
due to ToxR-TcpP interaction bringing Cya18 and Cya25 together was monitored by !-
galactosidase assay. Stability of these constructs was monitored by anti-CyaA Western blot on 
cultures which had been grown in the presence of adenylate cyclase to induce expression 
independent of interaction. The ToxR-quad mutant Western blot shown was performed (with 
wild-type ToxR and empty vector controls) on a separate day from the other BACTH western 
blots. All strains were replicated at least nine times on at least 3 different days. 
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Several ToxR wing residues are required for DNA binding. Because the wing of w-HTH 
proteins is often involved in binding to the minor groove of the DNA, we determined whether 
ToxR wing residues required for toxT activation are involved in DNA binding. We selected 
ToxR wing mutants from each class of ToxR wing residues and measured their DNA binding by 
EMSA (Electrophoretic Mobility Shift Assay). Shifting of the toxT and ompU promoters by 
wild-type ToxR was detectable at 0.5 mg/ml and 0.19 mg/ml respectively (Fig. 4-7). However, 
mutation of any of the class III residues (ToxR wing residues required for both toxT and ompU 
transcriptional activation) tested resulted in an inability of the ToxR mutant to shift 50% of either 
probe even at the highest concentrations tested (2 mg/ml for toxT and 1.5 mg/ml for ompU) (Fig. 
4-7). The class I residues, which are involved in activation of both promoters, but preferentially 
affect toxT activation under some conditions, were also required for DNA binding (Fig. 4-7). 
High levels of membrane containing ToxR-Y96A or ToxR-I108A were required to shift the toxT 
and ompU promoters, indicating a dependence upon these residues for maximal DNA binding. 
Furthermore, these ToxR derivatives were enriched in their respective membrane preparations 
relative to wild-type ToxR, yet still required more membrane than wild-type ToxR to elicit 
similar gel shift activity. Mutation of ToxR-L107 resulted in an inability of ToxR-L107A to shift 
50% of either probe even at the highest concentrations tested, indicating that this residue is a key 
residue for DNA binding (Fig. 4-7). Thus, all of the ToxR wing residues tested for DNA binding 
that were involved in activation were also involved in promoter binding.  
 Of the class II residues tested that are not required for transcriptional activation of either 
promoter (ToxR-S90, T91, Q95, V100, Q106, V111), none were required for DNA binding of 
either the toxT or ompU promoter. None of the class II mutants tested had any decrease in 




Figure 4-7. Certain wing residues of ToxR are required for DNA binding. DNA binding by 
ToxR wing mutants was monitored using EMSA. V. cholerae membranes containing the ToxR 
wing mutants, but lacking TcpP, were bound to 32P end-labeled probes containing either the toxT 
promoter (A) or the ompU promoter (B). ToxR stability for all membranes was monitored by 
anti-HA Western blot. Representative gels and quantification are shown from a minimum of two 
replicates. * indicates an intermediate shifted ompU promoter that is dependent on a factor in the 
membrane extract other than ToxR (2). 
!
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increase in DNA binding efficiency to both the ompU and toxT promoters. This corresponded to 
a slight, but significant (p<0.05) increase in transcriptional activation of both of these promoters  
(Fig. 4-2, 4-4, and 4-7). Based on all of the wing mutants tested, ToxR activity at both the toxT 
and ompU promoters corresponded to the ability of the ToxR wing to bind these promoters.  
 
Discussion 
The wing of ToxR is primarily required for DNA binding to both the toxT and ompU 
promoters. All of the residues in ToxR that were required for transcriptional activation of toxT 
and ompU were also required for DNA binding. Different regions of the wing are more or less 
critical for DNA binding and transcriptional activation by ToxR. The majority of the residues in 
the !-hairpin of the wing of ToxR are required for transcriptional activation and DNA binding 
(Fig. 4-2, 4-4, and 4-7). This is to be expected since this region of the wing is often inserted into 
the minor groove of the DNA (3, 24). Based on the modeled location of these residues, they may 
be involved in positioning of the wing relative to the rest of the w-HTH domain or actually 
interact with the DNA backbone. K102 is predicted to protrude from the tip of the wing and 
likely interacts with nucleotides in the minor groove, similar to R220 in PhoB (3, 24). ToxR-
T99, G104, and Y105 correspond to PhoB-T217, G222, and Y223 which interact with the 
backbone of DNA (3, 24). ToxR-V97, Y105, and L107 may contribute to the hydrophobic core, 
since they correspond to residues that comprise the hydrophobic core in OmpR and PhoB (24, 
28). Furthermore, mutation of two of these residues (ToxR-V97A and ToxR-L107A) renders the 
molecule unstable (Fig. 4-4), an anticipated phenotype of a mutant deficient in folding of the 
hydrophobic core. Mutation of a few residues near the hinge of the !-hairpin (Y96, L107 and 
I108), where it joins the rest of the w-HTH domain, were preferentially required for toxT 
! "%"!
expression when expressed from a plasmid (Fig. 4-2). However, this is likely an effect of 
overexpression since these mutants lost the differential defect in toxT expression when expressed 
from the chromosomal toxR locus (Fig. 4-4). It is likely that these residues are involved in 
positioning of the wing relative to the DNA-binding helix. Although a crystal structure of the 
ToxR w-HTH domain is not currently available, I-TASSER modeling of ToxR, based on other 
members of the w-HTH family (2), places many of these residues aimed towards the core of the 
protein indicating that they are likely involved in positioning of the wing. 
Some residues in the loop leading from the DNA-binding helix ("3) to the !-hairpin of 
the wing were critical for DNA binding and activation of toxT and ompU, while others were not 
(Fig. 4-2, 4-4, and 4-7). It is possible that these residues contribute to the hydrophobic core of 
ToxR, but this is not likely since no residues in this loop have been shown to be part of the 
hydrophobic core in either OmpR or PhoB (24, 28). The residues required for DNA binding and 
transcriptional activation may be involved in positioning the wing relative to the DNA-binding 
helix. D89 is positioned at the end of the DNA-binding helix and may affect helical structure or 
positioning of the DNA-binding helix. Since mutation of residues C-terminal to amino acid 109 
had minimal effect on transcriptional activation of either promoter, it is likely that R110 marks 
the beginning of the variable linker region that tethers the w-HTH domain to the membrane (34).  
Although some residues in the wing of ToxR were preferentially required for toxT 
activation, all of the residues tested lost this preferential requirement when expressed from the 
chromosome. Therefore, the preferential requirement of the wing for toxT activation is likely an 
effect of the overexpression system and not an actual increased dependence on the wing for toxT 
activation. Furthermore, the residues in the wing do not appear to preferentially be required for 
binding to one promoter or the other, since mutations leading to disruption of binding to the toxT 
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promoter result in similar disruption of binding to the ompU promoter. The consensus sequences 
for ToxR binding to toxT and ompU are similar (11). Additionally, a majority of the residues 
required for DNA binding are present in regions of the wing not likely to come into direct 
contact with the DNA, but instead are most likely involved in positioning of the wing such that it 
is able to insert into the minor groove. Together this shows that the role of the wing is to stabilize 
ToxR binding to the promoter. 
None of the ToxR residues tested by ToxR-TcpP co-immunoprecipitation were required 
for TcpP interaction. Since ToxR-TcpP interaction should only be required for toxT activation, 
mutations disrupting ToxR-TcpP interaction would be expected to result in a preferential defect. 
However, five of the six ToxR residues that were preferentially required for toxT activation when 
expressed from a plasmid have been tested for interaction defects either in this or previous 
publications using DSP crosslinking (2). Additionally, any ToxR wing residues that were 
identified as being important for ToxR-TcpP interaction via the BACTH assay (Fig. 4-6) were 
not required for ToxR-TcpP interaction when tested by co-immunoprecipitation. Based on these 
findings it is likely that the wing of ToxR is either not required for ToxR-TcpP interaction or that 
ToxR-TcpP interaction is not required for toxT activation.  
Since the wing of ToxR does not appear to contribute to ToxR-TcpP interaction, there are 
two likely ways in which ToxR and TcpP could interact based on the interaction of other w-HTH 
proteins (24, 29, 31, 27, 32): ToxR N-terminal !-sheet to TcpP N-terminal !-sheet or ToxR !-
sheet to TcpP wing. Previous studies have shown that the wing of TcpP is required for ToxR-
TcpP interaction, since mutation of several residues of the wing of TcpP results in decreased 
interaction (7). Furthermore, one such TcpP mutant, TcpP-N99D, showed reduced interaction 
with ToxR in ToxR-TcpP co-immunoprecipitation studies as well (Fig. 4-5). As we have found 
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the wing of ToxR does not appear to interact with TcpP, we predict ToxR and TcpP dimerize by 
interaction of the wing of TcpP with the !-sheet of ToxR. If ToxR and TcpP interact in this 
orientation on the promoter it would place the wing of TcpP oriented upstream, away from the 
promoter, in the opposite orientation to other w-HTH proteins bound to their promoters (3, 24, 
29). Additionally, ToxR and TcpP bind to the toxT promoter three helical turns apart, making it 
difficult to picture how the w-HTH domains could interact when bound to the DNA (11). 
Finally, DNA binding by TcpP is required for toxT activation (8) and the wing of TcpP is 
required for DNA binding (6, 7). Thus, ToxR-TcpP interaction may enhance activation by 
recruiting TcpP to the toxT promoter along with ToxR, but this interaction may be disrupted 
upon DNA binding to allow TcpP to access the binding site three helical turns downstream of 
ToxR on the toxT promoter (Fig. 4-8).  
It has been previously shown that ToxR co-activation of toxT is due in part to alteration 
of the toxT promoter. ToxR relieves H-NS repression, recruits the promoter to the membrane, 
and exposes a DNAse I hypersensitivity site at the TcpP-binding site (1, 5, 6). All of these 
functions are dependent on ToxR binding to the promoter, making the wing critical for ToxR co-
activation of the toxT promoter.  
 
Materials and Methods 
Culture conditions. V. cholerae strains were routinely grown overnight in Vc LB (LB 
containing 5 g/L NaCl) at 37oC. Unless otherwise stated cultures were induced by backdilution 
into Vc LB pH 6.5 and grown at 30oC. Cultures were grown in the presence of 100 µg/ml 





Figure 4-8. Model of ToxR mediated co-activation of the toxT promoter. A) Prior to 
activation, the toxT promoter is silenced by H-NS (1). B) ToxR-TcpP interaction between the N-
terminal !-sheet of ToxR and the wing of TcpP recruits TcpP to the toxT promoter. C) Upon 
ToxR binding to the toxT promoter, ToxR and TcpP no longer interact. ToxR binding to the 
promoter results in relieving H-NS repression (1), bending the DNA to make the TcpP binding 
site more accessible (6), and recruiting the toxT promoter to the membrane (5). D) This results in 
enhanced TcpP binding to the toxT promoter and transcriptional activation. 
!
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Construction of strains and plasmids. ToxR wing mutants were generated by PCR using 
complimentary muta genic primers as described previously (11). Chromosomal ToxR wing 
mutants were created using chromosomal recombination of the suicide plasmid pKAS32 and 
selected for by loss of streptomycin resistance as described previously (35).  
!-galactosidase assay for transcriptional activation by ToxR. V. cholerae strains containing 
chromosomal ompU-lacZ or toxT-lacZ reporters (REF) were backdiluted 1:30 and induced as 
described above. ToxR expression from psk-ToxR-HA constructs was induced by addition of 
100µM IPTG. For all transcriptional activation assays, activation was assayed after 4 hours by !-
galactosidase assay as described previously (36). The OD600 was determined by 
spectrophotometry and used to normalize cultures for subsequent Western blot analysis using 
antibodies against HA (Covance) or ToxR (generated against the N-terminal 170 amino acids of 
ToxR by Covance). 
Co-immunoprecipitation of ToxR and TcpP. pMMB-TcpP-HSV (7) was mated into #tcpP V. 
cholerae strains containing chromosomal ToxR wing mutations. Cultures were backdiluted 
1:100 and grown under inducing conditions in the presence of 1mM IPTG for 6 hours. 
Membranes were isolated as described previously (37) and dialyzed into HEPES-buffered saline 
(HBS, 20 mM HEPES pH 7.0, 150 mM NaCl). Two mg/ml of membrane proteins was 
crosslinked using 5mM DSP (Pierce) for 30 minutes at room temperature. Subsequent 
crosslinking was blocked with 50mM Tris pH7.4 for 15 minutes at room temperature. Membrane 
proteins were denatured and solubilized by boiling in 1% SDS for 5 minutes prior to addition of 
IP buffer (1% Triton, 10mM MgCl, 5mM EDTA, 50mM Tris pH7.4). TcpP was 
immunoprecipitated by incubation for 2 hours at 4oC with 45µL of a 50:50 suspension protein G-
agarose beads (Calbiochem), which had been pre-incubated with 3µg anti-HSV (Calbiochem) for 
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Table 1: Strains and Plasmids 
Vibrio cholerae strains  
0395 #toxR toxT-lacZ (EK1072) (2) 
0395 #toxR ompU-lacZ (EK410) (5) 
0395 ompU-lacZ (EK383)  
0395 ompU-lacZ toxR-Y96A This study 
0395 ompU-lacZ toxR-L107A This study 
0395 ompU-lacZ toxR-I108A This study 
0395 ompU-lacZ toxR-S90A This study 
0395 ompU-lacZ toxR-T91A This study 
0395 ompU-lacZ toxR-Q95A This study 
0395 ompU-lacZ toxR-V100A This study 
0395 ompU-lacZ toxR-S90A/T91A/Q95A/V100A (quad) This study 
0395 ompU-lacZ toxR-V97A This study 
0395 ompU-lacZ toxR-K102A This study 
0395 toxT-lacZ (EK733)  
0395 toxT-lacZ toxR-Y96A This study 
0395 toxT-lacZ toxR-L107A This study 
0395 toxT-lacZ toxR-I108A This study 
0395 toxT-lacZ toxR-S90A This study 
0395 toxT-lacZ toxR-T91A This study 
0395 toxT-lacZ toxR-Q95A This study 
0395 toxT-lacZ toxR-V100A This study 
0395 toxT-lacZ toxR-S90A/T91A/Q95A/V100A (quad) This study 
0395 toxT-lacZ toxR-V97A This study 
0395 toxT-lacZ toxR-K102A This study 
0395 #toxT #toxR (EK459) (6) 
0395 #toxT (RY1) (10) 
0395 #toxT toxR-T91A This study 
0395 #toxT toxR-L107A This study 
0395 #toxT toxR-I108A This study 
0395 #toxT toxR-S90A This study 
0395 #toxT toxR-S90A/T91A/Q95A/V100A (quad) This study 
0395 #toxT toxR-V97A This study 
0395 #toxT toxR-K102A This study 
0395 #toxT toxR-Q95A This study 
0395 #toxT toxR-Y96A This study 
  
E. coli strains  

















Table 4-2. Primers used in this study 
Name Sequence 
toxR D89A top CGCAAAATGCTCAAAGCTTCGACAAAGTCCC 
toxR D89A bottom GGGACTTTGTCGAAGCTTTGAGCATTTTGCG 
ToxR S90A top CAAAATGCTCAAAGATGCGACAAAGTCCCCAC 
ToxR S90A bottom GTGGGGACTTTGTCGCATCTTTGAGCATTTTG 
ToxR T91A top ATGCTCAAAGATTCGGCAAAGTCCCCACAATAC 
ToxR T91A bottom ATTGTGGGGACTTTGCCGAATCTTTGAGCATTTTG 
toxR K92A top CTCAAAGATTCGACAGCGTCCCCACAATACGTC 
toxR K92A bottom GACGTATTGTGGGGACGCTGTCGAATCTTTGAG 
toxR S93A top CAAAGATTCGACAAAGGCCCCACAATACGTCAAAAC 
toxR S93A bottom GTTTTGACGTATTGTGGGGCCTTTGTCGAATCTTTG 
toxR P94A top GATTCGACAAAGTCCGCACAATACGTCAAAAC 
toxR P94A bottom GTTTTGACGTATTGTGCGGACTTTGTCGAATC 
ToxR Q95A top TCGACAAAGTCCCCAGCATACGTCAAAACGGTTC 
ToxR Q95A bottom GAACCGTTTTGACGTATGCTGGGGACTTTGTCGAATC 
ToxR Y96A top GACAAAGTCCCCACAAGCCGTCAAAACGGTTC 
ToxR Y96A bottom GAACCGTTTTGACGGCTTGTGGGGACTTTGTC 
ToxR V97A top CAAGTCCCCACAATACGCCAAAACGGTTCCGAAG 
ToxR V97A bottom CTTCGGAACCGTTTTGGCGTATTGTGGGGACTTG 
toxR K98A top GTCCCCACAATACGTCGCAACGGTTCCGAAGCG 
toxR K98A bottom CGCTTCGGAACCGTTGCGACGTATTGTGGGGAC 
toxR T99A top CACAATACGTCAAAGCGGTTCCGAAGCGCGG 
toxR T99A bottom CCGCGCTTCGGAACCCGTTTGACGTATTGTG 
ToxR V100A top CAATACGTCAAAACGGCTCCGAAGCGCGGTTAC 
ToxR V100A bottom GTAACCGCGCTTCGGAGCCGTTTTGACGTATTG 
toxR P101A top CAATACGTCAAAACGGTTGCGAAGCGCGGTTACC 
toxR P101A bottom GGTAACCGCGCTTCGCAACCGTTTTGACGTATTG 
toxR K102A top GTCAAAACGGTTCCGGCGCGCGGTTACCAATTG 
toxR K102A bottom CAATTGGTAACCGCGCGCCGGAACCGTTTTGAC  
toxR R103A top CAAAACGGTTCCGAAGGCCGGTTACCAATTGATC 
toxR R103A bottom GATCAATTGGTAACCGGCCTTCGGAACCGTTTTG 
toxR G104A top CGGTTCCGAAGCGCGCTTACCAATTGATCGC 
toxR G104A bottom GCGATCAATTGGTAAGCGCGCTTCGGAACCG 
ToxR Y105A top GTTCCGAAGCGCGGTGCCCAATTGATCGCCCGAG 
ToxR Y105A bottom CTCGGGCGATCAATTGGGCACCGCGCTTCGGAAC 
ToxR Q106A top CCGAAGCGCGGTTACGCATTGATCGCCCGAGTG 
ToxR Q106A bottom CACTCGGGCGATCAATGCGTAACCGCGCTTCGG 
ToxR L107A top GAAGCGCGGTTACCAAGCGATCGCCCGAGTGGAAAC 
ToxR L107A bottom GTTTCCACTCGGGCGATCGCTTGGTAACCGCGCTTC 
ToxR I108A top CGCGGTTACCAATTGGCCGCCCGAGTGGAAAC 
ToxR I108A bottom GTTTCCACTCGGGCGGCCAATTGGTAACCGCG 
ToxR R110A top GTTACCAATTGATCGCCGCAGTGGAAACGGTTGAAG 
ToxR R110A bottom CTTCAACCGTTTCCACTGCGGCGATCAATTGGTAAC 
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ToxR V111A top CAATTGATCGCCCGAGCGGAAACGGTTGAAGAAG 
ToxR V111A bottom CTTCTTCAACCGTTTCCGCTCGGGCGATCAATTG 
ToxR E112A top GATCGCCCGAGTGGCAACGGTTGAAGAAGAG 
ToxR E112A bottom CTCTTCTTCAACCGTTGCCACTCGGGCGATC 
ToxR T113A top GATCGCCCGAGTGGAAGCGGTTGAAGAAGAGATG 
ToxR T113A bottom CATCTCTTCTTCAACCGCTTCCACTCGGGCGATC 
ToxR V114A top GCCCGAGTGGAAACGGCTGAAGAAGAGATGGCTC 
ToxR V114A bottom GAGCCATCTCTTCTTCAGCCGTTTCCACTCGGGC 
ToxR V111A top CAATTGATCGCCCGAGCGGAAACGGTTGAAGAAG 
ToxR V111A bottom CTTCTTCAACCGTTTCCGCTCGGGCGATCAATTG 
ToxR E112A top GATCGCCCGAGTGGCAACGGTTGAAGAAGAG 
ToxR E112A bottom CTCTTCTTCAACCGTTGCCACTCGGGCGATC 
ToxR T113A top GATCGCCCGAGTGGAAGCGGTTGAAGAAGAGATG 
ToxR T113A bottom CATCTCTTCTTCAACCGCTTCCACTCGGGCGATC 
ToxR V114A top GCCCGAGTGGAAACGGCTGAAGAAGAGATGGCTC 
ToxR V114A bottom GAGCCATCTCTTCTTCAGCCGTTTCCACTCGGGC 
!
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2 hours at 4oC. Samples were taken prior to addition of protein G-agarose beads and anti-HSV, 
after incubation with protein G-agarose beads and anti-HSV, and after three washes with PBS 
and designated “INput, “UnBound,” and “ImmunoPrecipitated,” respectively. Samples were 
loaded onto SDS-PAGE gels in either a 1:1:1 ratio (IN:UB:IP) for anti-TcpP (generous gift from 
the DiRita Laboratory) Western blots or 1:1:5 (IN:UB:IP) for anti-ToxR (generated against the 
N-terminal 170 amino acids of ToxR by Covance) and anti-EpsL (generous gift from the 
Sandkvist Laboratory) Western blots. Western blots were developed using Alkaline Phospatase 
and band intensity was quantified using ImageJ. TcpP-dependant co-immunoprecipitation was 
calculated by subtracting the band intensity in the IP lane #tcpP + pMMB207 negative control 
from the band intensity in the IP lane of each strain tested. 
DNA mobility shift assay. DNA binding assays were performed essentially as described 
previously (6). Membranes were isolated from #toxR#tcpP V. cholerae strains (EK459) with 
pSK-toxR-HA which had been induced for 6 hours in 1mM IPTG as described previously (37). 
Membrane concentrations ranging from 0.19 to 2 mg/ml were incubated with either the ompU 
promoter probe (extending from -211 to +22 relative to the transcriptional start site), the toxT 
promoter probe (extending from -172 to +45 relative to the transcriptional start site), or the 
negative control probe (toxT promoter extending from-46 to +45 relative to the transcriptional 
start site). 3000 cpm of probe labeled with 32P-dATP was used in each reaction. Western blotting 
with anti-HA (Covance) was used to monitor ToxR protein levels.  
Adenylate cyclase bacterial two-hybrid (BACTH). BACTH assay was performed as described 
previously (2). ToxR wing mutants expressed from the pUT18c-ToxRS and TcpP expressed 
from pKT25-TcpPH were transformed into the reporter strain BTH101. Cultures were induced 
by addition of 0.5 mM IPTG to LB and grown 16 hours at 30oC. 20µL of culture was used for !-
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galactosidase assay as described previously (36). Stability was determined by induction of 
expression of pUT18c-ToxR in BTH101 in the presence of pKT25 with 0.5mM IPTG and 1mM 
cAMP added to induce expression. Samples were normalized by OD600 and analyzed by Western 
blot using anti-cyaA (Santa Cruz Biotechnology).  
Modeling of ToxR wing residues. ToxR wing residues were modeled using the program 
Chimera based on the threaded structure of ToxR as determined by I-TASSER (2). 
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An intramolecular periplasmic disulfide bond in TcpP prevents premature 
degradation and enables virulence gene expression in Vibrio cholerae 
 
Note: All of the strains created and all of the assays performed in this chapter were done either 
by myself or by Emily French under my supervision. 
 
Summary 
TcpP and ToxR coordinately regulate transcription of toxT, the master regulator of many 
virulence factors in Vibrio cholerae. TcpP and ToxR are both membrane-localized transcription 
factors each with a periplasmic domain containing two cysteines. In ToxR, it has been previously 
demonstrated that these cysteines form an intramolecular disulfide bond, and substitution of one 
of these cysteine results in an intermolecular disulfide bond affecting activity. We determined 
that the two periplasmic cysteines of TcpP also form an intramolecular disulfide bond. 
Disruption of this intramolecular disulfide bond by mutation of either cysteine resulted in 
formation of intermolecular disulfide bonds. Furthermore, disruption of the intramolecular 
disulfide bond in TcpP resulted in decreased stability by increasing TcpP sensitivity to 
proteolytic degradation by YaeL. The decreased stability of TcpP mutants lacking one or both 
periplasmic cysteines resulted in levels of toxT activation similar to that of a !tcpP mutant, 
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culminating in an ~10,000-fold decrease in cholera toxin production. Thus, the periplasmic 
intramolecular disulfide bond in TcpP is critical for TcpP stability and virulence gene expression. 
 
Introduction 
 Cholera is caused by ingestion of the aquatic gram-negative bacterium Vibrio cholerae. 
The profuse watery diarrhea characteristic of cholera is induced by cholera toxin (CT), an ADP-
ribosolating toxin that induces cyclic AMP production in intestinal epithelial cells resulting in 
massive secretion of water and electrolytes. Microcolony formation and colonization of the 
intestine requires expression of the toxin co-regulated pilus (TCP) (7). Transcription of the genes 
encoding CT and TCP, as well as several other virulence factors, is regulated by the transcription 
activator ToxT (9). toxT expression is regulated by two transmembrane winged-helix-turn-helix 
(w-HTH) transcription factors, ToxR and TcpP, and their co-activators ToxS and TcpH, 
respectively (1, 8, 11-16). Based on current models, upon entry into the intestine, environmental 
signals activate expression of tcpPH (18, 19). TcpPH, along with constitutively expressed 
ToxRS, activates transcription of toxT resulting in colonization and CT secretion in a temporally 
coordinated fashion (21). Under non-inducing conditions, TcpP is specifically targeted for 
degradation by an undefined periplasmic protease followed by the membrane-localized 
metalloprotease, YaeL. (8, 20). 
TcpP and ToxR have three distinct domains: an N-terminal cytoplasmic DNA-binding 
domain, a single pass transmembrane domain and a C-terminal periplasmic domain of unknown 
structure and function. The cytoplasmic domain of TcpP and ToxR is homologous to the 
OmpR/PhoB family of w-HTH transcription factors (22). Mutations in several key residues of 
the cytoplasmic domains of both TcpP and ToxR have been identified that inhibit DNA binding 
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and transcriptional activation (1, 4, 5, 23). TcpP binds to a direct repeat in the toxT promoter just 
upstream of the predicted RNA polymerase (RNAP) binding site (1, 24), whereas ToxR binds to 
a direct repeat, three turns upstream of the TcpP-binding site (1, 25). Based on the location of 
these binding sites, TcpP likely interacts with RNA polymerase and is the direct activator of 
toxT. This model is further supported by the fact that overexpressed TcpP can activate toxT in the 
absence of ToxR, but ToxR cannot activate toxT expression in the absence of TcpP (1, 5, 11, 12). 
Membrane localization of ToxR is required for toxT activation in conjunction with TcpP, but not 
activation of the TcpP-independent ompU promoter (26-28). Thus, ToxR is believed to serve as a 
co-activator, enhancing transcriptional activation of toxT by promoting TcpP recruitment and/or 
binding to the toxT promoter (1, 4, 5).  
Two periplasmic co-activators TcpH and ToxS coordinate with the periplasmic domains 
of TcpP and ToxR, respectively, for full activation of toxT (8, 12, 13, 16)}(11, 15). ToxS has 
been shown to increase ToxR dimerization and transcriptional activation of toxT by ToxR (16), 
while TcpH is required for TcpP stability and enhances transcriptional activation of toxT by 
protecting TcpP from degradation (8, 20). The periplasmic domain of TcpP is particularly 
vulnerable to proteolytic degradation resulting in instability of the entire protein (8, 20). 
Evidence for the role of the periplasmic domain in TcpP instability was provided when the 
periplasmic domain of TcpP was fused to ToxR, making a ToxR-TcpPperi chimeric protein. This 
resulted in an unstable ToxR species unless TcpH was present (8). Conversely, replacement of 
the periplasmic domain of TcpP with the periplasmic domain of ToxR resulted in increased TcpP 
stability (8). Proteolysis of TcpP is regulated in a multi-step process in which initially an 
unknown periplasmic protease recognizes the C-terminus and cleaves TcpP. This partially 
degraded TcpP, denoted TcpP*, is then further cleaved by the membrane-localized 
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metalloprotease YaeL resulting in complete degradation of TcpP (20). In E. coli, YaeL cleaves 
RseA, a transmembrane protein that tethers "E to the membrane. Cleavage and subsequent 
degradation of RseA releases "E from the membrane, thereby allowing "E to activate its target 
promoter (29-31). In the case of TcpP, TcpP is active in the membrane, and cleavage of TcpP by 
YaeL results in inactivation and degradation (20).  
Proper disulfide bond formation is important for the function of many periplasmic 
proteins (32). In V. cholerae, the disulfide isomerase DsbA is required for proper formation and 
activity of TCP, CT, ToxR and other virulence factors (33-36). The periplasmic domain of ToxR 
contains two cysteines that form an intramolecular disulfide bond, and disruption of this 
periplasmic intramolecular disulfide in ToxR by mutation of one of the cysteines to serine in the 
classical V. cholerae strain O395 resulted in formation of an intermolecular disulfide likely 
between two ToxR molecules (37). The resulting mutant, when expressed from a plasmid, was 
found to be 30-fold defective in induction of cholera toxin (CT) expression (37). A recent study 
expressing ToxR from the chromosome found that mutating both periplasmic cysteines of ToxR 
in the classical strain O395 led to a dramatic decrease in OmpU production, but less than a two-
fold defect in CT production in LB medium at pH 6.5 30°C (toxin inducing conditions, (36)). 
Differences in CT production in these two studies may be due to differences in the effects of 
replacing one (37) or both (36) cysteines or due to differences between plasmid-expressed and 
chromosomally-expressed ToxR. TcpP also has cysteines at similar positions in its periplasmic 
domain. In this study we determined that the TcpP periplasmic cysteines also form an 
intramolecular disulfide bond. In addition, we examined the role of TcpP periplasmic cysteines 
in toxT transcriptional activation and found that the intramolecular periplasmic disulfide bond of 
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TcpP is critical for TcpP stability and therefore transcriptional activation of toxT and V. cholerae 
virulence gene expression. 
 
Results 
TcpP forms an intramolecular disulfide bond. To determine whether TcpP, like ToxR, forms 
primarily intramolecular disulfide bonds, V. cholerae lysates containing pMMB207-expressed 
TcpP-HSV (TcpP which contains a C-terminal HSV tag) were run on non-reducing SDS-PAGE 
and analyzed by Western blot. To preserve disulfide bond formation and prevent additional 
disulfide bonds from forming during sample preparation, V. cholerae lysates were treated with 
iodoacetamide as described previously (37). Non-reduced TcpP-HSV ran slightly faster than 
reduced TcpP-HSV due to the presence of an intramolecular disulfide bond (Fig. 5-1 lanes 1 and 
4). Two fainter bands at approximately 70 kDa were also visible on the non-reduced gel; these 
bands are consistent with formation of intermolecular disulfide bonds between two TcpP 
molecules. These dimers could be the result of formation of a single intermolecular disulfide 
bond between two TcpP molecules or two disulfide bonds between two TcpP molecules. To 
determine whether the disulfide bonds observed were formed between the two periplasmic 
cysteines present in TcpP, each periplasmic cysteine was mutated to serine (C207S and C218S). 
Because these mutants were no longer able to form intramolecular disulfide bonds, TcpP-C207S 
and TcpP-C218S migrated either at the same position as reduced TcpP, or at a higher molecular 
weight consistent with a TcpP dimer formed by intermolecular disulfide bonds (Fig. 5-1 lanes 6-
9). The TcpP dimer bands migrated slightly differently depending on whether C207 or C218 is 
present, likely due to differences in the location of the disulfide bond relative to the C-terminus 
of the protein. Since proteins in this family tend to dimerize (27, 37-42), and this band was the 
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Figure 5-1. TcpP forms intramolecular and intermolecular disulfide bonds. Lysates of V. 
cholerae (EK459 !toxR!tcpP) expressing pMMB-TcpP-HSV and either pSK or pSK-ToxR-HA 
were incubated with iodoacetamide prior to resuspension in sample buffer with or without DTT. 
Blots were probed with anti-HSV primary antibody and alkaline phosphatase conjugated anti-
mouse secondary antibody. Mutations in either or both, periplasmic cysteines were used to 
perturb disulfide bond formation. The arrows and diagrams along the side of the blot indicate the 
state of the periplasmic cysteines in each form of TcpP detected.  
!
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expected size of a TcpP dimer, we predicted that this band was likely the result of an 
intermolecular disulfide bond formed between two TcpP molecules. To confirm this, the 
complex was isolated by immunoprecipitation and analyzed by mass spectrometry (data not 
shown). The only peptides detected by mass spectrometry were from TcpP, indicating that this 
band is likely the result of a TcpP homodimer. When both periplasmic cysteines were mutated to 
serine only a single band at the expected size for reduced TcpP was observed (Fig. 5-1 lanes 10-
11), confirming that the disulfide bonds observed were formed by the periplasmic cysteines and 
not any of the four cytoplasmic cysteines in TcpP. The presence of ToxR or TcpH had no effect 
on disulfide bond formation (Fig. 5-1 and data not shown). In conclusion, the periplasmic 
cysteines in TcpP form intramolecular disulfide bonds. However, when only one periplasmic 
cysteine is available, TcpP forms crosslinked homodimers. 
 
TcpP containing intermolecular disulfide bonds maintains toxT activation. The TcpP 
periplasmic cysteine mutants were tested for transcriptional activation of a chromosomal toxT-
lacZ reporter to determine whether intramolecular periplasmic disulfide bonds are required for 
activity. TcpP-C218S was able to activate transcription at >80% of wild-type levels (Fig. 5-2A). 
Since TcpP-C218S is not able to form intramolecular disulfide bonds, this demonstrates that the 
intramolecular disulfide bond is not required for transcriptional activation of toxT. Additionally, 
the presence of an intermolecular disulfide bond only partially interfered with toxT activation by 
TcpP-C207S, which maintained 48% activity. TcpP-C207S/C218S, on the other hand, was 
nearly completely defective for toxT activation (13% of wild-type), perhaps in part due to the 
modest instability of this mutant (Fig. 5-2B). However, TcpP-C207S has similar levels of protein 
present and maintained 48% toxT activation (Fig. 5-2). Thus, either intramolecular or 
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Figure 5-2. TcpP-HSV is able to activate transcription of toxT in the presence of 
intramolecular or intermolecular periplasmic disulfide bonds. A) toxT activation by the 
TcpP-HSV periplasmic cysteine mutants expressed from the pMMB207 plasmid was measured 
by #-galactosidase assay using chromosomal toxT-lacZ reporters (EK813 and EK1490, Table S1, 
(5)). Activation was measured both in the presence (black bars) and the absence (white bars) of 
chromosomally-expressed ToxR. B) TcpP-HSV expression was monitored by Western blot using 
anti-HSV antibody. * p < 0.005 relative to wild-type TcpP. 
!
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intermolecular disulfide bonds in the periplasmic domain of TcpP are required to maintain toxT 
activation capacity.  
TcpP-mediated toxT activation in the absence of ToxR decreased 10-fold, as ToxR 
facilitates TcpP-mediated toxT activation (1). ToxR-independent activation of toxT by 
overexpressed TcpP-C207S and TcpP-C218S was at or above wild-type levels (Fig. 5-2A white 
bars), again demonstrating that maintenance of either intramolecular or intermolecular 
periplasmic disulfide bonds in TcpP are sufficient for toxT activation activity. Mutation of both 
cysteines, TcpP-C207S/C218S, resulted in loss of toxT activation by TcpP overexpressed in the 
absence of ToxR (Fig. 5-2A), although in this strain background TcpP-C207S/C218S was 
particularly unstable, maintaining just 34% of the level of TcpP protein as wild-type TcpP (as 
determined by ImageJ software). 
 
Stability of TcpP periplasmic cysteine mutants is greatly reduced when expressed from the 
chromosome without a C-terminal epitope tag. Because our initial experiments were 
performed with C-terminally HSV-tagged TcpP, and the C-terminus of TcpP is known to be 
susceptible to periplasmic proteases (8, 20), we determined the consequences of disrupting TcpP 
periplasmic disulfide bond formation with untagged chromosomally expressed TcpP. tcpP-
C207S, tcpP-C218S or tcpP-C207S/C218S alleles were introduced on the chromosome, and toxT 
activation was measured using a plasmid-based reporter containing the toxT promoter. 
Expression of TcpP-C207S and the TcpP-C207S/C218S mutant resulted in a dramatic decrease 
in toxT expression, approaching the levels seen in the !tcpP strain RY1 (Fig. 5-3). This decrease 
in activity corresponded to profound TcpP instability, since little to no TcpP-C207S or TcpP-
C207S/C218S was detectable by Western blot (Fig. 5-3). TcpP-C218S was the most stable of all 
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Figure 5-3. The instability of chromosomally-expressed TcpP cysteine mutants lacking a C-
terminal epitope tag results in a toxT activation defect. A) Transcription activation of toxT 
was monitored by #-galactosidase assay in V. cholerae strains in which the wild-type allele of 
tcpP was replaced with alleles encoding TcpP cysteine mutants. toxT activation was monitored 
using the plasmid-based toxT-lacZ reporter, pTLI2 (3). A Western blot of lysates from the #-
galactosidase assay were probed with anti-TcpP antibodies demonstrating the instability of these 
constructs. While TcpP-C207S and TcpP-C207S/C218S were undetectable, TcpP-C218S was 
present at 13% the level of wild-type TcpP as determined by ImageJ software. * p < 0.005 
relative to wild-type TcpP. # p < 0.005 relative to !tcpP.  
!
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the chromosomally expressed mutants (although only present at 13% of wild-type levels) and 
maintained ~50% of toxT activation relative to wild-type TcpP. While TcpP-C207S was not 
detectable by Western blot, it was able to activate toxT expression 2-fold above background. 
Addition of extra TcpH from a plasmid did not increase stability of any of the mutants (data not 
shown). These findings suggest TcpP can be artificially protected from proteolysis by addition of 
a C-terminal HSV tag, and this likely accounts for the differences observed in stability between 
the mutants expressed from the chromosome and the pMMB207-tcpP-HSV plasmid (Figs. 5-2B 
and 5-3). 
To determine whether the defect in TcpP stability, and therefore toxT transcription, 
resulted in a defect in virulence gene production, CT secretion directed by each chromosomally-
expressed TcpP mutant was measured. As expected from the toxT activation data (Fig. 5-3), 
TcpP-C207S and TcpP-C207S/C218S directed background levels of CT production, a nearly 
10,000-fold decrease relative to the parental strain 0395 (Table 5-1). TcpP-C207S was able to 
produce CT levels just above the limit of detection for this assay indicating that the low levels of 
toxT induced in this strain (Fig. 5-3) may be sufficient to induce a small amount of CT 
production (Table 5-1). The dramatically reduced levels of CT produced by TcpP-C207S and 
TcpP-C207S/C218S corresponded to undetectable TcpP protein levels in their respective strains 
(Fig. 5-4), as was observed in the toxT activation assay (Fig. 5-3). TcpP-C218S was the most 
stable chromosomally expressed cysteine mutant in both the toxT activation and CT assays, 
although expression levels were still well below wild-type (Fig. 5-3 and 5-4). This resulted in a 
slight (2-fold) defect in toxT-lacZ induction (Fig. 5-3). This level of toxT expression is sufficient 
for levels of CT production approaching the wild-type, as CT levels were only reduced 6-fold in 
this strain (Table 5-1). Thus, the decrease in toxT expression and CT production by the TcpP 
! "$$!
Table 5-1. Some chromosomally-encoded TcpP periplasmic cysteine mutants are severely 
defective for CT production. Levels of cholera toxin secretion by each chromosomally-encoded 
TcpP periplasmic cysteine mutant were detected by a CT-ELISA on overnight cultures of V. 
cholerae. CT levels in TcpP-C207S and TcpP-C207S/C218S were not significantly above those 
in the !tcpP!toxR negative control strain (p=0.06 for TcpP-C207S). CT was measured in 










Figure 5-4. TcpP expression in strains assessed for CT production. Western blot analysis of 
TcpP expression from 0395, EK459 (!tcpP!toxR) and chromosomally-encoded TcpP mutants. 
!
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periplasmic cysteine mutants corresponds to their relative instability, indicating that defects in 
toxT transcription and virulence factor production by these mutants is directly related to their 
decreased stability.  
 
Degradation of the TcpP periplasmic mutants is mediated by YaeL. Since YaeL is a known 
protease of TcpP (20) we determined whether the periplasmic disulfide bond of TcpP protects it 
from degradation by YaeL. Thus, we constructed an 0395 !tcpP strain into which we added back 
pBAD18-TcpPH plasmids encoding the TcpP periplasmic cysteine mutants. Upon plasmid-based 
expression, the untagged TcpP-C207S, TcpP-C218S, and TcpP-C207S/C218S were still unstable 
(Fig. 5-5A). A residual degradation band at approximately 17 kDa was observed in the 
periplasmic cysteine mutant strains, as proteolysis was likely incomplete due to plasmid-based 
overexpression. When these constructs were expressed in a !tcpPH!yaeL background, the TcpP 
periplasmic cysteine mutants were processed to a protein of ~20 kDa, previously designated 
TcpP* (Fig. 5-5B) (20). This degradation product was previously described upon shifting wild-
type O395 cultures to non-inducing conditions in a !yaeL strain (20). The same pattern was 
observed when TcpP periplasmic mutants were expressed from the chromosome of a !yaeL 
strain (data not shown). The increase in levels of TcpP* in the !yaeL background of TcpP-
C207S, TcpP-C218S, and TcpP-C207S/C218S mutants indicates they are more vulnerable to 
cleavage by YaeL than wild-type TcpP. Their susceptibility under TcpP-inducing conditions is 
similar to YaeL-mediated degradation of wild-type TcpP under non-inducing conditions. 
Cleavage by YaeL is a two-step process, with a site-1 protease initiating cleavage 
followed by cleavage by the site-2 protease, YaeL. One likely candidate site-1 protease is DegS. 
DegS is the V. cholerae homolog of the site-1 protease responsible for initial cleavage of proteins 
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Figure 5-5. TcpP mutants with intermolecular or no periplasmic disulfide bonds are 
degraded through the YaeL pathway. A) Stability of untagged TcpP periplasmic cysteine 
mutants expressed from the pBAD18 plasmid in a !tcpP strain was monitored by Western blot. 
B) Deletion of yaeL from V. cholerae strains expressing TcpP with periplasmic cysteine 
mutations resulted in accumulation of partially degraded TcpP (designated TcpP*). The stability 
of the plasmid-expressed TcpP cysteine mutants was also monitored by Western blot in 
!tcpP!degS (C) or !tcpP!ptd (D) strains. TcpP was detected by Western blot probed with anti-
TcpP. A cross-reactive, non-TcpP band running at ~36 kDa was present in all lanes, even the 
!tcpP strain harboring the empty vector pBAD18. The % of full length TcpP remaining in each 
lane relative to wild-type TcpP for each panel is provided below each lane and was determined 
by ImageJ software (http://rsbweb.nih.gov/ij/). 
!
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prior to YaeL cleavage in E. coli (20, 30). Although deletion of DegS in V. cholerae did not 
result in increased stability of wild-type TcpP under non-inducing conditions (20), DegS could 
be involved in degradation of the more proteolytically-sensitive TcpP periplasmic cysteine 
mutants. Using the pBAD18 expression system we observed modest stabilization of TcpP-C207S 
and TcpP-C218S in the !tcpP!degS strain (present at 28% and 38% of wild-type TcpP levels, 
respectively), but minimal stabilization of TcpP-C207S/C218S (Fig. 5-5C). This indicates that 
although deletion of degS may have partially stabilized the TcpP periplasmic cysteine mutants, 
there is another periplasmic protease that is primarily responsible for the enhanced proteolytic 
degradation of these mutants. Another candidate for the site-1 protease mediating degradation of 
the TcpP periplasmic cysteine mutants is protease-DO (Ptd). Ptd is a periplasmic chaperone 
responsible for degradation of unstable or misfolded proteins in the periplasm (8, 43, 44). 
Deletion of ptd resulted in modest if any increased stability of TcpP-C207S and TcpP-C218S 
(Fig. 5-5D) indicating that Ptd is not the site-1 protease for misfolded TcpP. Thus, another yet to 
be identified periplasmic protease or combination of proteases is likely responsible for 
degradation of the TcpP periplasmic cysteine mutants.  
 
ToxR periplasmic cysteines also form intramolecular and intermolecular disulfide bonds. 
Previous work has shown that wild-type ToxR forms an intramolecular disulfide bond and that 
disruption of that bond by mutation of one of the cysteines results in intermolecular disulfides 
and a corresponding decrease in cholera toxin production (37). We wanted to re-examine the role 
of ToxR periplasmic disulfides using chromosomally expressed ToxR and looking at multiple 
loci activated by ToxR. As was seen by Ottemann and Mekalanos, under non-reducing 
conditions, wild-type ToxR migrates slightly faster than the fully reduced form indicating the 
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formation of an intramolecular disulfide bond between C224 and C281 (37) (Fig. 5-6A). ToxR-
C224S resulted in formation of a large molecular weight band at approximately 80 KD consistent 
with a ToxR homodimer formation of an intermolecular disulfide bond. A small portion of 
ToxR-C224S is found as a ToxR monomer. Despite its ability to form intermolecular disulfide 
bonds, ToxR-C281S is not found in disulfide linked homodimers and instead migrates at the 
same position as reduced ToxR (Figure 5-6A). Both ToxR-C224S and ToxR-C281S were 
slightly defective for activation of toxT-lacZ and ompU-lacZ. ToxR-C224S/C218S was 
preferentially defective for ompU-lacZ (approximately 60% activity) compared to toxT-lacZ 
(80% activity) (Fig. 5-6B). This may be due to the difference in roles of ToxR in activating these 
two promoters. The transcriptional activation defect is not likely connected to the formation of 
inappropriate disulfide bonds since both ToxR-C224S and ToxR-C218S were equally defective 
for activation despite only ToxR-C224S forming detectable intermolecular disulfide bonds. The 
observed transcriptional activation defect may be a result of a lack of proper intramolecular 
disulfide bond formation resulting in incorrect periplasmic structure or a slight instability.  
 
Discussion 
The purpose of this study was to determine whether TcpP forms periplasmic disulfide 
bonds, and if so, to determine whether the disulfide bonds are required for toxT promoter 
activation. We found that TcpP, like ToxR, has two periplasmic cysteines that form an 
intramolecular disulfide bond (Fig. 5-1). Disruption of this disulfide bond by mutation of either 
of the two TcpP periplasmic cysteines to serine results in an intermolecular disulfide, forming a 
TcpP homodimer (Fig. 5-1). An additional, faint band can be detected at approximately 50 kDa 
in both the TcpP-C207S and TcpP-C218S mutants (Fig. 5-1), which is the predicted size of a 
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TcpP-TcpH heterodimer. TcpH is somewhat unusual in that it is a periplasmic protein with a 
single cysteine and may serve a chaperone-like function for TcpP (45). TcpP mutants lacking the 
ability to form an intramolecular disulfide bond are unstable when chromosomally expressed 
(Fig. 5-3 and 5-4). This instability results in decreased toxT activation and ToxT-dependent CT 
production (Fig. 5-3 and Table 5-1). Disulfide bonds formed with C207 are particularly crucial 
for stability as can be seen by the increase in stability of the TcpP-C218S mutant relative to the 
TcpP-C207S mutant. The tcpP-C218S mutation overlaps the start site of tcpH (changing ATG to 
ATC) and may decrease translation of tcpH. However, expression of additional TcpH did not 
further stabilize the TcpP-C218S mutant (or any other periplasmic cysteine mutant, data not 
shown). The hypersensitivity of TcpP-C207S to proteolytic degradation may indicate that 
formation of a disulfide bond by this residue partially masks the unknown proteolytic recognition 
site on TcpP, thereby enhancing TcpP stability.  
 Under inducing conditions TcpP is protected from degradation by TcpH, allowing it to 
induce expression of toxT (8, 20). When switched to non-inducing conditions, TcpP is cleaved 
by an unknown site-1 periplasmic protease. This results in further cleavage by YaeL and 
degradation of TcpP, thus decreasing induction of toxT (20). When the intramolecular disulfide 
in TcpP is disrupted, TcpP is also readily degraded by the YaeL pathway, even under inducing 
conditions (Fig. 5-5 and 5-7). This could be due to decreased interaction with TcpH and/or 
improper folding of the periplasmic domain. The periplasmic domain of the TcpP cysteine 
mutants is degraded by an unknown site-1 periplasmic protease resulting in production of TcpP*. 
In the presence of YaeL this intermediate form is cleaved and degraded, preventing detection of 
the increased levels of TcpP* except in a !yaeL background (Fig. 5-5B). YaeL is a site-2 
protease, and therefore is only active on previously cleaved substrates. DegS, a periplasmic 
! "%+!
Figure 5-7. A model for disulfide bond and TcpH-mediated protection of TcpP from 
degradation. The intramolecular periplasmic disulfide bond, along with TcpH, protects TcpP 
from degradation under TcpP-inducing conditions A) A model showing protection of wild-type 
TcpP under inducing conditions. TcpH protects TcpP from proteolysis by an unknown site-1 
protease and YaeL. B) When the intramolecular periplasmic disulfide bond in TcpP is disrupted, 
TcpH is no longer able to protect TcpP leaving it venerable to degradation by DegS and another 
yet to be identified site-1 protease. This allows for degradation by the membrane-localized 
protease YaeL.  
!
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protease which is the site-1 protease for YaeL in other systems (30), while not required for 
proteolytic degradation of wild-type TcpP (20), plays a partial role in degradation of TcpP 
lacking proper periplasmic disulfide bonds (Fig. 5-5C). This appeared to be particularly true for 
TcpP-C207S and TcpP-C218S, which are able to form intermolecular disulfide bonds. TcpP-
C207S/C218S, which is unable to form any periplasmic disulfide bonds, was poorly stabilized by 
deletion of degS. Although proteolysis of the TcpP periplasmic cysteine mutants points to 
instability in the periplasmic domain, deletion of the gene encoding the general protease typically 
responsible for degradation of misfolded periplasmic proteins, Ptd (43, 44), did not increase 
stability of the TcpP periplasmic cysteine mutants (Fig. 5-5D).  
 Disruption of the periplasmic disulfide bond of ToxR, a protein of similar structure to 
TcpP in V. cholerae, is reported to not affect stability (37). In a ToxR overexpression system, 
Ottemann and Mekalanos found a 30-fold decrease in CT production when they disrupted the 
periplasmic disulfide bond by mutating a periplasmic cysteine to serine (37). However, using a 
chromosomally-expressed allele, Fengler et al. recently found that mutation of both ToxR 
periplasmic cysteines prevented ompU expression and allowed enhanced ompT expression 
(ompU is activated by ToxR, while ompT is repressed by ToxR) (36), under similar growth 
conditions to the Ottemann and Mekalanos studies (LB medium). Furthermore, chromosomally-
expressed ToxR lacking both periplasmic cysteines still directed nearly wild-type levels of CT 
(36). Using chromosomally-expressed toxR alleles in the V. cholerae classical strain O395, we 
found that mutation of either periplasmic cysteine in ToxR resulted in a 20% decrease in ompU 
transcription activation, and mutation of both cysteines in ToxR resulted in a 40% decrease in 
ompU transcription activation in LB (Fig. 5-6), similar to the findings by Fengler et al. 
Disruption of the periplasmic disulfide bond in ToxR did not have much effect on toxT activation 
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when ToxR was expressed from its chromosomal locus, as we observed only a 20% defect in 
activation of toxT in all of our ToxR periplasmic mutants. This corresponded to no significant 
defect in CT production in any of the strains we tested, similar to the results found by Fengler et 
al. in both classical and El tor V. cholerae strains (36). Thus, although both ToxR and TcpP 
contain similar periplasmic intramolecular disulfide bonds, these disulfide bonds appear to play 
different roles in these proteins. In TcpP, the periplasmic disulfide bond is particularly critical for 
stability of TcpP and therefore expression of toxT and production of CT. The TcpP periplasmic 
intramolecular disulfide, in combination with TcpH, enhances stability, allowing TcpP to be 
present long enough to induce expression of toxT (Fig. 5-7). Because the periplasmic disulfide 
bond is critical for TcpP stability and therefore virulence expression, formation of these disulfide 
bonds may be a good candidate as a future target for anti-cholera therapeutics. 
 
Materials and Methods 
Bacterial strains and plasmids: All strains and plasmids used in this study are listed in Table 5-
2. Specific mutants were generated by site-directed mutagenesis using primers listed in Table 5-3 
and Pfu Turbo (Stratagene) followed by DpnI digestion as described previously (24). Plasmids 
containing the mutants were cloned into DH5!. The sequences of all constructs were verified at 
the University of Michigan sequencing core. Plasmids were then transferred to reporter strains. 
For chromosomal mutations, the sequence containing the mutation was cloned into the suicide 
plasmid pKAS32 (17). The plasmids were mated into V. cholerae and chromosomal 
recombination was selected as described previously (17). This same system was used to delete 
tcpP from the chromosome of various V. cholerae protease deletion strains. The locus encoding 
non-epitope-tagged TcpPH was digested from of pMMB207-tcpPH (pEK32, Table 5-2) using 
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Table 5-2. Strains and plasmids 
Strains Genotype/Characteristics Source 
E. coli  
 DH5$  supE44 DlacU169(F80lacZDM15) hsdR17 




supE44 DlacU169(F80lacZDM15) hsdR17 




   thi-1 thr leu tonA lacY supE recA::RP4-2- 
Tc::Mu KmR (lpir) 
Laboratory collection 
EK3034  Rosetta (DE3) pLysS: F- ompT hsdSB(RB- 
mB-) gal dcm %(DE3 [lacI lacUV5-T7 gene1 
ind1 sam7 nin5])  
  + pLysSRARE + pET30b+toxRcyt2-TEV 
this study 
V. cholerae  
O395 0395, wild-type Classical biotype Laboratory collection 
RY1           0395 !tcpP (6) 
EK459 O395 !toxR!tcpP (1) 
EK813      0395 !tcpP toxT-lacZ (5) 
EK1490   0395 !tcpP !toxR toxT-lacZ (5) 
SM269     0395 tcpP-C207S this study 
SM492     0395 tcpP-C218S this study 
SM495     0395 tcpP-C207S/C218S this study 
JM84       0395 !yaeL (20) 
JM128 0395 !degS (20) 
NB43 0395 !ptd (8) 
JM160 0395 !tcpPH !yaeL (20) 
SM1651 0395 !tcpP !degS this study 
SM1664 0395 !tcpP !ptd this study 
EK410     0395 !toxR ompU-lacZ (26) 
EK383     0395 ompU-lacZ (26) 
SM1301 0395 ompU-lacZ toxR-C224S this study 
SM1264 0395 ompU-lacZ toxR-C281S this study 
SM1303 0395 ompU-lacZ toxR-C224S/C281S this study 
EK733     0395 toxT-lacZ (12) 
EK1072  0395 !toxR toxT-lacZ (4) 
SM1299 0395 toxT-lacZ toxR-C224S this study 
SM1260  0395 toxT-lacZ toxR-C281S this study 
SM1263 0395 toxT-lacZ toxR-C224S/C281S this study 
EK307     0395 !toxR (1) 
SM488 0395 toxR-C224S this study 





pEK41 (pMMB207-tcpP-HSV) (1) 
pMMB207 (2) 
pMMB207-tcpP-HSV-C207S this study 
pMMB207-tcpP-HSV-C218S this study 
pMMB207-tcpP-HSV-C207S/C218S this study 
pSK-toxR-HA (4) 
pACYC184-tcpH (8) 
pTLI2 (pTL61T-toxTpro) (3) 
pEK32 (pMMB207-tcpPH) (1) 
pBAD18 (KanR)  (10) 
pBAD18-tcpPH (wt) this study 
pBAD18-tcpPH-C207S this study 
pBAD18-tcpPH-C218S this study 
pBAD18-tcpPH-C207S/C218S this study 
pKAS32  (17) 
pKAS32-tcpP-C207S this study 
pKAS32-tcpP-C218S this study 
pKAS32-tcpP-C207S/C218S this study 
pKAS32-!yaeL (20) 
pKAS32-!tcpP (1) 
pET30b+toxRcyt2-TEV this study 
!
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Table 5-3. Primers used in this study. 
toxR C224S top             CGTCAATCGAACTGTCCGTTAAAAAATACAATG 
toxR C224S bottom         CATTGTATTTTTTAACGGACAGTTCGATTGACG 
toxR C281S top           GATGCCATCAAAGTGTCTGAGCTCGAGTACCC 
toxR C281S bottom         GGGTACTCGAGCTCAGACACTTTGATGGCATC 
tcpP C207S top             CTATTGATCAACATCAGTCTTCCGTGAATTATG 
tcpP C207S bottom           CATAATTCACGGAAGACTGATGTTGATCAATAG 
tcpP C218S top            CAGAAGACATTAGAATCCACAAAAAATGCCCC 
tcpP C218S bottom       GGGGCATTTTTTGTGGATTCTAATGTCTTCTG 
toxR C281S chrom top GATGCCATCAAAGTGTCTGAGTAGgatcttgc 
toxR C281S chrom bottom GCAAGATCCTACTCAGACACTTTGATGGCATC 
tcpP C218S chrom top  CAGAAGACATTAGAATCCACAAAAAATTAAAAGC 
tcpP C218S chrom bottom GCTTTTAATTTTTTGTGGATTCTAATGTCTTCTG 
pBAD NoBAMH1 top GATTAGCGGATCGTACCTGACGCTTTTTATC 
pBAD NoBamH1 bottom GATAAAAAGCGTCAGGTACGATCCGCTAATC 
pBAD NoNhe1 top ACCCGTTTTTTTGGGCAAGCGAATTCGAGC 
pBAD NoNhe1 bottom GCTCGAATTCGCTTGCCCAAAAAAACGGGT 








NdeI-ToxR orf-1 Forw GGAATTCCATATGAGTCATATTGGTACTAAATTC 




EcoRI and BamHI and cloned into the EcoRI and BamHI sites in a pBAD18 (Kan) plasmid in 
which the second BamHI site and the NheI site at the upstream end of the multiple cloning site 
were removed by site-directed mutagenesis.  
Culture conditions: V. cholerae strains were routinely grown overnight in Vc LB (LB 
containing 5 g/L NaCl rather than 10 g/L) at 37oC. To induce virulence gene expression and 
promote tcpP expression and stability, all samples were assayed after induction in Vc LB pH 6.5 
at 30oC. Cultures were grown in the presence of 100 µg/ml ampicillin, 25 µg/ml 
chloramphenicol, 100 µg/ml streptomycin, and 30 µg/ml kanamycin as needed.  
!-galactosidase assays: Cultures were diluted from overnight growth in Vc LB at 37oC and 
induced at 30oC for 4 hours in Vc LB pH 6.5 with 100 µM IPTG (as required). To monitor 
induction from plasmid-based TcpP, the previously described reporter strains EK813 ("tcpP 
toxT-lacZ), EK1490 ("tcpP"toxR toxT-lacZ), (5) were used. For quantification of toxT 
expression directed by chromosomally-encoded tcpP, a plasmid containing a toxT-lacZ reporter 
was utilized (pTLI2, Table 5-2, (3)). 20-100 µl of culture was used to measure #-galactosidase 
activity as described previously (46). For quantification of ToxR activation of ompU-lacZ and 
toxT-lacZ, the chromosomal reporter strains EK383 and EK733 were used (12, 26). The OD600 
was determined by spectrophotometry and used to normalize cultures for subsequent Western 
blot analysis. 
Western blot: Samples were resuspended in SDS-PAGE sample buffer containing 1mM DTT 
adjusted for OD600 and boiled for 5 minutes before being loaded onto a 10% polyacrylamide gel. 
TcpP-HSV was detected using mouse monoclonal anti-HSV at 1:10,000 dilution (Novagen) or 
rabbit polyclonal anti-TcpP at a 1:500 dilution. ToxR was detected using rabbit polyclonal anti-
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ToxR antibodies at a 1:10,000 dilution. Alkaline phosphatase conjugated anti-mouse (Invitrogen) 
or anti-rabbit (Invitrogen) secondary antibody was used at a 1:3000 dilution.  
Production of rabbit anti-ToxR antibodies: Two rabbits were immunized by Covance with a 
purified form of ToxR-His6 containing the first 170 amino acids of the ToxR cytoplasmic 
domain (ToxRcyt2) followed by a TEV protease cleavage site and C-terminal 6xHis tag, 
according to standard procedures. ToxRcyt2-His6 protein was expressed and purified from the E. 
coli overexpression strain Rosetta (DE3) pLysS (Table 5-2) following cloning of toxRcyt2 into 
the pET30b+ vector (Novagen) via NdeI and KpnI restriction sites (Table 5-2 and 5-3). 
Non-reducing Western blot: 1:50 dilutions of overnight cultures were grown in Vc LB broth 
with 100 µM IPTG for 3 hours at 30oC. 1 ml of culture was treated on ice for 15 min with 10 µM 
iodoacetamide (Sigma) to block free cysteines before being pelleted. The OD600 of the culture 
was used to determine the appropriate volume of SDS sample buffer with or without DTT for 
resuspension. Samples were analyzed by Western blot as described above.  
Immunoprecipitation and Mass Spectrometry: Membranes containing TcpP-HSV were 
prepared as previously described (13) and boiled for 5 min in 1% SDS. Samples were diluted 
1:100 in 50 mM Tris pH 7.4, 300 mM NaCl, 1% Triton X-100 and centrifuged to remove any 
precipitates. Mouse monoclonal anti-HSV (Novagen, 1:500 dilution) was used to bind TcpP-
HSV to protein A/G agarose beads (CalBiochem). After washing, the beads were resuspended in 
sample buffer +/- DTT. Samples were analyzed by Western blot and Coomassie and select bands 
were removed and analyzed by mass spectrometry by the University of Michigan Proteomics 
Consortium. 
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TcpP stability in protease deletion strains: Cultures were induced for 16 hours in Vc LB pH 
6.5 with 0.25% arabinose at 30oC. Samples were adjusted for OD600 and analyzed by Western 
blot using the antibody against TcpP as described above.  
ELISA for cholera toxin production: ELISAs for CT were performed as described previously 
(1, 47). The supernatant from induced cultures was allowed to bind to GM1 ganglioside-coated 
wells in a 96 well plate. Bound CT was then detected using an anti-CT primary antibody and 
anti-rabbit-AP conjugate secondary antibody. Color development of the substrate para-
Nitrophenylphosphate (pNPP) was measured after 20 min and the average of 2 replicate wells 
was used to determine CT content for each sample. 
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 The goal of this study was to understand how ToxR and TcpP co-activate transcription of 
toxT, and therefore virulence gene expression in V. cholerae. In order to do this, one of the 
critical questions that needed to be answered was how ToxR and TcpP bind to and interact on the 
toxT promoter. We identified a direct repeat on the toxT, ompU, ompT, and ctxA promoters that is 
bound by ToxR and required for ToxR-dependent regulation of these promoters. ToxR binding 
to a direct repeat is consistent with the tendency of ToxR to dimerize (3-6). Furthermore, we 
found that the ToxR-binding site is three helical turns upstream of the promoter proximal TcpP-
binding site on the toxT promoter. This brings into question whether ToxR and TcpP are able to 
interact while on the promoter. To better understand the role of ToxR in transcriptional 
activation, we investigated the dual role of ToxR as a direct activator of transcription of ompU, 
and as a co-activator of transcription of toxT. Two residues in the !-loop of ToxR are 
preferentially required for transcriptional activation of ompU. This is consistent with the role of 
the !-loop of other w-HTH proteins interacting with the RNA polymerase (7, 8). Both the DNA-
binding helix (!3) and the wing of ToxR are required for DNA binding and therefore 
transcriptional activation. Although the wing of many w-HTH family members is involved in 
protein-protein interaction, no residues in the wing of ToxR were found that were required for 
ToxR-TcpP interaction. Finally, we investigated the importance of the 
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intramolecular disulfide bond in the periplasmic domain of TcpP on stability and therefore 
activation of toxT. Disruption of the periplasmic disulfide, particularly by the TcpP-C207S 
mutation, resulted in an increase in the YaeL mediated stepwise proteolysis of TcpP. This results 
in TcpP instability, even under inducing conditions. Together this new information gives us 
insight into how ToxR and TcpP interact, bind to the toxT promoter, and activate transcription.  
 
Promoter Architecture 
ToxR binds to the toxT promoter three helical turns upstream of the TcpP-binding site. 
One of the keys to understanding how toxT transcription is activated is to understand the 
promoter architecture. Previous studies showed that TcpP binds to a promoter proximal direct 
repeat spanning from -53 to -38 (7, 9). The footprint of ToxR spanned from -104 to -68, partially 
encompassing an inverted repeat (from -94 to -78 and -73 to -58) (10, 11). However, mutational 
analysis indicates that ToxR actually binds to a direct repeat within the footprinted region from -
93 to -83 (Fig. 2-1 and 2-3)(12). There is a non-consensus ToxR-binding site in the opposite 
orientation (from -69 to -56), however ToxR does not appear to bind this site (Fig. 2-5). The 
discovery of the ToxR-binding site from -93 to -83 places the ToxR-binding site three helical 
turns upstream of the TcpP-binding site. This makes it unlikely that the w-HTH domains of 
ToxR and TcpP can interact with each other while bound to the promoter. However, the ToxR 
and TcpP-binding sites are spaced on the toxT promoter such that they are both on the same face 
of the DNA. This would allow membrane-localized ToxR and TcpP to simultaneously bind the 
promoter. Because ToxR and TcpP require membrane localization to co-activate transcription of 
toxT (13, 14), it has been hypothesized that ToxR recruits the toxT promoter to the membrane, 
thereby bringing it to TcpP. Due to spatial constrictions, it would be difficult for this to occur if 
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ToxR and TcpP did not bind to the same face of the DNA. Additionally, we have shown that the 
ToxR-binding site can be moved two helical turns upstream or downstream without disrupting 
transcriptional activation of toxT (Fig. 2-6). Further work is required to determine if the ToxR-
binding site can be moved further from the TcpP-binding site, and if ToxR and TcpP must be 
bound to the same face of the DNA to allow for transcriptional activation.  
 One of the roles of ToxR is to bind to the toxT promoter and relieve H-NS repression 
(15). Truncation of the toxT promoter shows that the majority of the H-NS repression occurs 
upstream of -172 (15). However, in E. coli, the toxT promoter fragment from -172 to +45 is 
repressed approximately 2-fold by H-NS (15), indicating that H-NS can bind to this portion of 
the promoter, although the majority of H-NS recognition sites are further upstream. Based on this 
information it can be hypothesized that ToxR binds to the toxT promoter at the promoter 
proximal end of the H-NS bound region. Binding by ToxR to the toxT promoter would displace 
H-NS from this region, likely resulting in a cascade of H-NS released from the promoter, and 
decreased repression of toxT. More work is required to understand where H-NS binds to the toxT 
promoter, and determine if this binding site does overlap with the ToxR and/or TcpP-binding 
sites.  
 Another hypothesized role for ToxR co-activation of the toxT promoter is to bend the 
DNA, resulting in increased accessibility of the TcpP-binding site. ToxR binding to the toxT 
promoter results in a DNAse I hypersensitivity overlapping the TcpP-binding site (10). 
Furthermore, other w-HTH proteins have been observed to bend the DNA due to insertion of the 
DNA-binding helix (!3) into the major groove and the wing into the minor groove (1). Moving 
the ToxR-binding site relative to the TcpP-binding site on toxT does result in approximately a 
20% defect in transcriptional activation of this promoter. This may be due to the ToxR induced 
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bend in the toxT promoter no longer being in the appropriate location to expose the TcpP-binding 
site. This could be confirmed by DNAse I footprinting of toxT promoters with the ToxR-binding 
site moved relative to the TcpP-binding site. One important question that still needs to be 
addressed is to determine if ToxR binding to the toxT promoter enhances TcpP binding. 
Traditionally, this would be determined by looking for supershifting of the toxT promoter by 
EMSA assay, however supershifting by two transmembrane proteins cannot be observed in this 
assay due to retention of membrane-localized proteins in the well. Therefore, ToxR facilitation 
of TcpP binding of the toxT promoter must be tested with a cytoplasmic form of ToxR. Such 
reagents are currently being developed for these studies. 
 
ToxR-binding sites are found in two different orientations on ToxR-regulated promoters. It 
is also important to examine how the orientation and binding site location differs between ToxR-
regulated promoters to provide insights concerning the different roles of ToxR. ToxR is a co-
activator that facilitates TcpP-mediated activation of toxT, a direct activator of ompU and ctxA, 
and a repressor of ompT. On the toxT promoter, where ToxR is a co-activator, ToxR binds to a 
single direct repeat in the orientation TNAAA-N5-TNAAA (Fig. 2-1)(Fig. 6-1), three helical 
turns upstream of the TcpP-binding site. Similarly, ToxR binds to two sets of direct repeats on 
the ompU promoter in the same orientation as the toxT promoter (TNAAA-N5-TNAAA) five and 
seven helical turns upstream of the promoter proximal ToxR-binding site on the ompU promoter 
(Fig. 2-7 and 6-1). However the promoter proximal ToxR-binding site of the ompU promoter, 
which is required for transcriptional activation (Fig. 2-7), is in the opposite orientation (TTTNA-
N5-TTTNA) (Fig. 6-1). The promoter proximal ToxR-binding site of ctxA is also in this 
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Figure 6-1. Orientation of ToxR binding-sites on ToxR regulated promoters. ToxR-binding 
sites are shown as orange pentagons indicating the orientation of the ToxR sequence (TNAAA 
sequences have the point towards the promoter and TTTNA sequences have the point facing 
away from the transcriptional start site. An X above a ToxR-binding site indicates a site we have 
shown to be required for ToxR binding and ToxR-dependent regulation (Chapter 2). Blue boxes 
indicate TcpP-binding sites. Location of ToxR and TcpP binding sites relative to the 
transcriptional start site (indicated with an arrow and +1) are designated below each promoter. 
!
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orientation (TTTNA), indicating that ToxR must bind to the promoter in a specific orientation in 
order to directly activate transcription. However, the ctxA promoter does not contain any ToxR-
binding sites in the co-activation orientation (TNAAA), but instead contains multiple repeats of 
the ToxR-binding site in the direct activator orientation (TTTNA) with non-consensus spacing 
(N2 between repeats) (Fig. 6-1). The combination of the non-consensus spacing and the lack of a 
co-activation oriented ToxR-binding site may explain why ToxR only activates this promoter 
under over-expression conditions (16). The ompT promoter is repressed by ToxR, and contains 
two ToxR-binding sites in the TTTNA-N5-TTTNA orientation (Fig. 2-9 and 6-1). The promoter 
proximal ToxR-binding site spans from -47 to -33, placing ToxR on top of the -35 element, and 
likely resulting in disruption of RNAP binding when ToxR is bound. Since all of the promoters 
that are directly activated by ToxR contain a promoter proximal ToxR-binding site in the 
TTTNA-N5-TTTNA orientation, it is likely that this orientation is required for ToxR activation, 
presumably because it places ToxR in the correct orientation to interact with RNAP. More 
research is needed to determine if the more promoter distal ToxR-binding sites are able to co-
activate transcription in either orientation. Additionally, crystal structures of ToxR bound to the 
ToxR recognition sequence should be used to determine the orientation with which ToxR binds 
to these promoters.  
 
ToxR and TcpP structure and function 
The hydrophobic core of w-HTH proteins is conserved in ToxR. Much of the structure and 
function of the cytoplasmic w-HTH domain of ToxR and TcpP can be hypothesized based on the 
structure and function of other w-HTH proteins. The hydrophobic core of w-HTH proteins is 
primarily comprised of residues in the "-sheet, the three !-helixes, and the wing (Fig. 6-2). The 
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Figure 6-2. Model of ToxR w-HTH residues by function. Putative ToxR residues comprising 
the hydrophobic core are shown in purple. B) ToxR residues required for DNA binding and 
transcriptional activation are shown in yellow for putative DNA backbone contacts and red for 
putative contacts with DNA bases (based on PhoB contacts with DNA) (1, 2). C) ToxR residues 
preferentially required for ompU activation are shown in green. D) Alignment of the ToxR, 
TcpP, PhoB, and OmpR w-HTH domain. ToxR residues in A, B, and C are highlighted with the 
same colors as in the above figures. PhoB and OmpR hydrophobic (purple) and DNA contact 
(yellow for backbone contacts and red for base contacts) are highlighted (1, 2, 7). 
!
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hydrophobic core maintains w-HTH structure and likely positions the DNA-binding helix (!3) 
and the wing in the proper orientation to bind to DNA (17). Although our mutational screens 
were not designed to identify hydrophobic core residues, we have found four mutants (ToxR-
L83P, V97A, Y105A, and L107A) that we believe disrupt the hydrophobic core since these 
residues correspond to the hydrophobic core of OmpR and PhoB. One of the hydrophobic core 
residues in the DNA-binding helix of OmpR and PhoB corresponds to ToxR-L83. The three 
residues in the wing of PhoB and OmpR that are part of the hydrophobic core correspond to 
three residues in the wing of ToxR (ToxR-V97A, ToxR-Y105A, and ToxR-L107A) that are 
required for DNA binding, transcriptional activation, and stability. As would be expected, the 
four putative hydrophobic core mutants are defective for DNA binding and transcriptional 
activation (Fig. 3-1, 3-3, 4-2, and 4-7). Further evidence that these residues are involved in the 
hydrophobic core of ToxR is that mutation of any of these residues results in ToxR instability. 
Additionally, all of these residues are pointed inwards in the ToxR model (Fig. 6-2A). 
 
DNA binding by ToxR is primarily mediated by the DNA-binding helix (!3) and the wing. 
Our screens for ToxR transcriptional activation mutants have identified several residues that we 
believe to directly contact DNA. Mutation of residues required for DNA binding prevents 
transcriptional activation, of both ompU and toxT since these promoters contain identical or 
nearly identical ToxR-binding sites (Fig. 2-1 and 2-7). Unlike mutation of the hydrophobic core 
residues, mutation of DNA binding residues does not affect ToxR stability. The majority of 
residues that come into direct contact with DNA are in the DNA-binding helix (!3) and the wing 
of w-HTH proteins, as these features insert into the major and minor groove of the DNA, 
respectively (1, 2). However, additional contact sites occur where the !1 and !2 helixes and the 
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!-loop contact the backbone of the DNA. Three residues of ToxR have been found in the !1 
helix, the !2 helix, or the !-loop that correspond to PhoB residues that contact the backbone of 
promoter DNA. Mutation of any of these residues (ToxR-E39K, R56K/L, V71A) resulted in 
decreased DNA binding to both the ompU and toxT promoters (Fig. 3-3 and 3-4) although, two 
of the mutants (ToxR-E39K and ToxR-V71A) were only modestly defective for promoter 
binding. ToxR-E39K was able to fully activate transcription of toxT, but was only able to 
activate transcription of ompU at 19% of wild-type (Table 3-1). ToxR-V71A was approximately 
4 fold more defective for ompU activation than toxT activation, but was defective in activating 
both promoters (Fig. 3-1). Because these mutants were preferentially defective for activation of 
ompU relative to toxT, these backbone interactions may be more critical for ompU activation. 
Alternatively, this could be an artifact of the ToxR overexpression system used to analyze these 
mutants.  
 The DNA-binding helix (!3) and the wing of w-HTH proteins sit in the major and minor 
grooves, respectively, and both regions can interact with the DNA backbone and the nucleotide 
bases. We have found three residues, one in the DNA-binding helix (ToxR-R84) and two in the 
wing (ToxR-G104 and ToxR-Y105) that correspond to residues in PhoB that contact the DNA 
backbone (Fig. 6-2). These residues are required for DNA binding and transcriptional activation 
of both the toxT and ompU promoters Fig. 3-4, 4-2, 4-7 and Table 3-1). We found three residues, 
two in the DNA-binding helix (ToxR-S75 and ToxR-Q78) and one in the wing (ToxR-T99), 
which correspond to PhoB residues that interact directly with the nucleotide bases of the DNA. 
Mutation of any of these residues also prevents DNA binding and transcriptional activation of 
ompU and toxT (Fig. 3-1, 3-3, 3-5, 4-2, 4-7 and Table 3-2). Additionally, ToxR-K102A is 
positioned at the tip of the wing, similar to PhoB-R219, which protrudes from the tip of the wing 
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into the minor groove of the promoter to make base specific contacts. ToxR-K102 is modeled to 
protrude from the tip of the wing and is required for DNA binding and transcriptional activation 
of ompU and toxT (Fig. 4-2, 4-4, and 4-7). Although these two residues are in slightly different 
locations on the tip of the wing, it is likely that they both bind DNA in a similar manner. All of 
the ToxR residues hypothesized to make contact with the DNA are oriented towards the DNA in 
the ToxR model (Fig. 6-2B) further indicating that these residues likely interact with the DNA, 
however a crystal structure of ToxR bound to DNA would confirm this. 
 
Direct activation of the ompU promoter. ToxR directly activates transcription at the ompU 
promoter, but does not directly activate transcription at the toxT promoter. We can use this to 
identify residues that are particularly required for direct activation, and therefore possibly 
involved in ToxR-RNAP interaction. Three ToxR mutants were identified that are preferentially 
defective for ompU activation compared to toxT activation (ToxR-E39K, ToxR-F69A, and 
ToxR-V71A). Surprisingly, two of these mutants (ToxR-E39K and ToxR-V71A) map to 
residues that correspond to PhoB residues that interact with the backbone of the promoter, and 
have modest defects on DNA binding. However, all three of these residues are modeled to point 
towards the same region of the w-HTH domain (Fig. 6-2C). Mutation of either of these residues 
does result in decreased DNA binding on both the ompU and toxT promoters, despite being 
preferentially defective for activation of the ompU promoter. ToxR-F69A maintains DNA 
binding activity on both the ompU and toxT promoters. It is tempting to speculate that ToxR-F69 
interacts with RNAP, since it is not involved in DNA binding, but is required for direct 
activation of the ompU promoter, and it is in the !-loop of the w-HTH domain, which is 
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presumed to interact with RNAP ("(). However, further study is required to confirm this 
hypothesis. 
 
The wing of ToxR is not required for ToxR interaction with TcpP. Based on the interaction 
of other w-HTH proteins, ToxR and TcpP might interact in four different orientations: ToxR N-
terminal "-sheet to TcpP N-terminal "-sheet, ToxR N-terminal "-sheet to TcpP wing, ToxR wing 
to TcpP N-terminal "-sheet, or ToxR wing to TcpP wing. A previous study identified mutations 
in the wing of TcpP that disrupt ToxR-TcpP interactions indicating that ToxR and TcpP interact 
either via ToxR "-sheet to TcpP wing or ToxR wing to TcpP wing (18). However, we found that 
no residue in the wing of ToxR is required for ToxR-TcpP interaction (Fig. 4-5 and 4-6), leading 
us to hypothesize that ToxR-TcpP interaction occurs between the N-terminal "-sheet of ToxR 
and the wing of TcpP. Based on the tendency of ToxR and TcpP to form homodimers (Morgan, 
unpublished)(Fig. 5-1)(3-6) it is likely that oligomers of ToxR and TcpP occur with a ToxR 
dimer interacting with a TcpP dimer. Despite multiple mutational screens of ToxR (Chapter 3 
and 4), no ToxR mutant has been found that is defective for ToxR-TcpP interaction. However, 
no mutations in the ToxR N-terminal "-sheet, which we now hypothesize to be the region of 
ToxR involved in ToxR-TcpP interaction, have been characterized at this time. 
 
Periplasmic cysteines in both TcpP and ToxR form intramolecular disulfide bonds. It is 
challenging to predict structure/function relationships of the periplasmic domains of ToxR and 
TcpP since these domains are not homologous to other known proteins. The periplasmic domain 
of TcpP, along with TcpH, is primarily involved in regulating stability of TcpP. Under inducing 
conditions TcpH protects the periplasmic domain of TcpP, preventing degradation (13). 
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However, under non-inducing conditions TcpP is proteolytically cleaved in a stepwise fashion, 
first by a site-1 protease and then by YaeL (19). We have shown that the periplasmic domain of 
TcpP contains two periplasmic cysteines, which form an intramolecular disulfide bond. Mutation 
of a single cysteine (TcpP-C207S or TcpP-C218S) results in formation of an intermolecular 
disulfide bond (Fig. 5-1), however this disulfide bond is not able to protect TcpP from 
proteolysis as effectively as the intramolecular disulfide bond, particularly when TcpP-C207 is 
mutated (Fig. 5-3). This instability appears to be the result of an increase in the stepwise 
proteolysis TcpP undergoes under non-inducing conditions because deletion of the protease 
YaeL results in accumulation of TcpP cysteine mutants in the TcpP* form, which has been 
cleaved by the site-1 protease, but not fully degraded (Fig. 5-5) (19). Yang et. al. found no defect 
in stability of TcpP when either or both periplasmic cysteines were mutated in V. cholerae El Tor 
strains, however this may have been due to their use of a C-terminal FLAG tag.  Furthermore, 
they observed intermolecular disulfide bonds only in the presence of bile or upon mutation of 
TcpP-C218 (20). The absence of an intermolecular disulfide bond correlated to an decrease in 
transcriptional activity (20), however this may have been due to instability of TcpP-C207S in the 
absence of a C-terminal tag similar to our observations (Fig. 5-3). 
The periplasmic domain of ToxR has long been hypothesized to sense environmental 
conditions, but this hypothesis has never been confirmed. The periplasmic domain of ToxR 
appears to be involved in ToxR dimerization (21), although the cytoplasmic domain of ToxR is 
able to dimerize independently of the periplasmic domain (3-5). As was found with TcpP, ToxR 
forms intramolecular disulfide bonds, and disruption of this disulfide by mutation of either 
periplasmic cysteine results in formation of an intermolecular disulfide bond (Fig. 5-6) (22). 
Unlike with TcpP, the periplasmic intramolecular disulfide bond of ToxR is not required for 
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stability. Furthermore, mutation of either ToxR periplasmic cysteine does not result in a dramatic 
decrease in transcriptional activation of ompU or toxT or a decrease in CT production (Fig. 5-6). 
Under inducing conditions in minimal media, disruption of the ToxR periplasmic disulfide 
results in a partial defect in activation of ompU and repression of ompT, however this defect was 
not detected when the same strains were grown in inducing (AKI) conditions in rich media (23).  
Since the ToxR periplasmic disulfide bond is required for ToxR activity only under specific 
conditions, it is possible that this disulfide bond is part of an environmental signaling system.  
However, understanding of ToxR responsiveness to environmental signals has been obscured 
historically by laboratory induction conditions, which do not reflect in vivo conditions.   
 
Transcriptional activation of the virulence cascade 
At the beginning of this study we proposed three possible models for how ToxR co-
activates transcription of toxT with TcpP, two of which were dependent on ToxR-TcpP 
interaction (Fig. 1-3). In the “hand-holding model” ToxR-TcpP interaction is maintained on the 
promoter, helping to position TcpP on the toxT promoter. However, we have found that ToxR 
binds to the toxT promoter three helical turns upstream of the TcpP-binding site. It is therefore 
unlikely that the w-HTH domains of ToxR and TcpP are able to interact while both ToxR and 
TcpP are bound to the promoter. Furthermore, moving the ToxR-binding site two helical turns 
upstream or downstream does not dramatically reduce transcriptional activation of toxT, even 
though this would potentially disrupt any ToxR-TcpP interaction maintained on the promoter. 
We cannot rule out interaction between the periplasmic domains of ToxR and TcpP, however, 
mutational analysis of TcpP indicates that the wing of TcpP is required for ToxR-TcpP 
interaction (18). Additional evidence against the “hand-holding model” is that residues in the 
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wing of TcpP are required for both ToxR interaction and DNA binding (18) indicating that TcpP 
likely interacts with ToxR and the toxT promoter sequentially, not simultaneously.  
The second model for ToxR co-activation of the toxT promoter is the “catch and release” 
model in which ToxR-TcpP interaction recruits TcpP to the toxT promoter, but ToxR-TcpP 
interaction is released upon DNA binding (Fig. 1-3). Based on the lack of identification of any 
ToxR wing residues that are required for ToxR-TcpP interaction, we propose that ToxR-TcpP 
interaction occurs between the N-terminal "-sheet of ToxR and the wing of TcpP. Several 
mutations in the wing of TcpP have been previously identified that disrupt ToxR-TcpP 
interaction (18). However, mutation of these residues also disrupts binding to the toxT promoter 
(18). Since TcpP binding to DNA is required for transcriptional activation (9), we are unable to 
determine if transcriptional activation defects by these TcpP mutants are due only to DNA 
binding defects or due to a combination of DNA binding defects and ToxR-TcpP interaction 
defects. Although it is possible that ToxR-TcpP interaction is only an artifact of similarities 
between the structures of ToxR and TcpP, it is likely that ToxR-TcpP interaction aids in 
transcriptional activation of toxT. Identification of ToxR mutants defective for TcpP interaction, 
but competent for DNA binding will be required to test this hypothesis. 
 The third model for ToxR co-activation of the toxT promoter is the “promoter 
modification model” in which ToxR binding to the toxT promoter modifies it, thereby enhancing 
TcpP binding (Fig. 1-3). One way that this occurs is by ToxR recruitment of the toxT promoter to 
the membrane. Evidence for this mechanism is that ToxR membrane localization is required for 
TcpP-mediated transcriptional activation of toxT, but not transcriptional activation of ompU or 
repression of ompT, both of which are TcpP independent (14). This is consistent with our finding 
that ToxR and TcpP-binding sites are on the same face of the toxT promoter and therefore likely 
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both face the membrane. Additionally, ToxR relives H-NS repression (15). H-NS repression of 
A/T rich DNA is a common method of repressing foreign DNA (24), so it is not unexpected that 
the toxT promoter, which was likely acquired from a mobile genetic element (25) is regulated in 
this manner. Finally, ToxR likely bends the DNA to expose the TcpP-binding site. ToxR binding 
to the toxT promoter results in a DNAse I hypersensitivity site corresponding to the TcpP-
binding site (10). Since w-HTH protein binding can introduce curvature into the DNA (1), it is 
likely that ToxR binding to the toxT promoter introduces a curvature into the promoter thereby 
exposing the TcpP-binding site. All of these modifications are dependent on ToxR binding to the 
toxT promoter, but independent of ToxR-TcpP interaction. Since ToxR binding to the promoter 
is required for toxT activation, it is likely that all three of these mechanisms are critical for ToxR 
co-activation of toxT. 
 Based on these findings, it is likely that ToxR co-activation of toxT occurs as a 
combination of the “catch and release” and “promoter modification” models. When V. cholerae 
is in the aquatic environment, the virulence cascade is turned off and the toxT promoter is 
repressed by H-NS. Upon ingestion of V. cholerae, environmental signals induce expression of 
tcpP and possibly increase activity of ToxR (Fig. 1-1). The N-terminal "-sheet of ToxR interacts 
with the wing of TcpP, recruiting TcpP to the toxT promoter. ToxR binding to the toxT promoter 
releases ToxR-TcpP interaction, relieves H-NS repression, brings the toxT promoter to the inner 
membrane, and bends the DNA to expose the TcpP-binding site. This enables TcpP binding to 
the toxT promoter and transcriptional activation (Fig. 4-8). 
 Activation of toxT by ToxR and TcpP represents a decision point for V. cholerae.  
Environmental signals from a variety of sources coalesce to activate ToxR and expression of 
tcpP.  Upon activation of these two transcription factors the gene encoding the master virulence 
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regulator (toxT) is induced allowing for intestinal colonization and secretion of cholera toxin.  
Because activation of both ToxR and TcpP is required to activate the virulence cascade 
virulence, gene expression only occurs under specific conditions, making this a carefully 
regulated system. The majority of virulence genes in V. cholerae are encoded in two 
pathogenicity islands, one of which encodes genes for TcpP, ToxT and TCP and the other 
encodes the genes for cholera toxin and the CTX phage.  TcpP does not appear to regulate 
expression of any other genes besides toxT. ToxR is present in environmental non-toxigenic, 
Vibrio spp. and regulates expression of the outer membrane porins ompU and ompT in addition 
to toxT.  It is likely that ToxR regulation of toxT is an adaption that allows for tighter regulation 
of the toxT promoter and therefore both pathogenicity islands. By cooperative activation of toxT, 
the virulence genes in V. cholerae can be carefully regulated and only activated under the 
appropriate environmental conditions. 
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